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Abstract
Introduction. The disruption of electrotonic interactions between cells is observed
in heart failure as a result of cellular uncoupling. This disruption may unmask
intrinsic dispersion of repolarisation. It is know that inhomogeneities in the
recovery of excitability and restitution properties may be arrhythmogenic. Cellular
uncoupling may be experimentally induced by gap junction uncouplers such as
I-heptanol and carbenoxolone.
Aims. The aim of this study was to study the electrophysiological and mechanical
effects of the gap junction uncoupler l-heptanol in the left ventricle (epicardial
surface) of the artificially perfused Langendorff rabbit heart. Specifically,
electrical restitution and the dispersion of repolarisation were studied.
Methods. Using a single monophasic action potential (MAP) electrode, in the
healthy and failing (coronary ligated) heart, the effect of I-heptanol was studied on
rate dependent changes in action potential duration. Dispersion of repolarisation
was measured sequentially.
A 32 MAP electrode array was developed to simultaneously record dispersion of
repolarisation from the epicardial surface of the left ventricle of healthy hearts.
Restitution was studied using an extrastimulus protocol that involved electrically
stimulating the heart with 16 S I stimuli (350ms intervals), and an extrastimulus S2.
SI-S2 interval was increased progressively from 70 to 600ms. SI-S2 changes of
Sms were made between 70 and ISOms, IOms between 150 and 3S0ms, and 50ms
between 350 and 600ms. Protocols were run at 37°C, initially in Tyrode's solution,
then after addition of 0.3mM l-heptanol,
Results. The single catheter study showed that failure significantly (P<0.05)
prolongs MAP duration between cycle lengths of 250ms and 650ms. No base to
apex changes, changes in dispersion of repolarisation or ventricular fibrillation
thresholds were observed. l-Heptanol, at cycle lengths above 350ms, significantly
(P<0.05) decreased MAP duration in failing and healthy hearts. l-Heptanol
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however did not alter the dispersion of repolarisation or ventricular fibrillation
threshold in healthy and failing hearts.
The last SI MAP in the 16 beat train and the S2 MAP obtained using the 32
electrode array were analysed at 90% repolarisation (MAPD90). S2 MAPD90
increased with S I-S2 interval up to -180ms but decreased at longer intervals.
0.3mM l-heptanol exacerbated this negative slope in the restitution curve from
(mean±SEM) -0.031±O.004 in Tyrode's compared to -O.063±O.005 in O.3mM 1-
heptanol (P<O.OOI). Dispersion of repolarisation was increased (p>O.05) in the
presence of O.3mM l-heptanol. Conduction delay was increased from
(mean±SEM) 44.2±0.82ms to 49.2±O.87ms (P<O.OOI).
The possibility of an effect on the single cell being the mechanism behind the
exacerbation of the negative slope by l-heptanol was investigated in a single cell
study. The effect of l-heptanol on single cell fractional shortening and Ca2+
handling was examined. At 1 and 3Hz l-heptanol decreases fractional cell
shortening from (mean±SEM): at 1Hz 9.3±0.8% in Krebs to 5.7±O.7% (O.03mM 1-
heptanol), 5.6±O.9% (O.lmM l-heptanol) and 3.2±0.8% (O.3mM lheptanol)
(P<O.Ol); at 3Hz lO.6±O.8% in Krebs to 6.S±1.4% (O.03mM l-heptanol), 7.7±1.4%
(O.lmM l-heptanol) and 4.7±l.S% (O.3mM l-heptanol) (P<O.Ol). The negative
inotropic (Le. the reduction in contractility) effect of I-heptanol indicated that this
agent is not a specific gap junction uncoupler. SR ci+ release was reduced at 3Hz
only by (mean±SEM) 7.8±O.04% (O.03mM l-heptanol), 5.0±0.03% (O.lmM 1-
heptanol) and 7.9±O.02% (P<O.OS), indicating an effect on the L-type Ca2+ channel
or ryanodine receptor.
The effect on the L-type Ca2+ channel was investigated by the use of nifedipine
firstly in single cells then in the whole heart. Nifedipine decreased single cell
fractional shortening at 1Hz from (mean±SEM) 8.9±O.7% in Krebs to S.8±O.7%
(O.lJ,tM nifedipine), 3.4±O.9% (O.l5J,tM nifedipine, P<O.OOI)and O.8±O.2% (O.2JlM
nifedipine, P<O.OOl). SR Ca2+ release was also reduced from (mean±SEM)
O.75±O.017% in Krebs to O.72±O.024% (O.IJlM nifedipine), O.73±0.024% (O.l5JlM
nifedipine), O.71±O.016% (O.2J,tM nifedipine) (P<O.OS). In the whole heart
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nifedipine did not induce a negative slope in the restitution curve indicating no role
of the L-type Ca2+ channel in this phenomenon.
Carbenoxolone, a novel specific gap junction uncoupler failed to induce a negative
slope in the electrical restitution curve of the whole heart. but did increase
dispersion of repolarisation (P>0.05) and caused a significant conduction slowing
from (mean±SEM) 45.50±2.I2ms in Tyrode to 55.11±2.82ms in carbenoxolone
(P<0.05). Carbenoxolone has an inconsistent effect on single cell fractional
shortening and Ca2+ handling.
Conclusions. The biphasic relationship and the increased dispersion of
repolarisation in the presence of 0.3mM I-heptanol may have implications for the
development of alternans and/or arrhythmias (Gilmour and Chialvo, 2000). The
cause of the negative slope is as yet unknown. but it is likely that it is an effect on
the single cell rather than gap junction uncoupling.
Key words: L-heptanol, gap junction uncoupling, carbenoxolone, nifedipine,
restitution, Ca2+, heart failure, fractional shortening,
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Aims and objectives
The initial aim of the study was to investigate the electrophysiology of the whole
heart using a single monophasic action potential (MAP) contact catheter electrode.
Left ventricular epicardial MAP reordings were obtained from healthy and failing
Langendorff perfused rabbit hearts. Dispersion of repolarisation was mapped
sequentially. Using the gap junction uncoupler I-heptanol it was the aim to
compare the instrinsic dispersion of repolarisation from healthy and failing hearts
using a steady state restitution protocol.
The sequential recording of electrical activity is limited in accuracy. A further aim
of this study was to develop and construct a method of simultaneously recording up
to 32 MAPs from the epicardial surface of the left ventricle. Due to restrictions in
the use of the electrode array in failing hearts and the apparent induction of a
negative slope in the electrical restitution (extrastimulus protocol) curve by the gap
junction uncoupler l-heptanol, the focus of the study changed. The mechanism by
which the (non-specific) gap junction uncoupler I-heptanol induced a negative
slope in the restitution curve became the primary aim of the study.
The negative inotropic effect of I-heptanol indicated that I-heptanol may have an
effect on single cell Ca2+ handling. The effect of I-heptanol on single cell fractional
shortening and Ca2+ handling was investigated. Nifedipine was also used in these
cells with the intention of investigating the effect of partial L-type Ca2+ channel
blockade on the slope of the restitution curve in the whole heart.
Whole heart and single cell studies were also undertaken with the novel specific
gap junction uncoupler carbenoxolone. The aim of this section of the study was to
determine whether the induction of a negative slope in the restitution curve is
attributable to gap junction uncoupling or to other mechanisms.
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1.1 Introduction
This introductory chapter deals primarily with the dispersion of cardiac ventricular
repolarisationirefractoriness and also electrical restitution and their consequent
effects on arrhythmogenesis. The effect of electrotonic interactions and the
uncoupling of cells on the dispersion of repolarisation are all addressed. It is know
that cardiac arrhythmias can be due to inhomogeneities in the recovery of
excitability and restitution, and that this in itself may be a result of the disruption of
electronic interactions by gap junction uncoupling.
1.2 Dispersion of ventricular repolarisation/refractoriness
In early studies by Han and Moe (1964) dispersion of refractoriness was described
as a measure of the non-uniform recovery of excitability in the myocardium. In a
separate study Han, Garcia Delalon and Moe (1964) established a connection
between non-uniform recovery of excitability and a reduction in fibrillation
threshold. They concluded that whether the average refractory period was
increased or decreased, agencies found to favour the development of ventricular
fibrillation were found to increase the temporal dispersion of recovery of
excitability.
In normal atrial or ventricular tissue refractoriness is proportional to the duration of
repolarisation, whereas in the diseased or otherwise altered myocardium the
recovery of excitability may lag behind repolarisation. Activation times,
refractoriness and action potential duration all determine the dispersion of
refractoriness. If dispersion of activation times remain constant then the dispersion
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of refractoriness is greater at faster heart rates. Kuo et al (1983) found that in dog
hearts a five-fold increase in dispersion of refractoriness did not induce arrhythmia,
however it did facilitate arrhythmia induction by premature stimulus.
Han & Moe (1964) showed that non-uniform recovery of excitability exists in
ventricular muscle. Re-entry (see section 1.5.3) could be facilitated by
unidirectional block caused by a differential dispersion of repolarisation between
adjacent myocardial fibres (Han, 1969). A prolongation of action potential
duration is associated with heart failure although this is not an arrhythmogenic
mechanism in itself if the prolongation is homogeneous (Tomaselli et al, 1994).
However, variations in action potential duration can cause a dispersion of
refractoriness that may be arrhythmogenic.
In the normal healthy heart the characteristics of the action potential and the
distribution of ion channels varies between atrial, nodal, Purkinje, and ventricular
cells and also within each of these. The variation in action potential duration
occurs in both the intact heart and single myocytes isolated from individual
regions. However, action potentials are generally longer at early activation sites
and shorter at later activation sites to ensure homogeneous recovery of excitability.
It is therefore normal for hearts to have a certain degree of intrinsic dispersion of
repolarisation. Because repolarisation is important to cardiac arrhythmogenesis
there is much interest in the variability of ionic currents that govern repolarisation.
Variations or gradients in action potential duration may occur between cell layers
and also across the epicardium.
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1.2.1 Transmural dispersion
Regional, or transmural (i.e. transversely across the ventricle endocardium to
epicardium), variations in action potential configuration and ionic currents in the
left ventricle of the rabbit heart have been noted by several authors (Fedida &
Giles, 1991; Cook et al, 1997; Antzelevitch et al, 1991; Anyukhovsky et al, 1996;
Drouin et al, 1995). The epicardial action potential shows a shorter duration and
also has a prominent 'spike and dome' morphology that is lacking in the
endocardium. Fedida & Giles (1991) and also Li et al (1999) in their work on
isolated cells from the human right ventricle, suggested that the heterogeneities in
the action potential duration and the spike and dome morphology was due to the
transient outward current, Ito. The transient outward current is much more evident
in the epicardium than the endocardium and therefore explains this heterogeneity.
Laurita et al (1996) in work using the guinea pig heart found that the cellular
kinetics of repolarisation across the epicardial surface vary despite normal cellular
coupling. It is thought that regional differences in the K+ currents IK and IKI playa
role in the heterogeneity of the action potential configuration. M cells, present in
the mid myocardial wall, show repolarisation properties that are strongly
influenced by a reduction in the expression of the delayed rectifier (lKs) which
renders these cells susceptible to factors which cause prolongation of the action
potential (Viswanathan et al. 1999). It is indeed the case that M cells have a longer
action potential duration than either epicardial or endocardial cells and they also
have a greater Vmax (rate of rise of action potential upstroke). M cells also have a
more prominent late fast sodium inward current (INa) (Eddlestone et al, 1996).
4
Chapter 1- General Introduction
These transmural differences in action potential duration are more prominent in
dissociated isolated myocytes than the intact heart. In the intact heart intrinsic
differences in action potential duration are masked by electrotonic interactions
between cell layers. However, in the diseased heart these electrotonic interactions
may be disrupted and intrinsic dispersions revealed.
1.2.2 Apex to base dispersion
In addition to heterogeneities in action potential duration between cell layers. a
trans-epicardial dispersion in the left ventricle has also been reported. Action
potential durations have been seen to be longer in the basal regions of the heart
compared to apical regions. Brahmajothi et al (1997) found that in the ferret
ventricle the expression of ERG, the gene that encodes the protein responsible for
the fast component of the outwardly directed K+ current (lKr), was more abundant
in apical areas. This is consistent with the findings of Cheng et al (1999) in their
study on the heterogeneous distribution of IKr and IKs (slow component) in the left
ventricle of the rabbit heart. The greater abundance of IKr in the apex produces
action potentials of shorter duration.
1.2.3 Heart rate
The balance between various K+ currents and their consequent importance in
repolarisation can be drastically altered by heart rate (editorial: van Ginneken and
Veldkamp, 1999). Cheng et al (1999) found that, upon stimulating single rabbit
cardiac myocytes at 1Hz, action potential duration was longer in the apex than the
base and that at stimulation frequencies higher than this the role of IK is more
important than the transient outward current (Ito). The role of IKr in repolarisation
5
Chapter 1- Genera/Introduction
is less frequency dependent than IKs• When the heart rate is increased there is less
time for the decay of the slower K+ current after each action potential. Changes in
heart rate are also important in relation to electrical restitution.
1.3 Electrical restitution
It is essential that in the working heart an increase in heart rate is accompanied by a
decrease in the duration of systole to ensure enough time for the ventricles to fill
during diastole. In vivo adrenergic stimulation is partly responsible for this,
although in the isolated heart there is a purely rate dependent shortening of action
potential duration that may contribute to the shortening of systole.
One very important determinant of action potential duration is the length of the
preceding diastolic interval. In multicellular mammalian preparations (Boyett and
Jewell, 1978; Litovsky and Antzelevitch, 1989; Bass, 1975), electrical restitution is
the rate dependent phenomenon that describes the relationship between action
potential duration and the preceding diastolic interval (Elharrar and Surawicz,
1983). Action potential duration remains constant where diastolic interval is
constant, but this changes where there is a premature action potential. Action
potential duration lengthens as the preceding diastolic interval becomes longer.
However, in some species (e.g. rabbit) action potential duration can lengthen as
diastolic interval decreases over some portions of the restitution curve (Hiraoka,
and Kawano, 1987).
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1.3.1 Cellular mechanisms responsible for restitution
The typical electrical restitution curve. as shown in Figure 1.1. reflects the time
course over which membrane ionic currents return to their pre-stimulus values.
Action potential duration depends on the inactivation of the slow inward current
and activation of the outward current. Following repolarisation of a cardiac
myocyte, changes in the state of individual ion channels still occurs. If another
action potential is triggered prior to recovery of ionic currents its duration will be
decreased because less inward current can be generated or because the outward
current has not had enough time to decay.
Test interval CSI-S2 interval) (rns)
Figure 1.1 A typical electrical restitution curve. A typical electrical
restitution curve. Action potential duration decreases as the preceding
diastolic interval is shortened.
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1.3.2 Ion accumulation
A possible mechanism for the rate dependent shortening of action potential
durations is that of ion accumulation. Boyett and Jewell (1978) discussed the
involvement of Ca2+ and K+, and later in 1980 the involvement of Na+ ions in this
hypothesis. Intracellular Ca2+ ions may accumulate at the higher stimulation rates
and hence produce a shorter action potential by i) a reduction in the slow inward
current or by ii) an increase in the outward current (Reuter, 1973). Shortening may
also arise from extracellular accumulation of K+.
1.3.3 Incomplete recovery of ionic currents
Incomplete recovery of ionic currents can be a cause of rate dependent changes in
action potential duration. Following each action potential, time is required for
recovery from inactivation and activation of currents, namely the Na+ current INa,a
slow inward current lsi, transient outward current Ito, and time-dependent K+
currents (see section 1.6.1). If a premature stimulus occurs prior to the recovery of
these currents, less INa, lsi, and Ito and more time-dependent K+current will be
activated. Therefore incomplete recovery will have significant consequences on
action potential configuration.
Membrane potential governs the speed of recovery of ionic currents, and since
recovery is slower at more positive potentials it will be after repolarisation that
recovery will mainly occur. Hence recovery depends on diastolic interval (time
between repolarisation of one action potential and depolarisation of the next) rather
than the interval between consecutive stimuli.
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1.3.4 Dispersion of restitution
By measuring restitution properties across the heart the influence of restitution
heterogeneities on the substrate for re-entry (see later in introduction) could be
investigated. The heterogeneity of ion channel distribution across the epicardium,
between ventricles, and transmurally may be expected to produce a heterogeneity
of rate dependence and restitution. Not only is there a spatial heterogeneity of rate
dependence and restitution but there also exists a beat to beat variation in
restitution at constant pacing rates. However, the limitations that conventional
electrical recording techniques impose on multiple simultaneous recording restrict
the measurement of the spatial heterogeneity of restitution in the whole heart to a
few sites only. Little is know about how dispersion of restitution interacts with
normal or pathological substrates to produce arrhythmias.
1.4 Intercellular coupling
1.4.1 Gap junction structure and function
In the working myocardium, adjacent myocytes are abutted onto each other, end to
end, via intercalated discs. Three types of junction act in unison to make up the
intercalated disc, these are the desmosome, the fascia adherens and the gap
junction. The desmosome and fascia adherens are anchoring junctions and are
primarily concerned with attachment between cells. Gap junctions ensure
intercellular communication and electrical coupling of the cells by connecting the
cytoplasmic compartments of adjacent cells. Whilst gap junctions provide an
intercellular gap between adjacent plasma membranes of 2-3nm, desmosomes and
fasciae adherens have a much wider intermembrane space. The small intercellular
gap allows the rapid spread of excitation from one cell to the next.
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The gap junction channel consists of two hexameric hemichannels, or connexons
(see Figure 1.2), one provided by each myocyte. These integral membrane proteins
span the full depth of the membrane and have a central channel of <2.Snm at the
widest point. This channel provides a pathway for the direct exchange of nutrients,
metabolites, ions and small molecules «lkDa), described by Delmar (2000) as an
'information superhighway'. The main function of the gap junction however is to
allow low resistance electrical coupling of excitable cells that is necessary for
normal cardiac conduction and contractile function.
Each one of the six subunits of the connexon structure consists of one connexin
molecule. In mammals connexins are part of a rnultigene family of at least 15
distinct proteins (Gros et al, 1996) of which at least 3 are expressed as different
cellular subtypes of the heart; Connexin43, Connexin45 and Connexin40 (Johnson
et ai, 1999), each SUbtype being named by its size in kDa. The connexins of each
connexon are arranged in a circular fashion with each unit protruding so as to
interlock with the neighbouring connexon. Each connexin consists of four
hydrophobic transmembrane domains with the N- and C- termini located on the
cytoplasmic side of the membrane.
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CONNEXON
eaaH
CONNEXIN
CYTOPLASMIC SIDE
EXTRACELLULAR SIDE
HJ
eOOH
Figure 1.2 The connexon and connexin. The connexon is a hexameric
structure. Each of the 6 subunits consists of a single connexin molecule.
(Taken from Severs, 1994)
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1.4.2 Gap junction channels and cardiac conduction
The size and distribution and the properties of the intercellular channels contribute
importantly to conduction velocity and conduction patterns in the myocardium.
The conductance of each of the channels that a gap junction is composed of
determines the overall conductance of the gap junction. At a given potential
difference across the cell membrane, the more channels between cells the more
current can flow between them and the higher the conduction velocity (Jongsma,
1997). In the heart longitudinal conduction is faster than transverse conduction due
to the distribution of the gap junction around the perimeter of the cell. This is an
important factor in determining the pattern of impulse conduction.
1.4.3 Electrotonic interactions and gap junction uncoupling
The heart normally acts as an electrical syncytium coupled via gap junctions.
Changes in intercellular coupling may predispose the heart to arrhythmias by i)
slowing conduction and ii) by increasing dispersion of repolarisation and
refractoriness. Myocardial ischaemia and hypertrophy further complicate the
complex electrical arrangement in the heart and are associated with ventricular
arrhythmias. In these conditions an increase in electrical heterogeneity in the heart
can be attributed, in part, to functional or mechanical intercellular uncoupling.
However, in the normal heart, electrotonic interactions between cells (which are
mediated by gap junctions) act to reduce or mask the intrinsic differences in
repolarisation between cells. Therefore, if gap junction coupling or gap junctional
resistance are altered, an increased heterogeneity of repolarisation can be expected.
This exaggerated dispersion may be arrhythmogenic.
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Dhein et al (1999) used the gap junction uncoupler palmitoleic acid to
pharmacologically intervene on gap junction coupling. They found that, using a
256 unipolar electrode array, that 20j.lM palmitoleic acid caused activation
recovery intervals (ARls) to become highly heterogeneous. They saw a dramatic 6
fold increase in the dispersion of ARls (from 6 to 35ms). I-Heptanol has also been
used to attempt to study the effect of gap junction uncoupling in both the intact
heart (Keevil et al, 2000) and paired myocytes (Rudisuli and Weingart, 1989;
Takens-Kwak et al. 1992). However, the effect of l-heptanol on dispersion of
repolarisation and its possible arrhythmogenic effects were not determined.
1.S Arrhythmias
Under normal circumstances the propagating action potential, originating at the
sino-atrial node (SAN), will sequentially stimulate the atria and ventricles to
contract in sequence before dying out when refractory tissue is encountered.
However, under abnormal circumstances, where there is an obstacle, the
propagating action potential may continue to stimulate non-refractory tissue in a
self-sustained fashion thus giving rise to a re-entrant circuit. This is known to be
the mechanism for several important cardiac arrhythmias. Tachyarrhythmias are a
result of re-entrant excitation and have been investigated since the turn of the
century.
There are three prerequisites for re-entry to occur: i) unidirectional conduction
block, ii) slow conduction to permit recovery of excitable tissue and allow the re-
entrant circuit to continue, and iii) a closed circuit around an anatomical or
13
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functional obstacle. On the basis of mechanisms, re-entry may be divided in to
three groups: i) anatomical re-entry, ii) functional re-entry, and iii) anisotropic re-
entry.
1.5.1 Unidirectional block
1.5.1.1 Due to non-uniform recovery of excitability
Differences in refractory period durations may cause impulse propagation to fail in
regions with longer refractory periods. Even at fast heart rates there is a sufficient
diastolic interval where excitability is normal. Therefore, such a situation as
conduction block is more likely to occur in the instance of a premature stimulus. A
premature stimulus facilitates re-entry as refractory period shortens as cycle length
shortens and hence the pathway for impulse propagation is shortened. There is
only a small degree of non-uniformity of refractory periods that is necessary to
induce conduction block following a premature stimulus. Allessie et al (1976)
measured refractory periods in isolated rabbit left atria. They found that a minimal
difference of 11-16ms was necessary for unidirectional block following a
premature stimulus. They also argued though, that this is not the decisive factor for
the initiation of re-entry. Conduction velocity and the volume of the unidirectional
block are also important. The critical timing of the premature stimulus is essential
for the initiation of re-entrant arrhythmias if it occurs on the basis of temporal
dispersion of recovery of excitability.
1.5.1.2 Due to geometrical factors
Unidirectional block may occur where there is a sudden increase in the
cross-sectional area of interconnected cells. Re-entry may have both a functional
and an anatomical basis (Pye & Cobbe, 1992). Re-entry may be functional in that
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it does not occur around an anatomical obstacle but the anisotropy provided by the
anatomical structure of the muscle fibres causes the re-entrant circuit to occur, and
not the transmembrane properties of the myocytes. Spach et al (1982) showed that
the anisotropy of the muscle fibre orientation might allow re-entry to occur, even in
cardiac tissue with normal transmembrane properties and uniform refractoriness.
They suggested that the direction of the muscle fibres is important as conduction
velocity tends to be faster in the direction that the long axis of the fibres run rather
than perpendicular to it, although in certain regions of the infarct border zones the
reverse may be true.
1.5.1.3 Based on asymmetrical depression of conduction and excitability
Unidirectional block may also occur as a result of asymmetry in a region of
depressed excitability. Experiments by Schmitt and Erlanger (1928) produced
asymmetrical conduction block by localised pressure and elevated extracellular K+.
This led to a sudden increase in the excitation threshold in one direction but a
slower rise in the other, inbetween which was an inexcitable gap. In the retrograde
direction, where the abrupt change was encountered, if the gap was below a critical
length the impulse was transmitted, but not in the other direction where there was a
gradual decrease of excitability which decreased the amplitude and driving force of
the electrotonic transmission. (Kleber et al in: Handbook of Physiology, 200 I)
1.5.2 Conduction delay
One of the conditions that can make re-entry possible is the slowing of conduction.
It has been shown that zones of slow conduction present in the infarcted heart
facilitate re-entry due to the extra time given for the tissue in the re-entrant circuit
to regain its excitability and allow the excitation wavefront to enter again (de
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Bakker et al. 1993). Several factors determine the velocity of the propagated
action potential. but are of no concern here. A focus of conduction slowing in this
introductory section is intercellular coupling resistance. Conduction depends on
local current circuits. where once cell excites the next. Conduction velocity is one
of the factors that is determined by coupling resistance between cells. As coupling
resistance increases. conduction velocity decreases. A sizeable increase in
coupling resistance is required to produce a marked decrease in conduction
velocity. Tissue anisotropy caused by differences in coupling resistance
perpendicular and parallel to the fibre axis can predispose to unidirectional block
and re-entry.
1.5.3 Re-entry
Depending on the area of the block around which the wave is propagated. the
re-entrant movement may be classified as anatomical or functional. although can be
classified as both. Several factors influence re-entry. Anatomical re-entry requires
a large barrier around which the wavefront circulates whilst altered
electrophysiological properties allow functional and anisotropic re-entry to occur.
In the case of functional re-entry. transmembrane potential properties are
responsible for providing the conditions for re-entry to occur; in the case of
anisotropic re-entry. microanatomy is the crucial factor. Another difference lies in
anisotropic re-entry having a large excitable gap. Dispersion of refractoriness
and/or non-uniform anisotropy around an infarction site may be a cause of slow
conduction and unidirectional block (Vassallo et al. 1988).
16
Chapter 1- General Introduction
1.5.3.1 Anatomical re-entry
Mines described the simplest model of re-entry which is illustrated in Figure 1.3
(adapted from Wit & Dillon, 1990). He was the first to suggest re-entrant
excitation as a reason for arrhythmias in humans. Mines formulated criteria for the
re-entrant basis of arrhythmia in 1914, and are summarised as follows:
i) Unidirectional block must be demonstrated
ii) There must be a circuit to allow the wavefront to return to its origin.
iii) "The best test for circulating excitation is to cut through the ring at one
point. If the impulse continues to arise in the cut ring, circus movement as
a cause can be ruled out" (Mines, 1914)
Figure 1.3 Mines model of anatomical re-entry. (Adapted from Kleber et
a/ in: Handbook of Physiology, 2001). The arrow is the head of the
wavefront, the black area is absolute refractory tissue, the stippled area
illustrates relative refractoriness and the white area shows the excitable
gap.
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In this type of re-entry the wavefront propagates around an inexcitable obstacle.
The length of a pathway involving an anatomical circuit is dictated by the size of
the obstacle around which it travels, and the length of this pathway is fixed. An
anatomical circuit has a fully excitable gap; the length of the re-entrant pathway is
significantly greater than the wavelength of the re-entrant impulse (conduction
velocity x effective refractory period). The time taken for an excitation wave to
complete one revolution of an anatomical circuit, where there is an excitable gap, is
determined by the conduction velocity. Therefore, if an impulse initiated outside
the circuit can invade, via the excitable gap, the arrhythmia may be terminated,
Due to the excitable gap and the stability of the circuit, propagation can be
maintained for hours (Kleber et al in: Handbook of Physiology, 2001). Dispersion
of refractoriness must be relatively large to influence conduction velocity.
In the case where the wavelength is longer than the re-entrant circuit the front of
the wave is situated within its own refractory tail. In this situation there is no
longer an excitable gap and external stimuli cannot penetrate in to the circuit.
There is instability in the re-entrant circuit where there is an interaction between
head and tail. This instability originates from two sources: a restitution dependent
instability as well as one arising from the reliance of conduction velocity on the
excitation interval.
1.5.3.2 Functional re-entry: The leading circle theory
Re-entry in cardiac tissue may occur in structurally intact tissue with altered
functional properties such as heterogeneities of refractory period. The leading
circle phenomenon of re-entry was proposed (Allessie et al, 1976, 1977) and
explains this (Figure 1.4). They induced circuit movement in isolated rabbit atrial
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tissue, where no anatomical obstacle is present, by premature stimulus. Here, the
propagating impulse travels around a centre of refractory tissue, it follows the path
of shortest refractory period with unidirectional block occurring in those fibres
with a longer refractory period. The activation spreads in an arc around the block
before merging again and re-exciting the tissue proximal to the block. The leading
circle theory, as proposed by Allessie et al (1977), is described as "the smallest
possible pathway in which the impulse continues to circulate and in which the
stimulating efficacy of the wavefront is just enough to excite the tissue ahead
which is still in its relative refractory period". Dispersion of repolarisation and
conduction velocity may influence the size of the circuit and hence the time taken
to complete one revolution of the circuit. Due to this lack of an excitable gap,
impulses initiated outside the circuit cannot easily penetrate into it. In some cases
of functional re-entry there may be a large difference in refractoriness (dispersion)
and therefore there is the existence of an excitable gap. In these cases, an external
stimulus may penetrate the circuit and termination of the tachycardia may occur.
The length of a functional circuit is variable and is determined by the
electrophysiological properties of the cardiac fibres that it is composed of.
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Figure 1.4 Schematic representing the leading circle theory of re-
entry. The arrows represent the crest of the circulating wavefront. Black
areas show areas of absolute refractoriness, dotted areas relative
refractoriness.
The border zone of infarcted tissue may provide the ideal setting in which
re-entrant arrhythmias can occur. Fibrosed tissue in the peri-infarct area may cause
a loss of cellular electrical coupling resulting in slow conduction or unidirectional
block and dispersion of refractoriness which may predispose to re-entry (Kurz et
al, 1993). Hypertrophied, non-infarcted, myocardium that is remote from the
infarcted tissue also has altered electrophysiological characteristics. Heterogeneity
of refractoriness in the tissue remote from the infarct may be involved in the
degeneration of VT to VF (Ramdat Misier et al, 1995).
1.5.3.3Anisotropic re-entry
In the absence of an anatomical obstacle, unidirectional block may arise as a result
of non-uniform recovery of excitability (dispersion of repolarisation), differences
in conduction velocity as a result of altered cellular connections, or depression of
electrophysiological properties. The conduction of impulses moving through a
volume of myocardium with regional differences in refractoriness may fail where
20
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there is a long refractory period. This form of re-entry, termed anisotropic re-entry,
also demonstrates an excitable gap.
1.6 The action potential
1.6.1 The ionic basis of the action potential
The action potential consists of 5 phases as illustrated below in Figure 1.5: phase 4,
the resting membrane potential; phase 0, rapid depolarisation/upstroke; phase I,
early repolarisation; phase 2, the plateau and; phase 3, final repolarisation. Each
phase is determined by different ionic fluxes across the cell membrane and are
described as follows.
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Figure 1.5 Phases of the action potential and indication of the ionic
influxes involved.
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1.6.1.1 Resting potential (Phase 4)
Phase 4, or the resting membrane potential, is due mainly to the high intracellular
K+ concentration and the high permeability of the sarcolemma to these ions.
Although there is a tendency for the K+ ions to move out of the cell down a
concentration gradient, the negative intracellular ions are unable to accompany
them. There is a separation of charge across the sarcolemma and the interior of the
cell becomes negative with respect to the exterior. The intracellular K+
concentration remains high and the Na+ concentration low due to the electrogenic
Na+-K+ ATPase pump (3Na+ out for 2K+ in) that operates at the sarcolemma.
Background currents involved in phase 4 of the action potential include an
inwardly directed Na+ current, Ib, and an outwardly directed K+ current, IKI. This
movement of ions across the cell membrane determines the resting membrane
potential of the myocyte, which in the ventricles is between -80 and -90mV and is
stable until stimulated to contract.
1.6.1.2 Action potential upstroke (Phase 0)
In ventricular myocytes the action potential upstroke, phase 0, is very rapid with a
large Vmax. The main current involved in this phase is the fast inward Na+ current
(INa) which lasts for approximately 1-2ms. When the membrane potential reaches
between -70mV to -60mV, the membrane ionic conductances suddenly change and
there is a rapid influx of Na+ through the fast channels. This produces a
regenerative depolarisation that activates the slow inward Ca2+ current, lsi or lea,
through which the membrane is depolarised to between +30 and +40mV. Thus
towards the latter part of phase 0, current flows through fast and slow type
channels. Two types of inward Ca2+ current are also involved in this phase; the
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slow or L-type current and the fast or T-type current. The L-type Ca2+ channel
begins to open in phase 0 when the membrane voltage approaches -40mV.
1.6.1.3 Phase 1
During phase 1 of the action potential, INais inacti vated and a transient outward
current (Ito) is activated which facilitates the rapid repolarisation of the membrane
to near OmV. Ito is a current carried mainly by K+ and shows voltage dependent
activation and inactivation (Antzelevitch et al, 1991). Two subtypes of Ito have
been described in the rabbit left ventricle; a slow component Itol, and a fast
component Ito2 (Fedida and Giles, 1991). Ito is an important repolarising current
that can influence action potential duration and configuration by interacting with
the inward Ca2+ current, ICa. Another transient outward current that is activated
during the plateau phase of the action potential is the Ca2+-activated K+ current,
IK(Ca)' Since this current is activated by intracellular Ca2+ there is an overlap with
the slow inward current. A slight cr influx and a Na+-K+ exchanger pump (3Na+
out for 2K+ in) also contribute to the earlier phases of repolarisation.
1.6.1.4 The Plateau (Phase 2)
Phase 2 of the action potential is a long plateau mediated by a balance between an
outwardly directed K+ current (lKI), an inward Ca2+ current (Ica), and an inward
slow inactivating Na+ current. It is thought that 2 SUbtypes of IKexist: a slow, (lKs)
and a fast (lKr) component. The Ca2+ channels are voltage-gated channels that are
activated during phase 0 when the membrane potential reaches approximately
-40mV. This current is responsible for the Ca2+ induced Ca2+ release (CICR) via
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the ryanodine receptor in the sarcoplasmic reticulum that initiates contraction of
the myocyte (see E-C coupling).
During phase 2 Na+ conductance is low due to Na+ channel inactivation. A
Na+-Ca+ (lNa-Ca) exchanger current (3Na+ in for lCa2+ out) sustains the late plateau
phase and removes intracellular cytoplasmic Ca2+. INa-Ca can operate in either an
outward or an inward direction depending on the membrane potential and Na+ and
Ca2+ concentrations (Coraboeuf and Nargeot, 1993). During plateau potentials the
Na+-Ca2+ exchanger operates in reverse mode to pump Ca2+ in and Na+ out. The
balance between the movement of ions across the cell membrane during the plateau
phase maintains the membrane potential at around OmY for up to several hundred
milliseconds.
1.6.1.5 Repolarisation (Phase 3)
Repolarisation occurs rapidly during phase 3 of the action potential, this is due to
the increase in K+ conductance and the inactivation of the Ca2+ channels. In
ventricular myocytes several types of K+ are involved in repolarisation of the
action potential. These are the inward rectifier (IK1); the delayed rectifier (lK); the
transient outward current (Ito); and possibly the plateau current (lKp) (Luo and
Rudy, 1991). At a membrane potential of approximately -50mY the fast Na+
channels are closed from an inactive state and hence the myocyte is excitable
again, although a larger than normal stimulus is required to produce a smaller than
usual action potential. Figure 1.6 (Bers, 2001) illustrates the basic membrane
conductances to individual components of the action potential.
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Figure 1.6 Membrane conductance to Na+,Ca2+and K+during a rabbit
cardiac action potential (taken directly from Bers, 2001).
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1.6.2 Refractory periods
Periods of refractoriness are essential to the action potential to ensure that the heart
has enough time to refill prior to the next contraction. If a cell is excited by a
stimulus at some time and another stimulus arrives before the cell returns to rest,
the second stimulus may elicit no response at all. If the second stimulus is delayed
slightly, it may elicit a reduced or "graded" response. If the strength of the second
stimulus is sufficient, and the onset is delayed enough, it may elicit another full
action potential, in which case we say it has come during the relative refractory
period (RRP).
Figure 1.7 illustrates these refractory periods. During the absolute refractory
period (ARP) the myocardium is completely inexcitable and stimulation is
ineffective. The effective refractory period (ERP) includes the ARP but extends
into a period where the myocardium may be stimulated but an action potential is
not propagated. During the RRP the myocardium may be stimulated but the
propagated action potential is weaker than normal and thus moves slower. The
supernormal (SNP) period is a hyper-excitable time period. The actual full
recovery time is indicated in Figure 1.7 as FRT as is the time when a full 'normal'
action potential can be produced again.
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Figure 1.7 Refractory periods of the MAP.
1.6.2.1 Measuring refractoriness
Refractory periods can be measured and used to determine the minimum length of
a re-entrant circuit that may lead to the introduction of a ventricular arrhythmia
(Burton & Cobbe, 1998). Refractory periods may be determined directly using the
premature extrastimulus technique. This is the most common and conventional
method used to map refractoriness. The heart is paced at a basic cycle length (SI)
and a premature extrastimulus (S2) is applied at an interval SI-SZ. The SI-S2
interval is decreased until the refractory period is found. Ifmultiple sites are to be
mapped, this may be a time consuming process as varying intervals must be tested
separately at each recording site. It must also be assumed that the refractory period
at one site does not alter whilst the other measurements are made. The problems
associated with multiple site recording using a limited number of electrodes
prompted the introduction of multi-site simultaneous recordings.
Ventricular fibrillation intervals (VFIs) can be used as an indirect measurement of
refractoriness at multiple sites (Burton et al, 1998). When a heart is in VF cells
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become re-excited as soon as they have recovered from the previous excitation, the
time interval between these activations is the VFI. VFI has been closely correlated
with the action potential and ERP durations (Surawicz, 1997; Ramdat Misier et al,
1995). Providing a train of extrastimuli at progressively increasing current
stimulus induces VF. The details of this method are described in the relevant
methods sections of individual results chapters.
Simultaneous multiple recordings of monophasic action potentials (MAPs) provide
an indirect measurement of refractoriness. MAPs reliably reproduce the
repolarisation time course of the transmembrane action potential, and are described
in detail in chapter 3. MAP recording can also be used as an index of
refractoriness provided that the APDIERP relationship is constant, Le. there is no
post-repolarisation refractoriness. Kuo et al (1983), in studies on the
arrhythmogenic role of dispersion of repolarisation, used suction electrodes to
simultaneously record MAPs from six sites in the open chested dog. Behrens et at
(1997) simultaneously recorded ten MAPs from the epicardial and endocardial
surfaces of the Langendorff-perfused rabbit heart using the Franz contact MAP
catheter (refer to chapter 3) mounted on a spring mechanism to help eradicate
motion artefacts. However, even in experienced hands, the number of simultaneous
recordings that can be made is limited. Although not MAP recording, a non-
invasive method of recording myocardial electrical activity at multiple sites was
made by Burton and Cobbe in 1998. They used a flexible epicardial array
containing multiple unipolar electrodes to simultaneously record up to 240 unipolar
electrograms from the epicardial surface of the left ventricle.
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Intracellular microelectrodes (refer to chapter 3) adequately measure action
potential durations and repolarisation but are unsuitable for multiple recordings due
to the technical difficulty in maintaining more than one impalement. The
limitations of the intracellular and suction electrode methods for multiple site
recordings prompted the introduction of optically recording electrical activity using
voltage sensitive dyes (refer to chapter 3).
1.7 Excitation-contraction coupling and Ca2+ handling
Cardiac myocytes are single contractile units within the heart which under normal
circumstances act as a syncytium to allow the heart to perform efficiently in
helping to pump blood through the body. Excitation-contraction coupling (E-C
coupling) is initiated by the depolarisation of the sarcolemma by an action
potential. The arrival of the action potential at the sarcolemmal membrane causes a
transient increase in the sarcoplasmic Ca2+ concentration that subsequently
activates contractile proteins resulting in contraction of the cardiac myocyte. The
part that the action potential plays in E-C coupling has been described (see above).
The following section of this introduction will concentrate on the role that Ca2+
plays in cardiac contraction. Refer to Figure 1.8 for details.
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Figure 1.8 Excitation-contraction coupling. Schematic of Ca2+ handling
within a single cardiac myocyte. Adapted from Bers, 1993.
The action potential is propagated along the sarcolemma and into the cell along the
T-tubules. T-tubules are invaginations of the sarcolemma that run in to the cell
interior. Within the cell, junctional sarcoplasmic reticulum (SR) lies in close
proximity to the sarcolemma or the T-tubules. The SR is the main Ca2+ store
within the myocyte. The SR contains Ca2+ release channels (ryanodine receptors)
which are in the closed state during diastole and hence when diastolic cytoplasmic
Ca2+ is low (-lOOnM) the Ca2+ does not bind to the Ca2+ binding sites associated
with the contractile apparatus (myofibrils - see below). As the action potential
travels along the T-tubule lea causes a small rise in the intracellular Ca2+
concentration. This small influx of Ca2+ activates the ryanodine receptors which
causes the release of a large quantity of stored Ca2+ from the SR in to the cytoplasm
to occur - a process known as Ca2+ induced Ca2+ release (CICR).
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The myocyte contains contractile apparatus called myofibrils. Each myofibril is
composed of smaller units called sarcomeres that are joined end to end. This gives
the myocyte a striated appearance. The sarcomere contains thick (myosin) and thin
(actin) filaments that interdigitate. Actin comprises a double helix of F-actin and
G-actin. Embedded in this helix are 2 proteins - tropomyosin (closely associated
with actin) and troponin (binds to the tropomyosin). Troponin has 3 distinct
subunits: troponin- T links to tropomyosin; troponin-C has a high affinity for Ca2+;
and troponin-I interacts with the actin. At rest the troponinltropomyosin complex
inhibits the binding of actin to myosin. When calcium is released from the SR it
binds to Troponin-C producing a configurational change in the troponin unit.
Because troponin is tightly bound to tropomyosin, this results in a secondary
configurational change in tropomyosin. This permits formation of the actomyosin
complex and capacity for developing tension. Tropomyosin exerts its inhibitory
effect to reduce tension when Ca2+ is reduced.
The interaction of these contractile proteins, which induces a sliding mechanism
which is activated by Ca2+ and causes the cell to contract, is a process known as
cross bridge cycling. This mechanism was termed the sliding filament theory by
Huxley in 1969. Ca2+ released from the SR raises the cytoplasmic Ca2+
concentration, Ca2+ diffuses the short distance in to the sarcomere, and the cell
develops tension. Ca2+ enters the cell during the action potential via the L-type
Ca2+ channels and also via the Na+-Ca2+ exchanger working in reverse. During
systole the Ca2+ concentration is raised to -1~M. Following contraction Ca2+ must
2+ . tbe extruded from the cytoplasm in order to return the Ca concentration 0
diastolic levels.
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1.7.1 Intracellular Ca2+ removal
There are 4 main mechanisms which aid in the removal of Ca2+ from the
cytoplasm: the SR Ca2+-ATPase pump (SERCA); the sarcolemmal Na+-Ca2+
exchanger; the sarcolemmal Ca2+ ATPase, and; the mitochondrial Ca2+ uniporter.
SERCA and the sarcolemmal Na+-Ca2+ exchanger are the 2 dominant Ca2+ removal
mechanisms.
SERCA
The released Ca2+ ions are pumped back in to the SR by ATP-dependent Ca2+
pumps which are located in the network SR. Regulation of SERCA depends on the
phosphorylation state of another protein, phospholamban (PLB).
Dephosphorylation of PLB inhibits the pump, whilst in its phosphorylated state
SERCA is activated.
SARCOLEMMAL Na+-Ca2+EXCHANGER
Depending on the membrane potential and the intracellular and extracellular Na+
and Ca2+ concentrations, the Na+-Ca2+ exchanger can also function in reverse. The
exchanger is an electrogenic pump, so for every 3 Na+ it pumps in, 1 Ca2+ is
pumped out.
SARCOLEMMAL Ca2+ATPase
The sarcolemmal Ca2+ATPase pumps 1 Ca2+ out for each ATP molecule that is
hydrolysed.
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1.7.2 Contraction-excitation feedback
Contraction-excitation feedback, or mechanoelectrical feedback, is the reverse
scenario of excitation-contraction coupling. Contraction-excitation coupling
describes the process by which mechanical stress or strain produces changes in
membrane potential, either as a change in action potential duration or as a transient
depolarisation (Lab, 1982).
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2.1 Langendorff perfusion of whole hearts
2.1.1 The perfusion system
Before the experiments, a modified Krebs-Henseleit buffer solution, of the
following composition (mM): 120.9 NaCl, 2.8 KCl, 2.5 CaCh, 1.5 MgS04, 1.5
KH2P04, 24.8 NaHC03, 11 glucose, 2.0 sodium pyruvate was pumped through the
perfusion system to prime it. Figure 2.1 shows a detailed diagram of the
Langendorff perfusion system. The pH of the solution was maintained at 7.4 by
continuously bubbling with a 95% O2 I 5% C02 mixture. A 2-way tap incorporated
into the perfusion lines allows the rapid changing of solutions that is needed in
some protocols. Specific variations of the general methods and protocols involving
solution changes andlor stimulus regimes are discussed in the relevant chapters.
A cellulose nitrate membrane filter (5J,!m) (Whatman International Ltd, UK) was
incorporated in to the perfusion system to ensure the removal of contaminant
particles in the saline solution and tubing. This was renewed prior to each
experiment. A heated water bath was used to supply warm water to glass
water-jackets. One coiled water jacket heated the perfusion solution; another
maintained the temperature of the atmosphere surrounding the heart. The coiled
water jacket warmed the perfusion solution immediately prior to it descending the
tubing in to the cannula and heart. The water jacket encompassing the heart
directly warmed the atmosphere surrounding the heart. Therefore, a constant
temperature of 37°C was maintained.
Small air bubbles that form in the plastic down-tube that feeds into the stainless
steel aortic cannula coalesce to produce larger bubbles. If this spans the width of
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the tubing it may descend through the tubing and enter the heart via the aorta
causing an air embolus. Therefore, the system was continually observed for the
formation of bubbles. This air formation is due to the cooling properties of liquid
where gas becomes less soluble in the cooler solution, and hence comes out of
solution. Air emboli can block blood vessels within the heart thereby stopping
blood flow and causing regional ischaemia. Figure 2.1 illustrates the Langendorff
perfusion system.
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Figure 2.1 The Langendorff perfusion system.
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2.1.2 Experimental procedure
2.1.2.1 The infarct model of heart failure
A rabbit coronary artery ligation model of heart failure/left ventricular dysfunction
was used for some parts of this study. The rabbit coronary artery ligation model of
heart failure produces heart failure as a result of left ventricular dysfunction
following myocardial infarction. Coronary ligation causes eccentric hypertrophy
leading to increased left ventricular dimension. It also causes a significant increase
in myocyte length and a non-significant increase in myocyte diameter (McIntosh et
al, 2000). Heart failure causes manifestations such as liver and lung congestion
and heart and liver enlargement.
Before sacrifice all animals had echocardiography done to assess the degree of left
ventricular dysfunction produced by the procedure. End diastolic left ventricular
diameter and ejection fraction were measured. This model was developed by Dr.
M. Pye and Prof. S. Cobbe in the Department of Cardiology, Glasgow Royal
Infirmary. Surgery was performed by technicians at the animal house at the
Infirmary. Briefly, the procedure is as follows. Anaesthesia was induced using
Hypnorm and maintained with halothane and nitrous oxide/oxygen prior to
performing a left thoracotomy. The left anterior descending coronary artery was
ligated to produce an ischaemic area approximately 113the size of the left ventricle.
Post-operative analgesia was administered and the animals monitored. Heart
failure was allowed to develop for 8 weeks prior to sacrifice for experiment.
Sham-operated animals underwent the same operation as the failure animals but
without coronary artery ligation. These animals were also allowed 8 weeks prior to
sacrifice for experiment.
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2.1.2.2 Heart preparation and experimental set-up
Sham-operated and coronary-ligated animals were sacrificed by intravenous
administration of sodium pentobarbitone (lOOmg/kg) with 1000 IV heparin into the
left marginal ear vein. The absence of corneal and limb withdrawal reflexes were
checked prior to making the initial transverse subcostal incision into the abdomen.
The diaphragm was cut, and lateral incisions made along both sides of the rib cage
to expose the heart and lungs. With fingers carefully placed behind the heart to
protect the atria, the trachea and blood vessels supplying the heart were cut. Care
was taken to ensure that a reasonable length of aorta was preserved to allow later
cannulation. The heart was then placed into a beaker of ice cold saline solution.
The transfer to cold solution is made to stop contraction and reduce metabolic rate.
Two pairs of small, serrated, tipped forceps were used to pick the heart up by the
aorta and slip it over the cannula on the down tube of the perfusion apparatus. The
down tube is a short piece of silicon tubing that descends from the heated water
jacket and joins on to a small steel tube, the cannula. An arterial clip held the heart
in place whilst a silk ligature was tied around the aorta. A fine groove lathed in to
the stainless steel cannula prevented the ligature from slipping. The flow rate was
increased to give a constant perfusion rate of 40ml/min by a peristaltic pump
(Gilson Minipuls 3). The time taken from removal of the heart (and asystole) to
artificial reperfusion with saline solution was usually less than 2 minutes. Once the
heart was mounted on the apparatus a small incision was made in the pulmonary
artery to allow the perfusion solution to flow freely. The heart then began to beat
as coronary vessels were flushed of blood. Fatty and fibrous tissue was then
removed.
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Next, a latex water filled balloon was inserted in to the left ventricle (LV) via the
left atrium (LA) and secured with a silk ligature. A pressure transducer monitored
the left ventricular developed pressure (LVDP). The balloon was initially empty,
but was inflated after insertion to fill the cavity of the left ventricle. Balloon
inflation was adjusted to give a zero end-diastolic pressure. The volume of the
balloon could be set either manually or with a computer-controlled linear motor
driven pump. A second pressure transducer, situated at the top of the down pipe,
was used to measure the perfusion pressure. An increase in perfusion pressure
might indicate a block in the coronary vessels either by air, blood clot or debris.
Perfusion pressure, peak-systolic and end-diastolic pressures were used to monitor
the condition of the heart throughout the experiment.
Many experiments in this study involved pacing the heart over a range of cycle
lengths (typically between 150ms and I250ms). To obtain this large range in CL
the intrinsic heart rate had to be reduced. The intrinsic heart rate of the rabbit is
normally 180 beats/minute (CL=350ms), therefore the heart can normally be paced
faster than intrinsic, but not slower. Therefore, the entire right atrium (RA) was
dissected away from the whole heart. This procedure removed the sinoatrial node
(SAN) and hence the heart's primary pacemaker. The exact location of the
atrioventricular node (AVN) could often be discerned by a short period of asystole
that occurred when light pressure was applied to the correct region of the
interventricular septum. The AVN was located using a pair of fine tipped forceps.
A small amount «O.05rnl) of 5% formaldehyde was injected locally over several
applications. Usually this slowed the heart rate considerably, although sometimes
further action needed to be taken which involved stabbing the AVN region with the
syringe, or pinching the AVN region with fine tipped forceps. Often it was only
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necessary to give the AVN region a small pinch, this omitted the requirement of an
injection of formaldehyde. Itwas an unusual occurrence that this procedure did not
work. However, occasionally it was not possible to slow heart rate by these
methods. It was important to not compromise the condition of the heart by over
damage through ablation.
A pair of platinum pacing electrodes was hooked into the base of the right ventricle
(RV). Stimulation voltage was adjusted to twice diastolic threshold. A Digitimer
DS2 stimulator was used to provide constant voltage pulse with a width of 2ms.
Timing of the pulse was controlled with a PC running a locally developed program.
2.1.3 Electrical recording
Figure 2.2 shows a schematic diagram of the electrical equipment used in whole
heart experiments. MAPs, perfusion pressure and intraventricular pressure were
displayed on, and a paper record produced, by a chart recorder (Gould Electronics,
Ohio, USA.). Single channel MAPs were displayed on an oscilloscope (Nicolet
Instrument Corporation, Wisconsin, USA.). MAPs were recorded from the
epicardial surface of the LV via contact electrodes that were connected to a 32
channel custom-built MAP amplifier (Dr. Mark Watts, Glasgow Royal Infirmary).
The signals were digitised by a multichannel analogue-to-digital board (National
Instruments Corporation (UK) Ltd). All 32 channels could be displayed
simultaneously on the computer screen in real time. Data were stored on computer
disc for analysis. Data acquisition was via a custom made computer program
(Dr. Francis Burton, University of Glasgow).
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The heart was stimulated via bipolar pacing electrodes that were driven by a
computer system to allow customised pacing protocols to be used. One particular
pacing protocol (refer to specific methods sections of results chapters) was used to
induce VF via a catheter inserted in to the right ventricle. The catheter was
connected to a stimulator (Digiti mer, UK) which allowed increasing current pulses
to be applied to the heart. This stimulator was different to the afore mentioned one
that delivered a voltage pulse. The VF induction stimulator supplies a constant
current pulse.
42
Chapter 2 - General Methods
'E'
C3 s I""'"
\0 Sb '.::I Pot s5 'In :.e Pot ~~';'Q 0.. +=I ~
C/2 S 0 0
._ ~
u ~
C/2 ::s
£=~
~
C/2 'S 0..
0 "0 = 0'" 8
,~~ ~
- 1:: 5 ~ U1-1 -,_ O<X:Uu = u
~~~
C/2 .d ~ -0 U~
Pot
~Pot ..21l-.
1-1 gp<x:
U)~
C\J
M
..cl
0
~ U
~~ 8
C> O~ <x:MI .......... M
N S..cl ..cl§ bl)C/2 0 0 n<X:
+=I Q ~u
""'
;cog.e ~ 5.1:3
S ~ u u.d ~ ~
~~ ~~>u -I
-I
r---
C/2~
"0 "001)0 ""' I""'"Q.1:3 =
t'--
,_ U
N 0U ~ ~
~tn = - ~tn r.n t=0 Pot~ =0 s ::s ....~ , ~ , - '.Q - :35.6 ~ 6~ u ] 8~uu u> Q8 tnU -U
-
Figure 2.2 A schematic of the electrical set-up used for stimulation
and recording during whole heart Langendorff perfused experiments.
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2.1.4 MAP analysis
MAPs were analysed off line using a computer program developed locally. This
allowed semi-automated analysis of up to 32 channels of MAP signals.
Measurements extracted included: MAP duration at 50% and 90% repolarisation
(MAPDso and MAPD90 respectively), conduction delay (time from stimulus artefact
to MAP upstroke) and MAP amplitude,. Figure 2.3 illustrates these parameters
diagrammatically.
The MAP amplitude is measured from the baseline (the resting membrane
potential, RMP) to the crest of the MAP plateau. The peak of the upstroke (or
'overshoot') is an intrinsic deflection indicative of the time at which the excitation
wavefront passes underneath the electrode. MAP upstroke may be used to define
and characterise local electrical activity (Levine at al, 1986).
MAP duration is the time from onset of Phase 1 to return to the RMP. The time to
100% repolarisation (second derivative d2V/dt2) is not commonly used as a
measure of repolarisation although Efimov et al (1994) used this measure of
repolarisation and obtained accurate data. Using the second derivative amplifies
noise, making measurement of repolarisation inaccurate. MAPD90 is the most
commonly used point to provide information regarding repolarisation of the MAP
and is generally the accepted level for analysis as it is so ubiquitously used.
MAPDso is also used as changes in this can be indicative of ischaemia.
In this study, agents were used that affected conduction delay. Conduction delay
was measured as the period of time between stimulus artefact and maximum
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upstroke (Vmax), i.e. the time taken for the wavefront to move from the point of
stimulus to under the electrode(s).
Table 1.1 (taken directly from Franz, 1999) outlines the criteria set to describe a
good quality MAP.
1. MAP amplitude (baseline to plateau crest) not <10mV
2. Fast, clean upstroke (rise time not longer than 5ms)
3. No major contamination by intrinsic deflection or QRS
4. Smooth, upwardly convex plateau
5. Horizontal diastolic baseline (no undershoot during mechanical diastole, and no
upsloping potential for remainder of diastole)
6. MAP wave forms closely similar during normal and ectopic activation sequence
Table 2.1 Criteria for an optimum quality monophasic action potential.
The quality of MAPs obtained in this study is considered, for several different
methods of MAP recording, in chapter 3.
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Figure 2.3 Illustrative MAP showing analysis parameters.
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2.2 Single cell preparation
2.2.1 Single cell dissociation
Single left ventricular epicardial myocytes for fractional cell shortening and Ca2+
handling measurements were obtained using a different Langendorff perfusion
system to that described for whole heart electrophysiology experiments.
Prior to cannulation of the heart, de-ionised water was perfused through the system
to cleanse it. Base Krebs solution of the following composition (mM): 120 NaCI,
20.0 Hepes, 5.4 KCl, 0.56 NaH2P04, 3.5 MgCh6H20, 20.0 Taurine, 10.0 Creatine,
ll.l Glucose, was heated to 37°C. Two small beakers of Base Krebs were placed
in the freezer to cool ready for the heart dissection. Base Krebs solution containing
0.075, 0.125, 0.25, 0.5 and a l.OmM CaCh and 1% Bovine Serum Albumin (BSA)
solution were made. These were also heated to 37°C.
The dissection of the heart was performed as described for the whole heart
electrophysiology experiments. On removal, the heart was placed in the pre-chilled
Krebs solution and fatty and fibrous tissue quickly removed. The heart was
cannulated on the Langendorff apparatus and perfused with Base Krebs and then a
protease (0.0004% )/collagenase (0.07%) enzyme solution. After 1 minute the
enzyme was collected and re-circulated. Approximately 2-3 minutes in to the
digestion time CaCh was added to the re-circulating enzyme to make a 46.67 ILM
solution. After approximately 9-10 minutes (dependent on the size of the heart)
perfusion was switched to a low Ca2+ (0.075 mM)IBSA solution.
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The atria and right ventricle were removed and discarded. The epicardial layer of
the left ventricle, which comprises approximately the top l mm of the myocardium,
was dissected away from the left ventricle. The section was finely cut and placed
in low Ca2+ (0.125mM)IBSA solution (further referred to as (concentration) CaCh
solution). The preparation was then shaken at 37°C in a heated water bath for 60
minutes. After this time the supernatant from the preparation, containing single
cardiac myocytes, was decanted in to a centrifuge tube which was then gently spun.
The supernatant resulting from the spin was then discarded and the cells
re-suspended in 0.25mM CaCho The cells were then left to settle, which took
approximately 20 minutes. Once cells settled the supernatant was discarded and
the cells were re-suspended in 0.5mM CaCho Again, the cells were left to settle,
the supernatant discarded and the cells re-suspended in 1.OmM CaCh solution.
The cells were then ready for use.
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2.2.2 Single cell shortening/Ca'" measurements
Cell length shortening measurements and changes in cytosolic Ca2+ concentration
were measured using the set-up that is schematically illustrated in Figure 2.5. The
system was initially primed with a HEPES buffered Krebs solution of the following
composition (mM): 140 NaCl, 4.0 KCI, 0.3 Na2HP04, 1.0 MgCh 5.0 HEPES, 11.1
glucose, 1.8 CaCh. Cells were loaded with an initial concentration of IO)lM Fura-
2 AM in Krebs for 5 minutes at room temperature. The cell aliquot was diluted
with double the volume of superfusate to prevent any further loading of the cells
with Fura-2 AM. The pH of the solution was adjusted to pH 7.4 at 37° using
NaOH. The cell bath was superperfused at 37°. A small heater located within the
tubing from the stock solution to the cell bath warmed the superfusate. The
metallic cell bath was also heated. The superfusate outlet was mounted on a
micromanipulator that allowed perfusion directly next to the cell. Solution changes
were performed using a custom made 4-way solution changer. Single cells were
stimulated using 2 Ag-AgCI electrodes that were positioned either side of the
superfusate outlet and hence single cells were also stimulated directly. Square
wave pulses of 10ms duration were delivered to the electrodes at 80-90V using a
Digitimer DS2 stimulator.
The area of the microscope field in which fluorescence was measured was
restricted by an adjustable rectangular window on the side port of the microscope.
Cell orientation and window size was adjusted so that fluorescence and shortening
of a single cell was measured. A Xenon arc lamp source and spinning wheel
system rotating at 60Hz (Cairn Research Systems) stimulated fluorescence at
340nm and 380nm. A red filter selects the bandwidth of light that passes to the
cells, allowing only the bandwidth of light corresponding with the emission spectra
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of Fura-2 to pass. A 500nm long pass filter was used to collect wavelengths above
500nm which were then passed through a dichroic mirror to a photomultiplier. A
spectrophotometer (Cairn Research Systems) was used to measure the output from
the photomultiplier. A ratiometric measurement of intracellular Ca2+ concentration
was obtained from fluorescence emitted at 340nm and 380nm. These
measurements plus a ratio of the two were displayed on a chart recorder (Gould
Instruments Ltd), recorded to video tape, digitised to the data acquisition computer
program Whole Cell Program (WCP) (John Dempster, Strathclyde University) and
stored on hard disk. A schematic illustrating the single cell shortening/Ca "
measurement set-up is shown in Figure 2.5.
Cell shortening measurements were recorded simultaneously with Ca2+ transients
where possible. Ca2+ transients and shortening measurements from cells stimulated
at 1hz and 3hz were recorded under a variety of conditions. The variable
rectangular window was used to capture a single cell, which was displayed on a
monitor and recorded on to video tape. The intensity profile of the cell along a line
was positioned to run from one end of the cell to the other (length) and was
represented on an oscilloscope. The edges of the cell were represented as a
positive deflection for the left edge and a negative deflection for the right edge of
the cell. The windows and thresholds were adjusted so as to obtain a shortening
measurement alongside the Ca2+ transient on a separate oscilloscope. The
contractions were displayed and recorded in the same way as for the Ca2+.
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Figure 2.4 Schematic of the single cell shortening/Ca2+ measurement
set up. OM (dichroic mirror).
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2.2.3 Data analysis
Data were analysed off line using the computer program WCP. Using this
program, the last 8 Ca2+ transients and cell shortening measurements from periods
of recording were averaged. Measurements were rejected if not worthy of analysis.
Usually a trace was rejected if the signal to noise ratio was too high, although this
was not a quantitative measurement. Data were exported to a computer graph
program Origin (Microcal) and converted using a template (Prof. Godfrey Smith,
Glasgow University) to Fura-2 ratio and cell length (urn). Fractional shortening
was calculated and represented as relative changes in end systolic and end diastolic
length whilst the Ca2+ content of the cell was represented by the relative changes in
end diastolic and end systolic Fura-2 ratios. Figure 2.6 show how these parameters
were defined; Figure 2.6a illustrates the parameters used for the measurement of
fractional cell shortening, and Figure 2.6b for the measurement of Ca2+ transients.
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End Diastolic Length
Peak Systolic Length
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A. Parameters measured to calculate contractility of isolated single
cardiac myocytes. Percentage fractional shortening = (End systolic length
I End diastolic length) x 100.
Peak systolic Fura-2 ratio
End diastolic Fura-2 ratio
I
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I
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B. Ca2+ transient illustrating parameters measured.
Figure 2.5 The parameters used for measurement of single cell
fractional shortening (A) and Ca2+ transients (B).
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2.3 Statistical analysis
All statistical tests were performed using the DOS based computer program Instat.
Individual tests are indicated at the relevant points in the text. The null hypothesis
is a term that statisticians often use to indicate the statistical hypothesis tested. The
purpose of most statistical tests is to determine if the results obtained provide a
reason to reject the hypothesis that they are merely a product of chance factors.
E.g. in an experiment in which two groups of randomly selected subjects have
received different treatments and have yielded different means, it is always
necessary to ask if the difference between the obtained means is among the
differences that would be expected to occur by chance whenever two groups are
randomly selected. So, if the null hypothesis is true, the P value is the chance that
random selection of subjects would result in a difference as large (or larger) than
observed in the study. If the null hypothesis is true, there is a 5% chance of
randomly selecting subjects such that the trend is statistically significant.
2.3.1 Student's t-test
Paired and unpaired t-tests test the hypothesis that the mean value of a variable
differs between 2 groups. The paired t-test is used when each data point in one
group directly corresponds to a matching data point in the other group. The
unpaired Hest compares the means of 2 groups. When there are 3 or more data
sets to be compared multiple t-tests are not appropriate and the ANOV A (see
below) should be used instead. In using the Student's t-test, the data are assumed
to be continuous, with a normal distribution and equal variances in the two groups.
However, Hest is robust to departures to the assumption of normality, but is more
sensitive to unequal variances. Where a t-test was not appropriate for these reasons
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the non-parametric equivalent test (Wilcoxon test) was used. Where multiple
t-tests were applied a Bonferroni correction was also used.
2.3.2 ANOVA (Analysis of variance)
ANOV A is used to analyse data between 3 or more groups. One-way ANOV A
tests the hypothesis that the mean value of a variable differs among groups. Post
tests (Tukey) were also applied. The limitations of ANOVA are the same as those
for the t-test (see above); if these are not satisfied non-parametric tests are
available.
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Chapter 3 - Methods of recording cardiac electrical activity
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3.1 Development of methods used to record MAPs
In the clinical setting, there are several different methods that can be employed to
investigate electrophysiological abnormalities in the heart. Monophasic action
potential (MAP) recordings are one of the most recent developments in the
recording of local myocardial activity, both in the normal and pathological state.
MAP recordings are now commonly being used where no other technique is viable.
There are several different methods used to record MAPs that will be discussed
later. Firstly, attention shall be focused on other methods of recording
repolarisation times.
3.1.1 Unipolar and bipolar recordings
Before the technique of MAP recording was developed, local myocardial electrical
activity was recorded using biphasic or multiphasic deflections recorded by
unipolar or bipolar contact electrodes. These electrodes detect activation well but
provide little information concerning refractoriness and repolarisation. Activation
and repolarisation are detected, but the membrane potential during the process
between the two is not. Nevertheless, attempts to use these limited repolarisation
transients obtained using the unipolar configuration have regularly appeared in the
literature (Chinushi et al, 1998, Taggart et al, 2001) as "activation recovery
interval" (ARI). Therefore, information regarding repolarisation times can be
obtained by measuring the ARI. Activation is indicated by a sharp deflection in the
trace whereas the recovery (repolarisation) is indicated by a small 'bump' in the
trace. In this methodology, the interval between the activation complex and the
repolarisation bump (analysed by dY/dtmax and d2Y/dt2 respectively) is used as a
measure of repolarisation time. The ARI therefore indicates the time between the
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activation complex and repolarisation, but gives no indication of what is occurring
electrically during the repolarisation period. The advantages and disadvantages of
unipolar and bipolar electrodes are shown in Table 3.la and 3.lb respectively.
ADVANTAGES DISADVANTAGES
Lack of directional sensitivity Low amplitude local activity may be
obscured
Less severe myocardial contact
Definite criterion for detection of local
activation - maximum negative dV/dt
A. Advantages and disadvantages of the unipolar electrode.
ADVANTAGES DISADVANTAGES
Detects low amplitude local activity well Requires close contact with the
myocardium
Amplified easier than unipolar recordings Various criteria adopted for the detection
of local activity
Easier to reduce noise
B. Advantages and disadvantages of the bipolar electrode.
Table 3.1 The advantages and disadvantages of unipolar (A) and
bipolar (B) electrode recording.
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3.1.2 Transmembrane action potentials
The transmembrane action potential (TAP) may be considered the gold standard to
which other methods of recording are compared. The TAP is recorded by insertion
of a KCl filled glass microelectrode, with a tip diameter of approximately O.5f,.lm,
into a single myocyte. An extracellular ground electrode is placed near the cell
membrane in the surrounding fluid contained in the tissue bath, this permits a
potential difference to be recorded between the extracellular and intracellular
voltages.
3.1.3 Monophasic action potentials
MAPs are extracellular wave forms which provide accurate information on the
local activation time as well as representing the repolarisation time course of the
local electrical activity of excitable myocardium. MAPs resemble the TAP both in
configuration and duration (Franz, 1983; Levine et al. 1986; Runnals et al.
1987;Yuan et al, 1994). Whereas the MAP is recorded extracellularly, TAPs,
which have been previously discussed, are recorded via the impalement of
individual myocytes by a glass microelectrode and are therefore limited to in vitro
applications. MAPs however can be recorded from the endocardial and epicardial
surfaces of the in vivo and in vitro intact beating heart, including that of human
subjects. This allows the utilisation of such a method in the clinical as well as
experimental situation. The main applications of MAPs include: i) rate and rhythm
dependent changes in MAP duration (restitution), ii) investigation of the effect of
antiarrhythmic drugs, iii) triggered activity that may cause early- or delayed
afterdepolarisations, iv) detection of myocardial ischaemia, v) measurement of
dispersion of repolarisation/refractoriness, vi) measurement of activation times and
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vii) the effect of mechanoelectrical feedback on arrhythmia formation (Yuan et ai,
1994).
In comparative studies of the MAP and TAP recordings it has been concluded that
MAPs are not absolute representations of TAPs (Franz et al. 1986; Runnals et ai,
1987). Whilst the TAP is a recording from a single myocyte, the MAP electrode
records from a number of cells. The cells over which the MAPs record from
depolarise sequentially with time. This is thought to produce an action potential
with a lower amplitude (lO-50mV from a MAP recording compared to 120mV
from a TAP recording (Franz, 1991)) and slower maximum upstroke velocity, Vmax
(6.4V/s for the MAP compared to 200-300V/s for the TAP (Franz, 1991))
(Hoffman et al, 1959). Other factors influencing the MAP amplitude, as described
by Hoffman et al, include; the magnitude and direction of local current flow; the
degree of cellular coupling between the depolarised cells under the MAP electrode
and the adjacent normal cells; and the electrical conductance in the extracellular
and intracellular media surrounding the site of recording.
Monophasic action potentials have previously been used to characterise ventricular
fibrillation (VF) (Swartz et al, 1993), an observation that is near impossible using
the intracellular transmembrane method of recording. They characterised
monomorphic ventricular tachycardia by a regular shaped action potential in the
absence of electrical diastole. Ventricular fibrillation/polymorphic ventricular
tachycardia was characterised as a random event where re-stimulation occurred
prior to a resting membrane potential (Le. incomplete repolarisation and an absence
of resting membrane potential). Again, there was an absence of a diastolic interval.
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In 1882, Burdon-Sanderson and Page recorded monophasic action currents (later
termed potentials) from the frog heart by placing an electrode on uninjured, intact,
epicardial tissue and another on an injured site; hitherto only multiphasic
deflections had been used to record myocardial electrical activity. In 1951 Draper
and Weidmann, in experiments on the chordae tendinae ('false tendons') of the dog
heart, discovered that the transmembrane action potential was also monophasic.
For many years it was thought that injuring the myocardium was the only method
through which MAPs could be produced. The suction electrode method, devised in
1935 by Shultz (Franz, 1999), uses injury to generate MAP transients. Several
years later (Korsgren et al. 1969) demonstrated the use of the suction electrode in
recording electrical activity in the human subjects.
3.1.3.1 Suction electrode
This technique is based on the principle that when contact is made with the
myocardium, surface tissue is sucked into the tip of the catheter tubing, causing the
cells in this tissue to become ischaemic, and after a short time, inexcitable. The
electrode records the membrane potential difference between the still excitable
cells adjacent to the tip of the electrode and the inexcitable cells beneath the
electrode. A schematic drawing of a suction electrode is shown in Figure 3.1a.
There are several disadvantages in using the suction electrode for MAP recording:
a) Because of excessive injury that the electrode incurs to the myocardium at the
site of the electrode, the application of such a technique is limited to periods of
time less than approximately 2 minutes, after which localised ischaemia becomes
prominent. b) The necessity for pumps, stop-cocks, and the physical size of the
electrode itself makes the use of the suction electrode awkward. c) When recording
from the artificially perfused heart, the mechanical movement of the heart tends to
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cause motion artefacts that distort the MAP. The existence of these limitations led,
in part, to the development of the contact catheter electrode (which is a non-
traumatic method of recording MAPs). A major disadvantage of the suction
electrode, which is of special importance in this study, is the impracticalities (see
above: size, time limitations, motion artefacts) of using it to make simultaneous
recordings.
3.1.3.2 The contact catheter electrode
Franz developed the catheter electrode in 1983 and this is still the choice method
for evaluating myocardial repolarisation times in the clinical setting today. This is
primarily because it offers a less traumatic (in terms of tissue damage) way of
recording MAPs. Using the catheter electrode to record MAPs involves pressing a
non-polarisable Ag-AgCI electrode against viable myocardium (endo- or epi-
cardium). Typical electrode tips have a diameter of approximately 1 to 2mm. The
shape of a commonly used contact catheter electrode is shown in Figure 3.1b.
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EXPLCRtNG ELECTROOE
REFERENCE elECTRODe
A. The epicardial suction electrode. Taken from Leimer and Cestari
(1999).
Recording
Electrodes
Pacing
Electrodes
B. Tip of a MAP Catheter Electrode.
Figure 3.1 Schematic drawings of the suction (A) and contact catheter
(B) electrodes.
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3.1.3.3 MAP genesis
In attempting to explain how his contact catheter works, Franz (1999) proposed the
following mechanism. The force that the electrode tip exerts on the myocardium
causes the cells subjacent to it to depolarise to a fixed voltage of between -20 and
-30m V with respect to the diastolic extracellular reference potential. At this level,
Na+ channels are inactive and hence cannot contribute to the action potentials
occurring in the adjacent excitable cells. Assuming that electrical coupling is
unaffected, an electrical gradient is formed between the inexcitable cells and the
adjacent excitable cells, and electrical current is able to flow between the two.
When the heart is electrically diastolic, the cells subjacent to the electrode tip act as
a current sink; in systole, they act in the opposite way, as a current source. This
produces electrical fields of opposing polarity. Figure 3.2 summarises this
hypothesis.
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Figure 3.2 Diagram illustrating the hypothesis underlying the genesis
of MAP recording by contact electrode (adapted from Franz, 1999). (a)
Late electrical diastole. The cells are -90mV with respect to the outside.
The cells subjacent to the electrode tip are depolarised to a fixed voltage of
-20mV. The boundary gradient between the depolarised and surrounding
excitable cells creates current flow (circular lines). Here the depolarised
region is the current sink, The MAP recording (upper right) displays a
steady negative potential. An arriving action potential arrives at the site
(lower right). (b) Early electrical systole. An action potential arrives at the
contact site. The boundary current and the field polarity potential are
reversed. The MAP moves in the positive direction (upper right). (c) Mid
electrical systole. The propagating action potential has completely
encompassed the electrode site. The boundary gradients gradually
diminish and the MAP shows repolarisation.
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Because myocardial injury is less than with the suction electrode the contact
electrode method allows stable MAP recordings to be made over longer periods of
time (up to several hours). The ability of the contact electrode to record MAPs
long term with no myocardial injury is one of the reasons why it has succeeded the
suction electrode as the preferred method of recording in the clinical setting. This
raises the question: can cells be depolarised by applying pressure without causing
permanent injury? From preliminary experiments conducted as part of this study
where MAPs were recorded under excessive pressure, the electrode removed and
re-applied and MAPs recorded under light pressure, there is reason to believe that
permanent injury does not occur, at least on relatively short time scales (seconds to
minutes). However, in practice, several factors may militate against long term
usage. Firstly, the difference in pressure between the electrode and the epicardium
that is required to obtain sufficient depolarisation for a full amplitude MAP, and
that which causes localised ischaemia, seems to be small. Secondly, when a MAP
of acceptable amplitude is obtained where the electrode is very lightly touching the
surface of the epicardium, it is very likely that the amplitude of the MAP will
decline to the extent that analysis of durations becomes impossible or unreliable
(after approximately 20-40 minutes). Within limits, increased contact pressure
leads to an increase in the amplitude of the MAP. Even when contact pressure is
constant, amplitude tends to increase initially. Over a longer time scale the MAP
amplitude maya) stabilise at a maximum, b) decrease and stabilise or b) continue
to decline until it is inseparable from the background noise. A continued decrease
only usually occurs when the electrode has been left in place for an excessive
amount of time.
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The situation is further complicated by the changes in contact pressure caused by
the contractions of the heart - a problem not so easily overcome. In addition,
lateral movement of the electrode may cause artefacts on the recorded extracellular
waveform. Because the electrode is not physically attached to the heart,
contractions of the ventricle may move the electrode rhythmically, causing
distortions of the MAP. In practice, these motion artefacts could be reduced to
some extent by minimising heart motion in the Langendorff perfused set-up by
using a concave cradle on which the heart rests. However, it is possible that
contact pressure changes may produce transient alterations in the MAP amplitude
are confused with true electrophysiological changes. Despite these disadvantages.
the catheter electrode is relatively reliable in terms of a) obtaining usable MAPs
and b) repeatability of MAP measurements. Patient setting up can yield high
quality (see Franz, 1999, for the criteria of high quality) MAPs that may be
recorded over long periods of time.
Simultaneous multiple MAP recording is a technique that allows an accurate
measure of the dispersion of repolarisation to be obtained. Several groups have
made an attempt to simultaneously MAP repolarisation in the whole heart. A
multiple catheter electrode array was constructed by Franz (1992), based on a
cantilever mechanism (Figure 3.3). The device held 6 extensions, 3 of which held
cantilever arms attached to a coiled wire spring mechanism. Custom made Ag-
AgCl bipolar contact MAP electrodes were mounted in the distal end of the
cantilever arms. By adjusting the tension of these springs constant contact pressure
between the electrodes and the heart was maintained. When considering how best
to obtain multiple measurements from whole hearts in the present study, it was
decided that the intricacies of such a mechanism and the difficulty in manipulating
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the positions of the electrodes were impractical as a method of obtaining more than
3 simultaneous recordings using the contact catheter.
B61100n
electrodes
/
-
A. Buffer Reservok I. Heart
8. Ron. Pump J. MAP gecbode
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Figure 3.3 Experimental set-up used by Franz et a/ (1992) to
simultaneously record 3 MAPs using a cantilever and spring
mechanism. Taken directly from Franz, 1992.
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3.2 The contact catheter electrode - preliminary investigations and
limitations
3.2.1 Methods
Preliminary experiments were done to find out how long it takes for stable MAP
recordings to be obtained. In this context stable MAP recordings may be defined
as a state where no change in MAP duration is seen with time. A short protocol
involving cycle length (CL) changes at 4 minute intervals was conducted. This
involved pacing the heart at a constant CL of 350ms, followed by a change to
250ms, a return to 350ms, a change to 200ms, and a return to 350ms. Returning
the basic CL to 350ms between changes in CL enabled determination of recovery
of MAP duration following abrupt changes in CL.
The optimum contact pressure between the electrode and the myocardium was
determined by applying the catheter to the epicardium at different pressures. The
heart was paced at 350ms and perfused at 37°C with standard Tyrodes solution.
Initially a very light contact pressure was maintained for 15 minutes. The electrode
was then re-applied to the same location on the epicardium with firm pressure for a
period of 15 minutes. The pressure applied to the myocardium was not quantified.
MAPDso, MAPD90 and MAP amplitude were recorded. The ratio
MAPDso:MAPD9o was calculated in order to reveal changes in MAP morphology, a
decreasing ratio would indicate triangulation of the MAP. Triangulation of MAPs
is associated with ischaemia.
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3.2.2 Results
3.2.2.1 Time to steady state
A single experiment from a protocol carried out to determine the time taken for the
MAPs to stabilise is shown in Figure 3.4. Recordings were made at cycle lengths
of 350ms, 200ms, 350ms, 250ms and 350ms. Stabilisation is taken as time to
observation of no changes in MAP duration. Here, MAPDso and MAPD90 are
plotted against time. From these data a minimum period of 3 minutes is required to
allow stabilisation. From this it was concluded that a stabilisation period of 4
minutes should be allowed in subsequent experiments. MAPD90 returns to its
initial value on a return in pacing cycle length from a faster pace to the basic CL of
350ms. However, in this trace, a slight shortening of MAPDso was seen between
the start and the end of the run. This change may indicate a slight 'run down' in
this example, possibly due to mild ischaemia caused by slightly excessive contact
pressure between the electrode and the myocardium.
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Figure 3.4 Typical experiment illustrating the time required to ensure
stabilisation of MAP recordings. Both MAPD50 and MAPDgo are shown.
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3.2.2.2 The effect of electrode contact pressure on MAP recordings
Figures 3.5 illustrates the effect of a light (A) and a heavy (B) electrode contact
pressure on MAPDso and MAPD9o. Recordings were made at a steady state cycle
length of 350ms. Light contact between the electrode and the epicardium results in
a stable MAP recording where no increase or decrease is seen in MAPDso or
MAPD90 after the initial 4 minute stabilisation period. However, excessive
pressure between the catheter and the epicardium was seen to cause a triangulation
of the MAP. This is observed as a greater reduction in MAPDso relative to
MAPD9o, and is illustrated in Figures 3.6 by a drop off in the ratio
MAPDso:MAPD9o. This drop off is not observed with light contact.
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B. Excessive contact pressure between the electrode tip and the
myocardium causes a decrease in MAP durations, this is more evident in
MAPD5o.
Figure 3.5 The effect of contact pressure on MAP duration and
amplitude.
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A. MAPD50:MAPD90 under light contact pressure remains unchanged
where there is light contact between the electrode and the surface of the
epicardium indicating a MAP morphology is maintained.
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B. MAPD50:MAPD90 under conditions of excessive electrode
pressure decreases indicating a triangulation of MAP as part of a
continuing change in MAP morphology.
Figure 3.6 The effect of contact pressure on the ratio MAPD50:MAPDgo.
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3.3 The syringe electrode - construction and preliminary
investigations
3.3.1 Construction
The main objective of this part of the study was to develop a multiple MAP
electrode array that could be used to simultaneously record up to 32 MAPs from
the epicardial surface of the left ventricle. A unipolar electrode array had
previously been developed by Dr. F. Burton (University of Glasgow). This array
allowed the simultaneous recording of up to 256 unipolar electrograms from the
epicardial surface of the left ventricle. This array consisted of Ag-AgCI wires
embedded in a latex jacket (sheath). Developing a single syringe electrode on a
spring mechanism (Figure 3.7) tested the feasibility of using a latex jacket
electrode for the simultaneous recording of monophasic action potentials. MAP
genesis by this method would arise through the same mechanisms as previously
described. An electrode, the equivalent of the contact catheter electrode, would
protrude though the latex and would impart to the myocardium the needed force for
depolarisation of the myocardium. It was envisaged that other electrodes would be
recessed into the latex to act as reference electrodes. To explore this possibility, a
syringe was constructed with 3 of these reference electrodes to determine whether a
configuration yielding recognisable MAPs could be obtained. The rationale of
using 3 reference electrodes was that it might adequately approximate the ring with
a wide field of view corresponding to the reference electrode in the Franz catheter
(Figure 3.1b).
The syringe electrode consisted of a 2.5ml plastic syringe, a small circle of latex
cut from a thin sheet, a metal spring and 4 pieces (for a 3 reference electrode
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syringe) of insulated silver wire. The syringe was dissembled, and the plunger and
plunger tip removed. The spring was placed over the plunger and the barrel of the
syringe pulled on top to allow a spring action. The latex was moulded to allow one
protruding depolarising electrode and 3 recessed electrodes to be added. The latex
was fixed over the syringe using suture thread. The electrode terminals were made
by melting the end of the Ag insulated wire with a small blow torch to form a 'ball'
head. The more wire that was melted, the larger the terminal was, and possibly the
more myocardial depolarisation incurred. 3 of the 4 wires are blown to a smaller
size than the remaining 1 that is used as the protruding electrode (Figure 3.7).
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Figure 3.7 The syringe electrode including transverse section of the latex
showing the recessed and protruding electrodes.
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3.3.2 Methods
The syringe was held in place against the heart with a multi-hinged device (made
from parts found around the lab) that allowed full movement of the electrode
around the left ventricle. The spring mechanism enabled electrode contact with the
myocardium despite cardiac movement. Once the electrode was positioned against
the myocardium the heart was paced at a constant cycle length of 350ms for 4
minutes to allow stabilisation of MAP duration. During these preliminary stages
steady state restitution protocols (to measure rate dependent changes in action
potential duration) were performed as a test of the feasibility of the method. The
AVN and SAN were ablated (refer to chapter 2, general methods) and the heart
paced at 350ms for 4 minutes prior to the start of incremental changes in pacing
rate. A range of cycle lengths was explored from a minimum of 150ms to the
longest cycle length at which interference from intrinsic ventricular depolarisations
did not occur.
3.3.3 Results
The syringe electrode produced excellent results when MAP quality was good.
The restitution curve from a single experiment is shown in Figure 3.8. The results
show the shape of a typical restitution curve and indicate a sound working
electrode.
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Figure 3.8 A typical restitution curve obtained from the epicardial
surface of the left ventricle with the syringe electrode.
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In general, and under good conditions, the syringe electrode yielded better shaped
MAPs over a longer time period than the catheter electrode. However, the MAPs
recorded using this method were of lower amplitude than those of the contact
catheter. At low amplitudes contamination of the recordings by noise became
problematic: as the amplitude decreases with time, the error in the MAP duration
determination increases to the extent that the recordings can no longer be analysed.
On first contact with the epicardium, the MAPs obtained using the syringe
electrode did not seem to show the initial increase in amplitude that is seen with the
catheter electrode. Drift in baseline was also greater than with the catheter
electrode. On initial contact with the epicardium, and on obtaining a recording, a
considerable amount of drift is observed which, on the majority of occasions,
stabilised over time but is seen reproducibly at the start of each experiment. This
drift may be attributable to polarisation of the Ag as it becomes chlorided. This
was not observed with the catheter electrode.
It was not possible to use the syringe electrode on small hearts due to its size.
While the large area of the syringe end might have been expected to disperse the
pressure over a larger area and hence lessen the likelihood of the onset of ischaemia
it turned out to be unusable. This was because it caused the smaller hearts to
compress to an unacceptable extent causing a decrease in left ventricular developed
pressure (LVDP) and an increased perfusion pressure (PP) that was not observed
with the catheter. The relative size of the tip of the syringe also makes precise
location of the central electrode difficult, especially if the electrode is to be
removed from the epicardium and later replaced at the same site.
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The syringe incorporates a spring mechanism (see Figure 3.7) that allows a
constant contact pressure to be maintained. This helps in overcoming problems of
motion artefact. Nevertheless, support of the heart using the concave cradle was
still essential when using the syringe. In the absence of the cradle the spring
mechanism was defeated, because the unsupported heart was pushed away by the
syringe. Furthermore, motion artefacts appeared and smaller amplitudes were
obtained.
Following the success of the 3 reference electrode design, syringes incorporating 2
and 1 electrodes were built and tested. With 3 reference electrodes a consistent
MAP could be recorded despite the rotational position of the electrode. In contrast,
with only 1 reference electrode, only certain positions yielded a MAP like signal
necessitating rotation of the syringe (Figure 3.9). A syringe electrode with 2
reference electrodes also required no rotation.
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Figure 3.9 The effect of rotation of the syringe electrode. MAPs can
not be produced at all electrode positions on rotating the single reference
electrode syringe through 360°,
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3.4 The jacket electrode - development, construction, and
preliminary investigations
3.4.1 General construction of latex jackets and electrodes
Development of the jacket electrode array was driven by the desire to obtain
simultaneous recording of multiple MAPs to enable accurate measurement of the
dispersion of repolarisation across the epicardial surface of the left ventricle. The
jacket MAP array was an extension of the syringe electrode design with the 3
reference electrodes, using the latex technology developed by Dr F.L. Burton
(University of Glasgow). Initially a preserved heart was suspended in a container
of Sylgard silicone which was allowed to set, producing a heart shaped mould.
Liquid plaster was poured into the mould to make a plaster cast of the heart. After
hardening this was further sculpted and surface imperfections removed. The cast
was then painted with 2 coats of Hammerite to give a smooth finish. To produce
the recessed areas of the latex into which the 3 indifferent electrodes fit, Ag-AgCl
balls (also made by melting) were glued onto the 'left ventricle' of the cast at the
appropriate positions. The cast could then be used to manufacture any number of
latex jackets. The cast was dipped into liquid latex and air-dried, a process which
was repeated 3 times or until the required thickness was obtained. The jacket was
removed from the cast, the area corresponding to the right ventricle cut away and
discarded, all remaining edges reinforced with latex, and a hole punched in the
apex of the jacket to allow free drainage of the perfusate. Ag-AgCl electrodes were
fed through the recessed areas and a central protruding electrode fed through the
centre of the groups of 3 (exactly as described above, Figure 3.7). Ties (silk
ligature) were then inserted into the cut open edges, one pair towards the apex and
another towards the base of the jacket. These kept the jacket in position around the
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heart and also allowed contact pressure between the electrodes and myocardium to
be adjusted. The 2 pairs of ties were threaded through 2 short pieces of catheter
tubing to allow the tightness of the jacket around the heart to be adjusted. In the
early developmental stages, the electrodes were soldered to connecting pins and
connected to an 8 channel amplifier. However on completion of a 16 electrode and
full 32 MAP electrode the electrodes were soldered to 5 core wires that connected
to a custom-built 32 channel MAP amplifier. Results obtained during the
progression from 4, through 8 and 16, to 32 electrode arrays will be presented.
3.4.1.1 The 4 electrode array
The first step to building a 32 MAP electrode array was the 4 electrode array. This
electrode array was not embedded in a latex jacket, the electrodes were embedded
in to a strip of latex. This latex strip had 2 pins at either end that gripped in to the
epicardium. This method of holding the array on to the myocardium was found to
be unreliable as the strip would not maintain its position on the heart. Following
this attempt, the 4 electrode array using the jacket design was constructed. The
electrodes were arranged in a single line across the width of the jacket midway
between the base and the apex.
3.4.1.1.1 Methods
Steady state restitution protocols (to determine rate dependent changes in action
potential duration) were run to investigate the longer term viability of the 4
electrode array. For methods of the protocol refer to syringe electrodes methods.
The protocol was terminated when the pacing cycle length exceeded the intrinsic
cycle length.
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3.4.1.1.2 Results
MAPs were analysed at 50% and 90% repolarisation and the results plotted against
time. Figure 3.10 shows typical restitution curves from a single experiment where
3 MAPs have been obtained simultaneously using the 4 electrode array. A 4th
MAP was not obtained. A 75% success rate (3/4 electrodes) was the maximum
obtained at anyone time.
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Figure 3.10 Simultaneously recorded MAPs obtained from the
epicardial surface of the left ventricle by the 4 electrode array.
MAPDgo only is shown.
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3.4.1.2 The 8 and 16 electrode arrays
This stage of development was fairly rapid. The electrodes in these arrays were
arranged in an almost triangular fashion, tapering towards the apex of the heart.
The configurations of the electrodes from base to apex of the jacket were 4, 3, 1 for
the 8 electrode array and 6, 5, 4, 1 for the 16 electrode array. On average only 50%
of the electrodes yielded MAPs of quality sufficient enough to include in wavefront
analysis of restitution. This relatively low success rate could be attributed to a
gradient of MAP obtainability from base to apex. Basal areas tend to yield better
quality MAPs, at a higher success rate, than apical regions. This point has been
documented by Cowan et al (1987) in a study using a single MAP recording
technique. Clearly, the horizontal arrangement of the 4 electrode array would
preclude observation of such a gradient. Over this phase of development, the
stimulus protocols were refined to overcome the tendency of amplitude (and
ultimately the effective number) of the MAPs to decline over time.
3.4.1.3 The 32 electrode array
The 32 electrode array was constructed, from base to apex, with an 8, 7, 6, 5, 4, 2
electrode configuration. The 32 electrode array yielded good quality MAPs with a
25-50% success rate (i.e. 8-16 sites were usable). Figure 3.11 show photographs of
the array both alone (A) and on the experimental set-up during an experiment CB).
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A. The 32 electrode array showing apical and basal ties, intricacies of
the electrodes and a perspective on size.
B. The electrode array being used during an experiment. The
electrodes are connected via an intermediate plug board (at the left of the
picture) to a 32 channel MAP amplifier.
Figure 3.11The 32 electrode array.
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The elastic property of the latex enables electrode contact with the epicardium to be
maintained at all times when used with a heart that matches its shape and size. But,
because every heart differs in shape and size one jacket is not optimal for all hearts.
An inadequate fit may cause air to become trapped between the jacket and the
epicardium. If the air bubble lies beneath an electrode that signal is effectively
abolished. The ties permit a jacket to be used with a range of heart sizes by a
degree of tightening. However, even with these a good fit is not guaranteed. As
with the syringe electrode, the recorded MAPs are of lower amplitude than those
obtained with the catheter, they tend to diminish with time, and there is a
considerable amount of visible noise on analysis. A similar drift as seen with the
syringe electrode is apparent on first application of the jacket. In addition, because
the jacket is moulded to fit the shape of a heart, it is not possible to rotate the jacket
without losing contact between the epicardial surface and (some of) the electrodes.
Altering the position of the jacket more than a couple of millimetres can also cause
air to become trapped.
Several problems arose during the progress towards making a 32 electrode jacket,
some of which were overcome. One of the initial aims of this investigation was to
study infarcted hearts produced by coronary artery ligation. It was found that the
32 electrode array yielded extremely poor results from failure hearts. This was not
only due to the size of the infarct - severe infarctions may cover a large proportion
of the left ventricle - but also because the shape and size of these hearts varies so
much. The wide variation in the size of these hearts is due to the compensatory
hypertrophy seen in the tissue remote from the infarct. This makes it impossible to
construct a single jacket to work with all failure hearts. The stock hearts gave
roughly a 50% success rate from a single experiment (i.e. 16 of 32 electrodes gave
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good quality MAPs within minutes of setting up). However, the problem of
obtaining a sustained MAP recording for any reasonable length of time (> 1 hour)
persisted, despite the remaking of electrodes, and jackets, of different sizes.
3.5 Discussion and conclusions
With all of the electrodes described in this chapter it was impossible to predict the
quality of MAPs in advance. Apparent health and lack of surface abnormality was
no predictor of individual MAP quality. For example, a stock or control heart may
yield worse results, particularly when using the catheter electrode, in respect of
quality of MAP than a severely infarcted heart. Sometimes the syringe electrode
produced good quality MAPs that are sustained for a long period of time and are
fully analysable, and the catheter produced MAPs that do not begin to show signs
of ischaemia (as evident by triangulation of the MAP and reduction in
MAPD90:MAPDso).
Another problem lies in the nature of the epicardial surface: severely infarcted
hearts tend to have basally located fatty deposits that reduce the area over which
MAPs may be obtained. This problem also occurred in the control hearts, although
less often. MAPs were often not obtainable at one electrode site but were of very
high quality at another despite a uniformly healthy-looking epicardium. The
reason for this strange anomaly is unknown, but cannot be attributed to the
electrode alone because the same electrode site might yield a good signal in another
heart. Size of the protruding electrode which is known to affect the amplitude of
the MAP may be a relevant factor.
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Due to the progressive reduction in MAP amplitude that is observed with the jacket
array, experiments must be devised which involve a much shorter protocol (less
than 15 minutes) in order to obtain information on dispersion of repolarisation.
Changes in cycle lengths and perfusion with uncoupling agents must be undertaken
within this relatively short time scale. The extrastimulus technique for determining
electrical restitution will provide an ideal means of recording dispersion of
repolarisation.
In a study of the transmural dispersion of repolarisation in vivo and its relation to
the development of Torsade de Pointes, Weissenburger et al (2000) proposed a
radically different method of obtaining MAPs. They used a KCI inactivating
electrode that was remote from the unipolar recording electrode. The degree of
inactivation produced by this electrode was similar to that produced by the catheter
electrode. The recording electrodes consisted of tungsten wire insulated up to the
tip that can sit on the myocardium or be plunged into it. The recordings closely
resemble MAPs obtained from the more conventional methods. Genesis of the
MAP is assumed to involve the movement of current between the inactivated cells
beneath the inactivating electrode and the surrounding active cells. At first glance,
it would appear that they are recording the electrical activity of the area in contact
with the reference electrode rather than that adjacent to the inactivating electrode.
And yet they showed a variation in transmural MAP duration (24±9ms). This
method promises a phenomenal increase in the number of sites which could be
recorded simultaneously: tens to hundreds of MAP recordings could potentially be
obtained from the surface of the left ventricle with relative ease. However, as the
validity of this novel method remains to be proven the current project has therefore
relied on the more conventional approach.
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The use of voltage sensitive dyes has provided a new approach to mapping
repolarisation and refractoriness in the whole heart (Dillon, 1991; Girouard et ai,
1996; Homer et al, 1997; Efimov et al. 1998). Dyes (such as di-4-ANEPPS,
WW781, and RH-421) bind to cell membranes and fluoresce with an intensity that
varies proportionally with membrane potential. This fluorescence is captured and
quantified by photodetector arrays or CCD cameras. Optical mapping allows
multiple MAP recordings to be made simultaneously from hundreds of closely
spaced sites. This new method is not a panacea however as motion artefacts are a
serious problem. These may be suppressed partly or fully through the use of an
electromechanical uncoupler such as 2,3-butanedione monoxime, BDM (Cheng et
ai, 1997) or cytochalasin-D (Wu et ai, 1998). These agents have been found to
have a reversibly negative inotropic affect on cardiac contraction but they also have
side effects on ionic currents leading to changes (shortening) in MAP duration
(Biermann et al. 1998). The utilisation of the electromechanical uncouplers means
that this method cannot be employed in the in vivo human heart. Therefore,
methods employing electrode arrays may still have a place in whole heart
electrophysiology.
Table 3.2 summarises the techniques used to record the cardiac electrical activity
that have previously been discussed.
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Method Location In vivo and/or Maximum
in vitro simultaneous
recordings
Intracellular Transmural (single In vitro 1
microelectrode cells)
Suction Electrode Surface, endocardial In vitro and in vivo ?
or epicardial
MAP electrode Surface, endocardial In vitro and in vivo -12
or epicardial
Optical Mapping Superficial In vitro Hundreds to
thousands
Table 3.2 Techniques for measuring repolarisation times.
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Chapter 4 - The effect of heart failure on whole heart
electrophysiology recorded by the Franz MAP catheter technique
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4.1 Introduction
Coronary heart disease often with previous myocardial infarction (MI) is the major
cause of heart failure leading to sudden cardiac death in the industrialised world.
Hundreds of thousands of lives are taken each year. MI is an irreversible condition
where the cardiac muscle becomes necrosed due to prolonged ischaemia, as a result
of coronary artery occlusion. Survivors of MI are at an increased risk of sudden
cardiac death due to their predisposition to lethal cardiac arrhythmias such as
ventricular tachycardia (VT) and ventricular fibrillation (VF).
There are many pathophysiological changes associated with heart failure.
Ventricular arrhythmias are seen to be a common cause of sudden cardiac death in
patients suffering from heart failure. The pathogenesis of lethal ventricular
arrhythmias is not fully understood but it is thought that there are many underlying
mechanisms (Pye and Cobbe,1992). It is known that electrophysiological
abnormalities exist in heart failure, but current knowledge regarding electrical
restitution, dispersion of repolarisation and ventricular fibrillation threshold is far
from complete.
Abnormalities in repolarisation and refractoriness, such as those seen 10 heart
failure, may increase the propensity for the heart to become arrhythmic. Most of
the literature reports a lengthening of action potential duration and refractory
period in heart failure (Tomaselli et al, 1994; Qin et al, 1996) although some report
a shortening (Docherty and Cobbe, 1990). In addition, there is a switch in the
epicardial to endocardial gradient of action potential duration; the epicardial action
potential becomes significantly longer than that of the endocardial. These
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electrophysiological changes associated with heart failure are heterogeneous and
therefore create a dispersion of repolarisation and refractoriness that may cause
re-entrant arrhythmias to occur.
Repolarisation abnormalities can be studied in a limited way using conventional
external electrode techniques such as electrocardiography. However, the strength
of this technique is as a diagnostic tool rather than a probe of mechanism. Invasive
techniques, using the bipolar and unipolar electrodes, can detect local myocardial
activation unambiguously but give limited information concerning refractoriness
and the period of repolarisation. Monophasic action potentials (MAPs) however,
whilst detecting both activation and recovery, also provide detailed information
regarding the membrane potential between the two (i.e. the shape of the MAP
between depolarisation and repolarisation).
MAPs can be recorded from epicardial and endocardial surfaces of the in situ
beating heart, including that of human subjects, using a contact catheter electrode.
Due to its non-destructive nature, MAP recording is therefore the chosen method of
studying local myocardial electrophysiology, especially repolarisation, in the
clinical setting. So MAPs have bridged the gap between basic and clinical
electrophysiology in arrhythmia research.
This chapter presents the results obtained using the contact catheter electrode to
record the electrical activity over the epicardial surface of the left ventricle. The
aims were to investigate the changes in repolarisation and arrhythmogenesis due to
heart failure. Specifically the following were examined:
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i) Regional and global cycle length dependent changes in MAPD9o.
ii) Changes in sequentially recorded dispersion of repolarisation.
iii) Changes in ventricular fibrillation threshold.
Data from normal, healthy, hearts were compared to those from failing hearts.
4.2 Methods
General methods concerning Langendorff perfusion, SAN removal and AVN
ablation are described in chapter 2. MAPs were recorded from the epicardial
surface of the left ventricle using a single MAP catheter electrode as described in
chapter 3. 33 control hearts (ejection fraction (±SEM) = 74.5±1.76%) and 29
failing hearts (ejection fraction (±SEM) = 50.29±1.51 %) were used in this study.
Steady state restitution protocols allow cycle length (CL) dependent changes in
MAP duration to be investigated. This involves pacing the heart over a range of
CLs. The CL is abruptly changed at intervals once stabilisation of MAP duration at
the preceding CL has reached steady state. The protocol used in this investigation
involved the heart initially being paced at a CL of 350ms for 4 minutes, following
which incremental changes of lOOms were made at 4 minute intervals. Changes in
CL covered a range from 150ms to 1250ms. The protocol was terminated and CL
returned to 350ms if the pacing cycle length reached exceeded the intrinsic cycle
length of the heart (this became evident as extra-systoles or extended periods of
diastole), otherwise the full range of CLs were used. On each occasion the heart
was finally paced again at 350ms for 4 minutes to observe recovery of MAP
duration. In this chapter the steady state restitution protocol refers to the
relationship between frequency and action potential duration at a steady state.
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At the end of each experiment ventricular fibrillation (VF) was induced.
Ventricular fibrillation thresholds have previously been used in laboratory
investigations and human studies to assess the overall vulnerability to fibrillation.
VF was induced by inserting a catheter electrode into the right ventricle via the
opening made as a result removing the SAN. VF was induced by a stimulation
protocol using gradually increasing current in to the base of the right ventricle via
the catheter. The protocol consisted of a train of 16 basic SI stimuli at 350ms
intervals followed by a train of 40 stimuli at lOms intervals then a lOOOmsinterval
(square pulse, 2ms duration). Incremental increases of 5mA were made between
each protocol until VF was induced. Conversion back to normal rhythm was with a
small bolus of 1M KCI administered directly in to the perfusion line. Following
each episode of VF the heart was perfused with Tyrodes for 4 minutes, paced at a
CL of 350ms, to ensure that normal electrical activity returned.
To estimate the dispersion of repolarisation in these hearts, measured sequentially
using a single catheter electrode, the heart was arbitrarily divided into 9 regions as
shown in Figure 4.1. Dispersion from each heart was taken as the standard
deviation of MAPD9o. Dispersion data from all hearts at a range of CLs was
averaged to produce an overall mean dispersion of repolarisation.
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Figure 4.1 Schematic of the heart showing the division of the left
ventricle for dispersion analysis. The left ventricular epicardial surface
of the heart was arbitrarily divided into 9 areas to enable grouping of
recordings for determination of dispersion.
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4.3 Results
4.3.1 Cycle length dependent effects on MAP duration in sham operated and
failure hearts
33 control hearts and 29 failing hearts were used to compare the steady state
restitution properties of failing hearts with those of sham operated hearts. MAP
duration (90% repolarisation) were plotted against cycle length (Figure 4.2). Each
graph refers to one of the defined areas of the heart. Areas 8 and 9 are omitted due
to the inability to obtain recordings over the area of infarction in failure hearts. The
most obvious feature of these graphs is the general tendency for a prolongation of
MAPD90 in heart failure that is seen in 6 of 7 sites.
Data in Table 4.1 are absolute positive or negative changes in MAPD90 from sham
operated to failure heart data at a range of cycle lengths (150ms to 1250ms). This
numerically represents the data shown graphically in Figure 4.2. The level of
significance is indicated by asterisks. Numbers for each area at each cycle length
are shown in brackets (sham, failure). All data (sham versus failure MAP duration
at each cycle length) was analysed using an unpaired Student's t-test. The
prolongation of MAP duration was only significant (P<0.05) in data obtained from
area 5, other areas did not show a prolongation of MAP duration. However on
applying the Bonferroni correction, which adjusted the level of significance to
<0.005, there was no significant prolongation in MAP duration in area 5.
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Figure 4.2 MAP duration v CL in failure hearts and sham operated
hearts. All values are shown as mean±SEM.
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CL Area
(rns) 1 2 3 4 5 6 7
150 +4.27 -4.93 +8.42 -6.22 +5.68 +7.08 +2.12
(9,7) (7,9) (13,6) (10,7) ( 10.5) ( 10.6) (10.9)
250 +5.61 +8.56 +8.74 +2.42 +17.8* +0.96 -0.45
(9, 10) (7.10) (13,10) (10.10) (10.10) (10,9) (10,10)
350 +13.16 +9.56 +9.1 +0.48 +19.23 +2.49 +4.21
(9,10) (7,10) (13,10) (10,10) (10,8) ( 10,8) (10,11)
450 +30.76 +10.72 +11.06 +1.94 +20.26* +0.13 +1.18
(8.8) (7,8) ( 13,8) (10,9) (9.8) (9.7) (10,11)
550 +12.57 +12.21 +4.71 +26.85* +1.44 +5.01
(8,7) (13,6) (l0.7) (8,8) (8,7) (9,7)
650 +18.3 +0.01 +15.31 -3.35* -3.05 -0.32
(5,7) (8,5) (9,6) (9,5) (9.5) (7.3)
750 -4.81 +2.4 +11.62 +15.09 + 11.23* -2.82 +7.3
(4,5) (5,4) (9.3) (9,3) (8,5) (7,5) (6,3)
850 -8.27 +0.72 +10.44 +17.44 +15.83* -4.67 +16.35
(3,5) (3,4) (10,2) (10,2) (4.3) (6,4) (4,2)
1050 +14.9 +22 -6.41 -6.74
(7,2) (7,2) (4,4) (4,4)
1250 -14.5 +18.5
(4,2) (4,2)
Table 4.1 The effect of heart failure on MAPDgo. Positive or negative
change in MAPDgo from sham operated to failure hearts. Perfusion with
Tyrodes. n-number in brackets (sham operated hearts, failure hearts).
*P<O.05,unpaired Student's t-test (uncorrected).
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4.3.2 Global differences in MAP duration between heart failure and sham
operated hearts
In Figure 4.3 all the area data from both the sham operated and failure hearts have
been pooled together to give a mean overall global MAP duration. The graphs
show that in failure there is a global increase in MAP duration at all cycle lengths,
although this increase appears to be more prominent at intermediate cycle lengths.
In heart failure there was significant (P<O.05, unpaired Student's Hest) increase in
MAP duration, between cycle lengths of 250ms and 650ms, as compared to sham.
Data were also statistically compared using a two way ANOV A which showed that
failure significantly increases MAP duration at a level P<O.OOO1.
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Figure 4.3 The effect of heart failure on global MAPDgo. Data points are
shown ±SEM. **P<0.01, ***P<0.001, unpaired Student's Hest. P<0.0001
by two way ANOV A.
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4.3.3 Base to apex differences between sham operated and failing hearts
Figures 4.4 illustrates the dispersion of repolarisation from basal to apical regions
of the heart in sham operated (A) and failure (B) hearts. The base encompasses
areas 1 to 4, mid areas 5 to 7, and apex areas 8 and 9. Apical regions (area 8 and 9)
are omitted in comparisons with failing hearts due to the area of infarction. The
graphs show that there is a slight, but non-consistent difference in MAP duration
between regions of the heart. Areas were compared using a one-way ANOV A test
in the case of the sham-operated data (base, mid, apical), and an unpaired Student's
Hest in the case of the failure data (base and mid). Regions were compared to each
other at each cycle length. The tests showed that MAP duration does not alter
differences between regions.
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A. Base to apex differences in MAP duration in sham operated hearts.
Values shown ± SD.
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B. Base to apex differences in MAP duration in failing hearts. Values
shown ± SD.
Figure 4.4 Base to apex differences in MAP duration.
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4.3.4 The effect of failure on dispersion of repolarisation
Dispersion of repolarisation was calculated for a range of CLs: 250ms, 350ms,
450ms, and 650ms. These specific intervals were chosen on the basis that the
quantity of data obtained for each was sufficient for statistical comparison. The
results in Figure 4.5a show no change in the mean dispersion of repolarisation
between normal and failing hearts over a wide range of cycle lengths (as compared
using an unpaired Student's Hest). Figure 4.5b represents the data as coefficient of
variation. Absolute values of the mean dispersion of repolarisation are shown in
Table 4.2.
Cycle Length DORSham n hearts DOR Failure n hearts
(±SEM) (iSEM)
250 9.49il.33 25 11.49i3.84 10
350 7.71±O.93 26 7.68i1.33 26
450 7.36iO.97 25 7.24iO.88 21
650 7.50i1.10 21 7.79i1.42 17
Table 4.2 Absolute changes in mean dispersion of repolarisation.
(DOR=dispersion of repolarisation).
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Figure 4.5 The effect of failure on dispersion of repolarisation at a
range of cycle lengths. Failure does not alter the sequentially recorded
dispersion of repolarisation (P>0.05, unpaired Student's t-test).
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4.3.5 Ventricular fibrillation thresholds
Figure 4.6 shows an experimental trace where VF was induced in Tyrodes solution.
The recording shows left ventricular developed pressure as recorded by the
intraventricular balloon. To the left of the trace the heart was being paced at 350ms
intervals, following this a train of stimuli was applied followed by an extended
diastolic interval. The train of stimuli was repeated at an increasing current (5mA
increases) until VF was induced (the ventricular fibrillation threshold). The
uncoordinated events to the right of the trace is VF. VFT in this case was 30mA.
The box and whisker plot in Figure 4.7 illustrates the difference in ventricular
fibrillation threshold (VFT) between sham-operated and failure hearts. Mean
threshold decreased from 34.58±8.54mA in sham operated hearts (n=12) to
26.16±3.89mA in failure hearts (n=43) (mean±SEM). This difference was not
significant (P>O.05).
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Figure 4.6 Experimental trace showing ventricular fibrillation
induction.
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Figure 4.7 The effect of heart failure on ventricular fibrillation
threshold. Failure causes a small decrease in VFT.
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4.4 Discussion
The main reported electrophysiological abnormalities in heart failure are action
potential duration prolongation and an increased dispersion of
repolarisation/refractoriness as a result of electrical remodelling (reviewed in Wolk
et al 1997). On theoretical grounds, one would expect to associate an increase in
dispersion of repolarisation with a decreased ventricular fibrillation threshold. Our
data indicates that heart failure does not change the dispersion of repolarisation nor
does it change ventricular fibrillation threshold.
4.4.1 Ionic basis of action potential duration prolongation in heart failure
Although the there was no change in MAP duration in individual areas, this study
saw an global increase in MAP duration in ligated hearts across a wide range of
stimulation frequencies with significant results being obtained at stimulation
frequencies up to 650ms. Much work has been done to attempt to explain the ionic
basis for the prolongation in action potential duration seen in heart failure. In
humans, a prolongation of the action potential plateau may be due to reduced
repolarising outward currents or a net increase in depolarising inward currents, or
both (Pye & Cobbe, 1992). Na+-Ca2+ exchange is the primary mechanism by
which Ca2+ is expelled from the myocyte. This generates an inward current that
may effect repolarisation time. Changes in this current may cause action potential
duration changes and an increase in arrhythmogenesis in hypertrophied hearts.
Several studies have investigated the effect of heart failure in human subjects.
Jongsma (1999) stated that the increase in action potential duration seen in failing
hearts is attributable to the decrease in expression of Ito. Hart (1994) also suggested
that changes in K+ (inward rectifier, IKJ,and the transient outward, Ito1)currents
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might play a role in the prolongation of the action potential duration in
hypertrophied hearts. Beuckelmann et al (1993) also attributed action potential
duration prolongation in severe heart failure to a reduction in the inward rectifier
K+ current and of the transient outward K+ current. It was also thought that the L-
type Ca2+ current could cause action potential duration prolongation by its delayed
inactivation, although at that time controversy existed as other workers had found
no change (Pye and Cobbe, 1992). However, in 1999 Jongsma reported that action
potential duration prolongation seen in heart failure (not end-stage) is attributed, in
.part, to an increase in the L-type Ca2+ current.
In a rabbit model of heart failure, Ng (1998) found that the time to peak of the
MAP recorded using the suction electrode technique, was significantly longer in
failing hearts than healthy hearts with the difference being maintained throughout
the rest of the signal. However, the time course of these signals were timed from
the start of upstroke of the action potential to various points of repolarisation
whereas those in this study were analysed from the maximum slope of the upstroke
(dv/dtmax). It was suggested that prolongation of the action potential in heart failure
occurs mainly in the earlier phases and that this may be a result of a reduced
outward current, increased inward current, or both.
4.4.2 Base to apex differences
Transmural heterogeneity in action potential duration is an area that has been
comprehensively researched both in the normal heart (Li et al, 1999) and the failing
heart (McIntosh, 1998). However base to apex differences in action potential
duration have been somewhat neglected. In this particular study there was no
change in the MAP duration between the basal and apical regions of the left
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ventricle in both the normal and the failing heart. However, this is in conflict with
the evidence of trans-epicardial differences found by other groups.
Cheng et al (1999) investigated base to apex differences in action potential duration
and the E-4031-sensitive component (lKr) and in sensitive component (IKs) of the
delayed rectifier, IK, in isolated myocytes from the left ventricle of the rabbit heart
using whole-cell patch clamping. They showed that action potentials obtained at
1Hz were substantially shorter in the base than the apex. They attributed this
disparity in action potential duration to a higher density of expression of IKr in the
apex than the base of the rabbit left ventricle. Similar gradients have been reported
in other species. For example, Brahmajothi et al (1996) who showed that ERG, the
gene that encodes the protein responsible for IKr is expressed more abundantly in
all areas of the epicardium of the ferret ventricle, except in the base.
In contrast to the results found by these groups who showed a trans-epicardial
dispersion of repolarisation, but in correlation with our results, a group from
Breithardt's laboratory in MUnster, Germany found no significant dispersion
(personal communication). They recorded MAPs from the left and right ventricle
of the rabbit heart using a cantilever system. This system allowed 2 MAPs to be
recorded from the base, 2 from the mid, and 2 from the apex of the heart. In this
personal communication, they commented that they did not observe base to apex
differences (compared only between left and right ventricle).
Dean and Lab (1990), in a study using the in situ pig heart, found that increasing
the left ventricular systolic pressure by aortic clamping caused a reduction in mean
effective refractory period that was associated with a decrease in action potential
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duration. The changes seen in this study were heterogeneous, with a larger change
occurring at the apex than the base. Heterogeneity of repolarisation is potentially
arrhythmogenic. Hence the findings of Dean and Lab suggest that increased
ventricular load, as seen in heart failure, may be arrhythmogenic (see below).
An interesting study by VanTyn and MacLean (1961) on the important factors in
determining ventricular fibrillation threshold indicated that there is also a base to
apex dispersion of ventricular fibrillation threshold in the left ventricle in the
canine heart.
4.4.3 Dispersion of repolarisation/refractoriness and ventricular fibrillation
threshold
An increase in dispersion of refractoriness has been associated with a decrease in
ventricular fibrillation threshold (Han and Moe, 1964; Janse and Wit, 1989;
reviewed in Burton and Cobbe, 2001). The results of our study showed heart
failure does not cause an increase in the dispersion of repolarisation nor does it
change ventricular fibrillation threshold. There may be several reasons for our
apparent lack of increased dispersion of repolarisation and decreased ventricular
fibrillation threshold in heart failure. One possible explanation may be that the
severity of heart failure in this study was too mild to show a significant difference.
However, previous results in this lab (Burton et al, 1998), obtained from the same
rabbit model of heart failure, showed that VFT was significantly lower in a severe
left ventricular dysfunction (LVD) group compared to controls. Burton et al
(1998) found that left ventricular ejection fraction was <45%. Using the intervals
between local activations during VF to measure local refractoriness they also found
that dispersion of refractoriness was greater in the severe LVD group than the
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control. Although ventricular dilatation decreased VFf in normal hearts, it did not
cause any further decrease in VFf in hearts with severe LVD. Latent
inhomogeneities in the local dispersion of refractoriness in the normal myocardium
of the LVD group were however apparent. Despite no observed increase in
dispersion of epicardial MAP duration in failing hearts, Bryant et al (1997)
concluded that the differences in action potential duration between sub-endocardial
and sub-epicardial myocytes in normal hearts is lost in hypertrophy (in guinea pig
hearts with mild cardiac hypertrophy induced by aortic constriction).
An interesting special communication by Cha et al (1993) delved in to the
hypothesis that ventricular fibrillation threshold testing is a probability function.
They tested ventricular fibrillation threshold in open chested dogs using the single
premature stimulus or the train of stimuli method with increasing current strengths.
They showed that there was a wide spread of stimulus strengths associated with a
0% and 100% probability of ventricular fibrillation induction, which they
concluded indicated that an all or none threshold for ventricular fibrillation is
absent. So taking this in to consideration, how accurate a measure of arrhythmia
inducibility is ventricular fibrillation threshold testing?
A further reason for an apparent lack of difference between control and LVD hearts
in dispersion of repolarisation or ventricular fibrillation threshold in this study
could be that Langendorff perfused hearts show less of a difference compared to
working hearts due to the difference in loading conditions. Although the effect of
heart failure on dispersion and ventricular fibrillation threshold has little been
studied, many groups have investigated the effect of increased ventricular load on
dispersion of refractoriness and its consequent effects on ventricular fibrillation and
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arrhythmia inducibilty. Since pressure overload or ventricular dilatation leads to
hypertrophy, which is a compensatory mechanism seen in heart failure, it is fair to
discuss such experiments in relation to heart failure itself.
Reiter et al (1988) linked dilatation of the left ventricle in the isolated rabbit heart
to an increase in dispersion of refractoriness. In a later study Reiter, along with
co-workers Jalal et al (1992), investigated the effect of acute ventricular dilatation
on refractoriness and fibrillation threshold, again in the isolated rabbit heart. They
showed that ventricular dilatation (of either ventricle) consistently decreased
ventricular fibrillation threshold and that this decrease was highly and linearly
correlated with the decrease in local refractoriness. Calkins et at (1989a) found
that, in the isolated blood perfused infarcted canine heart, an increase in left
ventricular end diastolic volume increased the inducibility of arrhythmia. This
increase in inducibility was, again, associated with shortening of refractoriness. In
contrast, in the normal isolated blood perfused canine heart, later work by Calkins
and co-workers (l989b), found no change in ventricular fibrillation threshold or
inducibility of arrhythmias on increased volume load in the ventricles. They
suggested that in the normal blood perfused mammalian heart under steady state
conditions, volume load is not a significant electrophysiological factor. Loading
conditions may be of greater significance in the infracted heart in both an
electrophysiological and pro-arrhythmic sense.
A final reason that may explain the absence of a decreased ventricular fibrillation
threshold in failing hearts is the method used to induce VF. The animal model of
heart failure used in this study produces an apical infarct in the left ventricle that
may extend into the apex of the right ventricle. Since the VF induction catheter is
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inserted in to the right ventricle and rests in the apex it is entirely possible that the
infarcted region restricts the induction of VF and hence increases the overall mean
threshold for induction.
4.4.4 Conduction delay
Although this part of the investigation did not involve measurements of conduction
delay or indeed conduction velocity it is a parameter that is measured in work that
will be discussed later. Left ventricular hypertrophy has been associated with
changes in cell to cell electrical coupling (Cooklin, 1997; Jongsma 1999). Cooklin
et al (1997) used a guinea pig model of myocardial hypertrophy where the aorta
was constricted for 150 days. They found an increase in intercellular resistance
that was attributable to an increase in junctional impedance between adjacent cells.
As mentioned, electrical conductance via connexins can be mediated by i) a fall in
intracellular pH or Ca2+ concentration, or ii) an alteration of the number,
distribution or type of connexin subtype. Cooklin et al suggested that conductance
is altered in myocardial hypertrophy by the latter of the above mentioned options.
This was concluded as an intracellular acidosis of 0.19 pH units that accompanies
left ventricular hypertrophy in the model they used would only decrease
conductance by approximately 4%. Also, pH buffering is greater in hypertrophied
hearts than normal hearts. Cooklin et al also discussed the importance of the effect
of an increase in intercellular resistance on a reduction in conduction velocity of
the action potential. If conduction velocity were to decrease equally in all
dimensions (longitudinally and transversely) during hypertrophy there may be an
increased propensity for the occurrence of re-entrant circuits to develop. The effect
of intercellular resistance is an important aspect of altered conduction velocity. A
change in conduction velocity may be implicated in arrhythmogenesis in the failing
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heart. Pharmacological interventions that alter intercellular resistance are a focus
of the remainder of this study.
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Chapter 5 - The effect of I-beptanol on whole heart
electrophysiology in normal and failing hearts recorded by the
Franz MAP catheter technique
121
Chapter 5 - Results
5.1 Introduction
5.1.1 Gap junction uncoupling and 1-heptanol
Gap junctional conductance (gj) is regulated by numerous mechanisms such as the
phosphorylation state of connexins (Bastide et al, 1995), transjunctional voltage,
[H+]j, [Ca2+]j, [ATP] and cellular fatty acid composition (Bastiaanse et al, 1993;
Jongsma and Wilders, 2000). Many substances have been found to reduce gj
including lipophilic agents such as halothane (He and Burt, 2000), aliphatic
alcohols such as heptanol and octanol (Zhang et al, 1996), and stearic acid
derivatives (Takens-Kwak et al, 1992). The focus of this study is however the
effects of l-heptanol.
The Takens-Kwak group correctly supposed the decrease in gj must be as a result
of either a reduction in the number of gap junction channels, a reduction in the
conductance of individual channels or a reduction in the duration each channel is
open. They suggested that heptanol does not remove gap junctions, or decrease the
conductance of the individual gap junction. If heptanol removed gap junction
channels a change in junctional current (Ij) would be expected. However there was
no change in Ij before uncoupling with heptanol and following washout of the
agent. Single channel conductances were also collected and no change shown
between the perfused and undisturbed cells, indicating that heptanol does not
uncouple cells by decreasing the conductance of single channels. It was however,
by process of elimination, assumed that heptanol changes the gap junction protein
conformation by altering the membrane and therefore decreases the gap junction
open probability. This hypothesis was also suggested by Lars Bastiananse et at
(1993). A direct interaction of heptanol with a membrane component is also
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suggested due to the speed at which electrical uncoupling occurs (2mM completely
uncouples cardiomyocyte pairs in less than 200 seconds). The speed at which this
occurs suggests that removal of gap junctions from the membrane is not likely.
5.1.2 Mechanisms of action of f-heptanol
Several hypotheses have been proposed for the possible mechanism of action of
heptanol. These are i) an alteration of the lipid environment around the channel
leading indirectly to alterations in the gap junctional protein conformation, ii) a
direct effect on the channel by binding to the protein, and iii) an indirect
mechanism mediated through an increase in intracellular Ca2+ concentration, or a
change in intracellular pH. The first hypothesis suggests that the uncoupling action
of heptanol, and other lipophilic molecules, is a result of alterations in the lipid
component of the membrane bilayer. This has been noted as the most likely
mechanism of heptanol induced uncoupling. Evidence to support this hypothesis is
discussed below. The second hypothesis assumes a direct interaction with the
channel protein, and is difficult to distinguish from the first proposed mechanism.
The third hypothesis suggests an effect of changes in pH and Ca2+ concentration on
cellular uncoupling. Buffering Ca2+ however, has been shown not to have an effect
on heptanol induced uncoupling in cardiac myocytes from guinea pigs and rats
(Rudisuli, 1989; Takens- Kwak, 1992). Rudisuli (1989) showed no change in the
single channel current upon moderate elevation of [Ca2+] by weak intracellular Ca2+
buffering (EGTA, O.1mM, no added CaCh) as compared to experiments using
strongly buffered (EGTA lOmM, CaCh ImM) solution.
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Lars Bastiaanse et al (1993) did a comprehensive investigation, using neonatal rat
myocytes in a combined fluorescence anisotropy and electrophysiological study.
They investigated the effect of heptanol on the fluidity of the membrane cholesterol
rich domains. Knowing that gap junction channels are embedded in cholesterol
rich domains of the membrane, this group attempted to assess the effect of heptanol
and another lipophilic agent 2-(methoxyethooxy)ethyl 8-(cis-2-n-
octylcyclopropyl)-octonoate (A2C) on the fluidity of the membrane. They did this
by measuring junctional and non-junctional membrane currents and steady state
anisotropy (rss), which decreases as membrane fluidity increases, in different
membrane domains. They found that both A2C and heptanol increased bulk
membrane (sarcolemmal) fluidity. However, while A2C does not affect gj, heptanol
decreases it indicating that sarcolemmal fluidity is not a determinant for gap
junctional conductance, and that the increase seen with heptanol is not responsible
for its uncoupling effect.
In whole cell voltage clamp experiments on pairs of cells, heptanol was found to
completely uncouple the cell pairs whilst A2C did not. Using dehydroergosterol
(OHE) to specifically assess the fluidity of the cholesterol rich domains it was
found that heptanol decreased fluidity whereas A2C had no effect. Increasing
cholesterol content of the cells decreased the gap junctional uncoupling effect of
heptanol whilst non-junctional conductance remained unaltered, highlighting the
relative importance of changes in the fluidity of the cholesterol rich domain rather
than merely the bulk membrane fluidity.
The effect of heptanol on dispersion of repolarisation has not been widely studied.
The effect of heptanol on arrhythmia inducibility has however been relatively
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widely studied (Boersma et ai, 1994; Callans et al, 1998). This part of the study
concentrates on the effect of heptanol on mechanical and electrical activity,
including dispersion of repolarisation and ventricular fibrillation threshold, in
normal and failing hearts.
5.2 Methods
MAPs were measured using a single catheter electrode (as described in chapter 3)
from the epicardial surface of the left ventricle. MAPs were measured from 9 areas
of the epicardial surface of the left ventricle (Figure 4.1). The heart was initially
perfused with Tyrode's solution and paced at a basic cycle length (CL) of 350ms
via bipolar pacing electrodes at the base of the right ventricle. A settling period of
approximately 20 minutes was allowed to allow the heart to physiologically
stabilise in the artificial system.
Once a good quality MAP recording was obtained the following protocol was
performed. The heart was initially perfused with Tyrode's solution and paced at
350ms for 4 minutes, prior to making incremental CL changes. CL was increased
in increments of lOOms starting with 150ms, proceeding until pacing cycle length
exceeded the intrinsic cycle length, or 1250ms was reached. Each cycle length was
maintained for 4 minutes prior to change. CL was then returned to the basic CL of
350ms for 4 minutes. In this chapter the steady state restitution protocol as
described refers to the relationship between frequency and action potential duration
at a steady state.
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Perfusion was then changed to 0.3mM heptanol (Sigma, Poole, UK) solution via
the 2-way switch incorporated in to the perfusion lines. Because of the lipophilic
nature of heptanol it is insoluble in water so it was dissolved in ethanol before
adding to Tyrode's solution. Keevil et al (2000) reported that heptanol is soluble in
aqueous solution up to a concentration of 9mM, however this was found not to be
the case in this study as 0.3mM heptanol would not dissolve in an aqueous
solution. The final concentration of ethanol in the solution was 0.005%. The heart
was perfused with 0.3mM heptanol at the basic CL of 350ms for 5 minutes prior to
running through the same protocol as described above for Tyrode perfusion.
In any single experiment several runs of the same protocol were made. At the end
of a protocol, the catheter electrode was removed and placed on a different area of
the epicardial surface of the left ventricle and the protocol run through again. This
allowed acquisition of sequential data to quantify dispersion of repolarisation.
Ventricular fibrillation (VF) was induced at the end of each experiment, both in
Tyrode's solution and 0.3mM heptano!. Refer to chapter 4 methods for details of
VF induction.
MAPs were analysed at each CL to obtain MAPDso, MAPD9o, and conduction
delay (CD). Stimulus artefact was not observed in all cases, and hence in these
cases CD could not be measured. Results were entered into an Excel database
(Microsoft) and graphed in Origin (Microcal). One way ANOV A and paired or
unpaired Student's t-tests depending on the data analysed. Refer chapter 2 general
methods for details of statistical tests.
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5.3 Results
5.3.1 The effect of ethanol on whole heart electrophysiology
Control experiments were done to ensure that the ethanol used to dissolve heptanol
does not effect the electrophysiology of the whole heart. 4 control hearts were used
in this study. Figure 5.1 illustrates the effect of 0.005% ethanol on MAP duration,
at 90% repolarisation, and conduction delay. The heart was paced at 350ms for 4
minutes in normal Tyrode solution followed by 15 minutes perfusion with Tyrode's
solution containing ethanol (0.005% final concentration). Ethanol was washed out
for a further 15 minutes with normal Tyrode's solution. The results show that
ethanol has no effect on MAP duration or conduction delay.
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5.3.2 J-Heptanol dose response curve
Preliminary experiments were done to determine a suitable concentration of
heptanol for study of gap junction uncoupling effects. Hepianol has previously
been observed to have a considerable negative inotropic effect on the working
myocardium. Reduction in contractility was used as the criteria for determining a
suitable heptanol concentration. The heart was perfused with a range of heptanol
concentrations (0.1 to 0.5mM), and the difference in peak systolic and end diastolic
pressures calculated from chart recorder traces. The graph in Figure 5.2 shows the
marked decline in left ventricular developed pressure (LVDP) with increasing
heptanol concentration. From these plots, it was decided that a concentration of
O.3mM heptanol would be used for subsequent electrophysiological measurements.
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5.3.3 I-Heptanol reversibly modifies the mechanical activity in the whole heart
A typical experiment illustrating the changes in LVDP prior to, during, and after
perfusion with 0.3mM heptanol is shown in Figure 5.3. The heart was perfused
with Tyrode's solution for a period of 20 minutes prior to a period of 30 minutes
perfusion with 0.3mM heptanol, followed by a period of 30 minutes
reperfusion/washout with Tyrode's solution. The experiment shows that the
negative inotropic effect of 0.3mM heptanol is completely reversible. The time lag
of approximately 2 minutes prior to observation of pressure decline is due to the
time taken for the new solution to reach the heart. The recovery of LVDP
(approximately 12 minutes) on reperfusion with Tyrode, is slower than the decline
(approximately 5 minutes) caused by perfusion with 0.3mM heptanol.
Figure 5.4 shows scanned traces of the LVDP recorded from a single experiment
where the effect of 0.3mM heptanol on LVDP was investigated. The heart was
initially perfused with Tyrode's followed by a 30 minute perfusion with O.3mM
heptanol solution. The negative inotropic effect of heptanol is illustrated in Figure
5.4a, and its reversibility by reperfusion with Tyrode's solution in Figure 5.4b.
131
Chapter 5 - Results
Cl) 110
ID
"0e 100
~
c 90
a..c>
...J
ID
.0ca.....
Cl)
ID
0)
ca.....
C
ID
~
IDa..
80
70
60
50
40
30
20+-~~~~~~~~~~~~~~~~~~~
t t
0.3mMheptanol Tyrode
o 10 20 30 40 50 60 70 80 90
Time (mins)
Figure 5.3 Reversible effect of perfusion with O.3mM 1-heptanol on
LVDP. Data are expressed as changes in the percentage stable pressure
in Tyrode's. BCL=350ms. Sham operated heart.
132
Chapter 5 - Results
60 seconds
A.The effect of O.3mM 1-heptanol on LVDP.
3S
o
60 seconds
B. The effect of O.3mM 1-heptanol on LVDP is completely reversible.
Figure 5.4 The effect of O.3mM t-heptanol on LVDP as illustrated by
experimental traces.
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5.3.4 L-Heptanol reversibly modifies the electrical activity of the whole heart
A typical experiment illustrating the changes in MAPD90 prior to, during, and after
perfusion with 0.3mM heptanol is shown in Figure 5.5. The heart was perfused
with Tyrode's solution for a period of 20 minutes prior to a period of 20 minutes
perfusion with 0.3mM heptanol, followed by a period of 30 minutes reperfusion
with Tyrode's solution. The effect of 0.3mM heptanol on MAP duration is
reversible. A similar time lag to that described above can be seen. The recovery of
MAP duration, on reperfusion with Tyrode's, is slower (IS minutes) than the
observed decline (2 minutes) in MAP duration on perfusion with O.3mM heptanoJ.
Figure 5.6 shows a control MAP obtained in Tyrodes solution with a MAP
obtained after perfusion with O.3mM heptano!.
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5.3.5 The effect of O.3mM L-heptanol on electrical activity in sham operated
hearts
26 control rabbits (ejection fraction (±SEM) = 73±2.76%) were used to investigate
the effect of heptanol on MAPD90 in the 9 designated areas of the LV using the CL
protocol as previously described. Table 5.1 shows the positive or negative changes
in MAPD90 caused by the effects of heptanol. At short CLs (l50ms and 250ms)
the majority of the changes are positive (P>0.05), whilst at longer CLs (above
250ms) changes are negative (some significant). Area 5 showed no significant
changes at any CL. On using a multiple test correction (Bonferroni correction) the
level of significance changed from P<O.05 to: <0.0051 for 10 tests, <0.0057 for 9
tests and <0.0063 for 8 tests. Values still significant following correction are
indicated in bold in Table 5.1.
Figure 5.7 shows all 9 area graphs (mean±SEM). In all areas, a greater difference
in MAP duration between Tyrode's perfused and 0.3mM heptanol perfused hearts,
was seen at longer CLs where O.3mM heptanol reduced repolarisation duration.
Small positive differences are observed at shorter CLs. Area 5 shows the least
significance between values.
To assess the possibility of a global dispersion of repolarisation over the LV, a
statistical comparison of MAPD90 between areas was performed using a one way
ANOV A. At a range of CLs (150ms to 1250ms) there was no change (P>0.05)
between area 1 to 9 of sham operated hearts.
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Figure 5.7 Graphs illustrating the effect of O.3mM 1-heptanol on stable
state restitution in sham-operated hearts.
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CL Area
(ms) 1 2 3 4 5 6 7 8 9
150 +6.6 +9.9 +5.8 +7.5 -1.4 +6.6 +6.2 +7.3 +2.8
(5) (4) (7) (5) (4) (6) (4) (3) (4)
250 +7.8 -2.0 +8.3 +1.4 -0.6 +5.0 -3.2 -4.1 +6.52
(5) (5) (7) (6) (4) (6) (4) (3) (5)
350 -5.8 -9.6 -4.2 -7.8 0.0 6.0 -11.8 -16.3* -4.9
(5) (4) (7) (4) (4) (6) (4) (3) (5)
450 -13.1 -15.2 -7.2 -11.7 -0.7 -12.2 -11.7 -14.6 -12.2
(5) (5) (7) (6) (4) (6) (4) (3) (5)
550 -21.8** -19.4 -13.5** ·15.2*** -3.8 -14.7* -14.8* -21.7* -14.0*
(5) (5) (7) (6) (4) (6) (3) (3) (5)
650 -17.7 -22.3 -10.62 ·17.3*** +6.3 -18.7* -20.3 -18.2 -12.1*
(5) (5) (7) (6) (4) (6) (3) (2) (4)
750 -23.6 -26.8* ·20.7** -14.6* -2.7 ·15.8** -6.3 -17.6** -16.0**
(2) (2) (4) (6) (3) (5) (3) (3) (4)
850 -23.8 -20.9** -23.3* -14.3* -4.5 ·18.9*** -15.0 -23* -16.6*
(2) (2) (3) (6) (3) (5) (2) (3) (5)
1050 ·21.8* -8.0 +5.2 -16.5* -14.4*
(3) (5) (3) (4) (5)
1250 -20.9 -19.7* +12.4 -16.3 -21.2 -8
(2) (3) (2) (3) (2) (3)
Table 5.1 The effect of O.3mM1-heptanol on MAPD90 in sham operated
hearts. Positive or negative change in MAPD90 on perfusion with O.3mM
heptanol, as compared to Tyrode perfused hearts. n-number in brackets.
* P<O.05, ** P<O.01, *** P<O.001 (paired Student's t-test). Bold indicating
significance following Bonferroni correction.
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5.3.6 The effect of O.3mM f-heptanol on electrical activity in failure hearts
25 failure hearts (ejection fraction (±SEM) = 48.91 ±1.0 1%) were used to
investigate the effect of heptanol on MAPD90 in areas 1 to 7 of the LV using the
steady state restitution protocol as previously described. Areas 8 and 9 were
always affected by a region of infarction, and hence MAP duration recording from
these areas was not possible. Table 5.2 shows the positive or negative changes in
MAPD90 caused by heptanol. Apart from the absence of data from areas 8 and 9,
the results were broadly comparable to those in sham hearts. At 150ms the
majority of the changes are positive (p>0.05), whilst at CLs above 150ms changes
are negative (some significant). Area 5 is again the only region that shows no
significant changes at any CL. On using a multiple test correction (Bonferroni
correction) the level of significance changed from <0.05 to: <0.0051 for 10 tests.
<0.0057 for 9 tests and <0.0063 for 8 tests. Values still significant following
correction are indicated in bold in Table 5.2.
Figure 5.8 shows all 9 area graphs (mean±SEM). In all areas, a greater difference
in MAP duration between Tyrode perfused and 0.3mM heptanol perfused hearts, is
seen at longer CLs where 0.3mM heptanol reduces repolarisation duration. Small
positive differences are observed at a CL of 150ms. Area 5 shows no significant
difference between values.
Analysis of variance of MAPD90 between areas again showed that, at a range of
CLs (150ms to 1250ms) there was no change between area 1 to 7 of failure hearts.
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Figure 5.8 Graphs illustrating the effect of O.3mM 1-heptanol on stable
state restitution in failure hearts.
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CL Area
(ms) 1 2 3 4 5 6 7
150 +3.3 +4.5 +3.9 +6.4 -1.16 +0.16 -2.6
(5) (4) (4) (5) (4) (5) (4)
250 +8.45 -3.8 -6.97 -0.68 -0.9 -4.4 -4.99
(4) (4) (5) (5) (4) (5) (6)
350 -2.4 -9.05** -13.09 -5.12 -3.4 -13.52** -14.67*
(4) (4) (5) (5) (4) (5) (6)
450 -11.35 -11.1 -22.75 -12.6 -8.2 -21.32** -14.76*
(4) (4) (5) (4) (4) (5) (6)
550 -16.95* -13.35 -26.69** -11.4* -19.5 -24.64** -14.46*
(4) (4) (5) (4) (4) (5) (5)
650 -17.1* -12.4* -28.59** -16.1 -12.6 -21.32* -16.97*
(4) (4) (5) (2) (4) (5) (3)
750 -18.5* -12.1 * -30.73* -20.2 -15.4 -19.36* -22.14*
(4) (4) (3) (2) (3) (5) (4)
850 -16.55* -7.33 -25 -24.6 -18.6* -25.1
(4) (3) (2) (2) (4) (2)
1050 -17.2* -11.2 -25.4 -27 -14.76*
(3) (3) (2) (2) (4)
1250 -18** -16.2 -29.1 -29.5 -16.4
(3) (2) (2) (2) (2)
Table 5.2 The effect of O.3mM 1-heptanol on MAPDgo in failure hearts.
Positive or negative change in MAPDgo on perfusion with O.3mM heptanol,
as compared to Tyrode perfused hearts. n-number in brackets. * P<O.OS,
**P<O.01, *** P<O.001 (paired Student's t-test). Bold indicating significance
following Bonferroni correction.
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5.3.7 The effect of O.3mM L-Heptanol on sham hearts v failure hearts
Graphs from all 7 regions illustrating the difference between heptanol perfused
sham-operated and failure hearts are shown in Figure 5.9. No changes between
sham operated and failure hearts were found at a MAP duration of 90%. Unpaired
Student's t-tests (P<0.05 considered significant) were used to statistically compare
sham operated and failure hearts perfused with O.3mM heptanol (omitting areas 8
and 9 from tests due to the region of infarction). The numbers of observations are
as follows:
Area
1 2 3 4 5 6 7
CL
(ms) S F S F S F S F S F S F S F
150 5 5 4 4 7 4 5 5 4 4 6 5 4 4
250 5 4 5 4 7 5 6 5 4 4 6 5 4 6
350 5 4 4 4 7 5 4 5 4 4 6 5 4 6
450 5 4 5 4 7 5 6 4 4 4 6 5 4 6
550 5 4 5 4 7 5 6 4 4 4 6 5 3 5
650 5 4 5 4 7 5 6 2 4 4 6 5 3 3
750 2 4 2 4 4 3 6 2 3 3 5 5 3 4
850 2 4 2 3 3 2 6 2 3 5 4 2 2
1050 3 3 3 2 5 2 3 4 4 5
1250 3 2 2 2 3 2 2 3 2
Table 5.3 Sham and failure n-numbers.
S - Sham operated hearts
F - Failure hearts
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Figure 5.9 Graphs illustrating the effect of O.3mM 1-heptanol on stable
state restitution in sham-operated v failure hearts.
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5.3.8 The global effect of O.3mM I-heptanol on MAP duration in sham
operated hearts
Figure 5.10 shows the overall effect of perfusing the heart with O.3mM heptanol on
MAPD9o. Data from all 9 areas have been pooled together to give a global value.
O.3mM heptanol significantly (P<O.05) induces an increase in MAPD<)oat a cycle
length of l50ms and a significant decrease in average MAP duration in sham
operated hearts at cycle lengths greater than 350ms.
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Figure 5.10 The effect of O.3mM 1-heptanol on MAPD90 in sham
operated hearts. Data shown mean±SEM. Paired Student Hest,
*=P<O.05. **=P<O.01. ***=P<O.0001.
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5.3.9 The global effect of O.3mM I-heptanol on MAP duration in failure hearts
Figure 5.11 shows the overall effect of perfusing the heart with O.3mM heptanol on
MAPD9o. All data from all 7 areas have been pooled to give a global value at each
cycle length. O.3mM heptanol induces a significant (P<O.05) decrease in average
MAP duration in failure hearts at cycle lengths greater than 350ms.
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Figure 5.11 The effect of O.3mM 1-heptanol on MAPD90 in failure
hearts. Data shown mean±SEM. ***=P<0.001.
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5.3.10 The effect of 0.3mM Ivheptanol on dispersion of repolarisation in sham
operated hearts
The mean dispersion of repolarisation as calculated as the average of the standard
deviation of MAPD90 within each heart, for Tyrode's solution (red bar) and O.3mM
heptanol (grey bar) is illustrated in Figure 5.12a. O.3mM heptanol induces no
increase (p>O.05) in dispersion of repolarisation at a CL of 350ms and 650ms only.
The data are represented as coefficient of variation in Figure 5.l2b. Table 5.4
indicates the dispersion of repolarisation at cycle lengths of 150ms, 350ms and
650ms.
Dispersion of repolarisation (ms±SEM)
150ms 350ms 650ms
Tyrode 7.94±O.56 6.32±1.56 7.00±1.53
0.3mM L-heptanol 6.60±1.15 8.94±2.61 7.69±1.52
Table 5.4 Dispersion of repolarisation in sham operated hearts.
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Figure 5.12 The effect of O.3mM 1-heptanol on dispersion of
repolarisation in sham operated hearts. O.3mM heptanol does not
increase dispersion of repolarisation (P>O.05, paired Student's t-test) at
350ms and 650ms only. n=11 hearts.
155
Chapter 5- Results
5.3.11 The effect of O.3mM L-heptanol on dispersion of repolarisation in
failure hearts
In failing hearts O.3mM heptanol causes a non-significant decrease in mean
dispersion of repolarisation at a cycle lengths of lSOms, 3S0ms and 6S0ms.
Statistical comparisons were made using a paired Student's Hest. The results are
illustrated in Figure 5.13a and b as dispersion of repolarisation and coefficient of
variation respectively. Dispersion of repolarisation results are also tabulated in
Table 5.S.
Dispersion of repolarisation (ms±SEM)
150ms 350ms 650ms
Tyrode 5.18±l.Ol 5.9S±l.S9 7.79±2.39
O.3mM J-heptanol 3.73±O.79 5.02±1.19 S.84±1.22
Table 5.5 Dispersion of repolarisation in failure hearts.
Figures 5.14a and b compares mean dispersion of repolarisation and coefficient of
variation respectively in failing and sham operated hearts. Dispersion is measured
at a cycle length of lSOms, 3S0ms and 6S0ms. Failure decreases dispersion of
repolarisation at all cycle lengths (P>O.OS). Statistical comparisons were made
using an unpaired Student's t-test.
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Figure 5.13 The effect of O.3mM 1-heptanol on dispersion of
repolarisation In failing hearts. 0.3mM heptanol causes does not
decrease dispersion of repolarisation (P>O.05, paired Student's Hest).
n=13 hearts.
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Figure 5.14 The effect of failure on the dispersion of repolarisation in
the O.3mM 1-heptanol perfused heart. Failure causes a significant
decrease in dispersion of repolarisation at 150ms only (P<O.05, unpaired
Student's t-test). n=11 sham operated hearts, 13 failure hearts.
158
Chapter 5 - Results
5.3.12 The effect of O.3mM f-heptanol on ventricular fibrillation threshold
Figures 5.15a and 5.15b show the effect on ventricular fibrillation threshold of
O.3mM heptanol on sham operated hearts and failure hearts respectively. Hcptanol
causes an increase in ventricular fibrillation threshold of (mcan±SEM)
31.88±4.27mA to 42.76±5.41mA in the sham hearts (P>O.05) and 32.16±3.90mA
to 36.67±6.24mA (P>O.05) in the failure hearts. Neither of these effects was
significant. The box and whisker plot in Figure 4.7 illustrates the difference in
ventricular fibrillation threshold between sham-operated and failure hearts on
perfusion with normal Tyrode's solution. Mean ventricular fibrillation threshold
was decreased (P>O.05) in failing hearts. Furthermore, as illustrated in Figure
5.15c failure caused a decrease in ventricular fibrillation threshold of 6.09mA, a
decrease from (mean±SEM) 42.76±5.41mA to 36.67±6.24mA (P>O.05) in heptanol
perfused hearts
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A. The effect of O.3mM 1-heptanol on ventricular fibrillation threshold
in sham operated hearts. Heptanol causes an increase (P>O.OS,unpaired
Student's Hest) in ventricular fibrillation threshold. (n=44 and 29 hearts
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B. The effect of O.3mM 1-heptanol on ventricular fibrillation threshold
in failure hearts. Heptanol causes an increase (P>0.05, unpaired
Student's Hest) in ventricular fibrillation threshold. (n=37 and 15 hearts
respectively)
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and 15 hearts respectively)
Figure 5.15 The effect of O.3mM1-heptanol on ventricular fibrillation
thresholds.
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5.5 Discussion
In this study, at 0.3mM, l-heptanol significantly decreased contractility and MAP
duration but did not have any effect on sequentially recorded dispersion of
repolarisation or ventricular fibrillation threshold. The effect of heptanol on the
first two confirms results from previous studies (see below). However the effect of
heptanol on dispersion of repolarisation is a poorly researched area.
5.5.1 Effect on contractility
Keevil et al (2000) studied the effect of heptanol on contractile function in the
isolated, perfused rabbit heart. Using similar methods to those used in this study,
they found that heptanol inhibited pressure generation as measured by the insertion
of a latex water filled balloon in to the left ventricle. Left ventricular developed
pressure CLVDP) was calculated as the difference between peak systolic pressure
and end diastolic pressure. Keevil et al showed that LVDP was abolished by
perfusion with 1mM or higher heptanol, A lower concentration (0.3mM) was used
in this study which led to approximately 50-60% reduction in LVDP. This effect
was seen to be completely reversible, in both studies, upon perfusion with normal
Tyrode's solution.
A reduction in junctional conductance may lead to a negative inotropic effect due
to increased asynchrony of force development across the syncytium.
Synchronisation of force development depends on a properly timed sequence of
ventricular depolarisation. This is reflected in a certain delay between the earliest
and latest activations in this sequence. As intracellular resistance increases, the
conduction velocity decreases, synchronisation of force development is delayed,
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and overall contractility is reduced. However, isolated cell studies suggest an
alternative explanation for the negative inotropic effect of heptanol. It is thought
that this is due to the inhibition of lea. Heptanol is able to enter the myocyte due to
its lipophilic properties and therefore may affect the sarcoplasmic reticulum Ca2+
release and re-uptake channels. The slow recovery of LVDP after perfusion with
heptanol (Keevil et al, 2000) could be due to the time taken to fully washout
heptanol from the intracellular compartments.
Shaw and Rudy (1997) stated that a non-membrane change such as decreased
intercellular coupling could cause the L-type Ca2+ current to become more
important than the Na+ current as the major ionic current supporting conduction.
5.5.2 Reduction in action potential duration
In both normal and failing hearts it was shown that 0.3mM heptanol caused a
significant decrease in MAP duration especially at longer stimulation intervals
(over approximately 250ms). Keevil et al (2000), in their work with heptanol on
the isolated perfused (healthy) rabbit heart, showed that heptanol over a wide range
of concentrations (0.001-1 mM) decreased repolarisation duration as recorded by
the activation recovery intervals of bipolar electrogram recordings. The size of the
effect varied from approximately 98% to 70% in the epicardium and 95% to 55%
in the endocardium. Activation recovery intervals are an unreliable index of
repolarisation duration compared to MAP recording, especially under ischaemic
conditions where S-T segment changes occur. In the same study Keevil et al also
recorded the effect of heptanol (0.001-0.56mM) using a MAP electrode. They
found that heptanol acts in a dose dependent manner to decrease repolarisation as
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measured by MAPD70. They also investigated the effect of heptanol on the latency
between stimulus and left ventricular activation. Low concentrations of heptanol
(less than O.3mM) were found to induce a gradual but significant increase whilst
higher concentrations (O.3mM-l.OmM) produced a sharp increase in latency.
These values were consistent with a reduction in conduction velocity.
A non-uniform reduction in repolarisation would result in a dispersion that may
facilitate arrhythmogenesis (Kuo et al; 1983; Surawicz, 1997). Consequently the
effect of heptanol on the dispersion of repolarisation and arrhythmia inducibility as
measured by ventricular fibrillation threshold (VFf) was investigated, in normal
and failing hearts.
5.5.3 Dispersion of repolarisation and effect on arrhythmogenesis
Heptanol has previously been used to study the electrophysiological consequences
of the disruption of cellular uncoupling and its relevance to the induction of re-
entrant arrhythmias (Callans et al, 1996). The disturbance of intercellular coupling
has been thought to have an effect on arrhythmogenesis. Lesh et al (1989)
investigated the ability of alterations in cellular coupling to mask or unmask
intrinsic differences in action potential duration in a sheet of ventricular
myocardium. They found that normal low resistance coupling masked dispersion
of repolarisation whilst increased axial resistance unmasked dispersion. If a cell
with a shorter intrinsic action potential is well coupled to a neighbouring cell with
longer action potential, electrotonic flow between them will produce synchronised
repolarisation, but if intercellular coupling is disturbed re-entry may be facilitated.
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This study showed that O.3mM heptanol caused no change in dispersion of
repolarisation. It must be remembered though that dispersion in this study was
recorded sequentially rather than with the more reliable method of simultaneous
MAP recording which is dealt with in the chapter 6. In fact this concentration of
heptanol actually caused a slight decrease in dispersion of repolarisation in failing
hearts. Furthermore, no changes in VFf were observed. This contrasts with the
results found when Callans et al (1996) investigated the effect of heptanol on
conduction and ventricular arrhythmias in infarcted canine myocardium. They
found that heptanol has a bimodal effect on susceptibility to inducible ventricular
tachycardia (VT) in infarcted canine hearts. Low doses (O.5mM) of heptanol
reproducibly induced VT whilst high doses (1.0mM) had an antiarrhythmic effect.
This also contrasts to earlier studies that investigated the effect of heptanol in
normal myocardium, where O.5mM heptanol had little effect and 1.0mM facilitated
the induction of VT.
Keevil et al (2000), during premature stimulation protocols, found that lower
concentrations of heptanol (O.1-0.3mM) caused a higher incidence of arrhythmias
than higher concentrations (>0.3mM) in the normal heart. They suggested that
there might be a critical range of slowed conduction in which re-entrant
arrhythmias could develop, although changes in repolarisation duration may
contribute to this pro-arrhythmic effect. This illustrates the point that heptanol can
be both pro-arrhythmic and antiarrhythmic depending on the concentration and the
state of intercellular coupling prior to heptanoI perfusion.
Evidence from the above mentioned study by Callans et al suggests that O.3mM
heptanol should be pro-arrhythmic. However, in this study there is very little
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change in ventricular fibrillation threshold on perfusion with O.3mM heptanol. It
may be that under the conditions of this study the concentration of heptanol used
may be at a point intermediate between pro- and anti-arrhythmic effects.
Spontaneous arrhythmias however did occasionally occur although not in any
consistent way with heptano!. Failure hearts understandably showed the highest
incidence of spontaneous arrhythmia but on a small number of occasions sham
operated hearts became tachycardic.
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Chapter 6 - The effect of the gap junction uncoupler J-heptanol on
the electrophysiology of the whole heart as recorded by the 32
MAP electrode array
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6.1 Introduction
Cellular uncoupling has been demonstrated in the later phases of ischaemia and
various types of injury. As cells become progressively uncoupled (gap junctional
resistance increases and gap junctional conductance decreases). conduction
velocity decreases monotonically (Rudy and Shaw, 1997). Reduced coupling
between cells causes longer delays in propagation across gap junctions and hence
reduces the conduction velocity. One of the prerequisites for re-entry is
unidirectional conduction block. Altered cell coupling leading to alterations in the
electrophysiological properties of the tissue may result in unidirectional block and
hence arrhythmia. Shaw and Rudy stated that non-sustained re-entry can be
transformed to sustained re-entry by a uniform. or non-uniform. reduction of
cellular coupling by gap junctions. In the case of severe gap junction uncoupling.
propagation cannot be sustained and conduction block occurs. Conduction block
has been discussed as a pre-requisite to arrhythmia in the general introduction
(chapter 1).
The importance of tissue refractoriness in arrhythmogenesis has long been known.
Increasingly restitution (the rate dependent alterations of action potential duration)
is being recognized as a factor for determining the ease with which re-entrant
arrhythmias are initiated and maintained. Generally, action potential duration is a
monotonic function of the coupling interval. However, restitution of action
potential duration has been found to be biphasic (Morgan et al, 1992; Bass 1975).
With increasing coupling interval action potential duration initially increased to a
local maximum, then decreases to a local minimum, and then increases to reach a
steady action potential duration. This biphasic relationship is particularly evident
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in the human ventricle (Bass 1975; Franz et al, 1988). It is expected that biphasic
restitution and steep gradient (>1) of the ascending slope would predispose the
heart to the development of complex dynamic behaviour. Watanabe et al (1976)
developed an analytical model to determine how biphasic restitution gives rise to
this behaviour.
The effect of heptanol on electrical restitution and the implications for
arrhythmogenesis are unknown and were therefore studied as part of this
investigation. The effect of heptanol on dispersion of repolarisation has already
been discussed as a poorly studied area. Sequential recording of dispersion
(chapter 5) provided inconclusive evidence concerning the effect of O.3mM
heptanol on the dispersion of repolarisation. An improved method of MAP
recording that potentially allows the simultaneous recording of 32 MAPs from the
epicardial surface of the left ventricle (chapter 3) was used in this study to obtain
more reliable dispersion results.
The 32 electrode array imposes a time limit to the period of recording that produces
reasonable, and analysable, MAPs. MAP quality and quantity declined rapidly
with time to the extent that the 32 MAP array could not produce good quality
MAPs for the time period required for a stable state restitution protocol (protocol as
previously described for single MAP recording). The 32 MAP electrode array is
discussed in detail in chapter 3. Due to the time limitations imposed by the
electrode array an extrastimulus protocol was used to measure restitution. In the
clinical setting, drive trains consisting of 8 SI stimuli followed by the premature
stimulus S2 are used. However, preliminary experiments suggested that such a
short protocol may not always produce stabilization of MAP duration by the end of
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the SI pulse train. (8 beat SI trains are usually used in such investigations
(Leerssen et al. 1994) but uncertainty in this study was with the stability of such a
short protocol.) Therefore a series of experiments was conducted to compare
protocols with 8 and 16 SI stimuli. Conduction delay as an indicator of gap
junction uncoupling was also studied.
6.2 Methods
Multiple MAPs were simultaneously recorded from the epicardia] surface of the
intact left ventricle with the 32 electrode array. The construction of and the theory
concerning this method of recording are described in detail in chapter 3. This series
of experiments were performed exclusively using norma] control hearts.
6.2.1 Protocols
General methods are described in chapter 2. The heart was perfused in
Langendorff mode with normal Tyrode's solution and with solution containing
O.3mM heptanol. Upon cannulation of the heart, adjustment of perfusion rate,
removal of the right atrium and ablation of the atrio-ventricular node, a 20 minute
stabilisation period was allowed. During the stabilisation period the heart was
paced at a constant pacing cycle length (CL) of 350ms. The electrode array was
positioned around the heart and adjusted so that the maximum number of MAPs
were obtained. A 4 minute MAP stabilisation period in normal Tyrode's solution
was then allowed. Stimulation protocols were then carried out under normal
Tyrode perfusion and also after a switch to 0.3mM heptanol solution. The solution
switch took place 2 minutes prior to the end of the extrastimulus protocol in
Tyrode's - the time required for the solution to travel from the stock solution to the
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heart. A further 4 minute period elapsed to allow stabilisation of MAP duration
and left ventricular developed pressure (LVDP). The extrastimulus protocol was
then performed under perfusion with O.3mM heptanol solution. The protocol is
shown diagrammatically in Figure 6.1.
Tjrndes O.3mM 1-Heptanol
4mins 4mins
350ms peL
II1II Extrastimulus protocol
Figure 6.1 Whole heart perfusion protocol, including stabilisation times
(solid thin lines), extrastimulus protocols (grey solid boxes), and solution
changes.
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Three different extrastimulus protocols were used to investigate the restitution
properties of the heart: 8 SI stimuli plus lOOOms diastole; 16 SI stimuli plus
lOOOms diastole; 16 SI stimuli with lOOOms diastole omitted. All protocols
involved 8 or 16 basic SI stimuli of 350ms intervals followed by an extrastirnulus
S2. The S2 followed the last SI of the train by between 70ms and 600ms and is the
S I-S2 interval. The intervals were increased from 70ms to 600ms in increments of
5ms between 70ms and 150ms, lOms between 150ms and 350ms, and 50ms
between 350ms and 600ms. In two of the protocols a lOOOms diastolic period
followed the S2 stimuli. The 8 SI and 16 SI protocols were performed in different
hearts. These protocols are shown diagrammatically in Figure 6.2.
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II I
(S1-S2= 70-600ms)
S2 S2
I II I I I I 11... 1 I I I • •••••••
350ms 8 S1 stimuli 1000ms
A. 8 S1 stimuli with 1000ms gap.
•••• II I
(51-52= 7D-6DDms)
S2 S2
1 1 1 1 1 1 1 1 1 1 I 1 I 1 1 1, 1 I I I • •••
350ms 1651 stimuli 1DDOms
B. 16 S1 stimuli with 1000ms gap.
(51-S2=70-600ms)
52 S2
I I 1, , I 1 I I I I I I I I I I I I I 1, , I I 1•••• • •••
350ms 16 51 stimuli
c. 16 S1 stimuli.
Figure 6.2 Whole heart extrastimulus protocols. For clarity 81 stimuli
are shown in thin lines whilst 82 stimuli (minimum and maximum) are
shown in bold lines. A. initial protocol used involves an 8 81 stimuli with
1000ms diastole. B. second protocol used involves a 16 81 stimuli with
1ODOmsdiastole. C. as B but without 1000ms pause.
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6.2.2 Data acquisition and analysis
Full details of data acquisition and MAP analysis are described in chapter 2. MAP
signals were digitally recorded and stored on to hard disk for off-line analysis using
Acq (Dr. F.L. Burton, University of Glasgow). MAPs were analysed to obtain
estimations of MAPDso, MAPD90 and conduction delay (CD) using NMAP
(Dr. F.L. Burton, University of Glasgow). The data was saved in to Excel 97
spreadsheets (Microsoft) and graphs were created in Origin 6.1 (Microcal). Due to
the time restriction imposed by the 32 electrode array on MAP recording, the
majority of data collected was from the 16 SI extrastimulus protocol with lOOOms
pause omitted, hence data was extrapolated from these experiments only. This
protocol allowed stable SI MAPs to be obtained prior to the extrastimulus S2.
Data was then analysed to look at:
i) stability of the extrastimulus protocol.
ii) dispersion of repolarisation within hearts, compared between perfusion
conditions (paired Student's t-test).
iii) conduction delay, compared between perfusion conditions (paired Student's
t-test) .
iv) the negative slope of each individual restitution curve obtained, compared
between perfusion conditions (paired Student's t-test)
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6.3.1 Stabilisation of the basic 81 MAPs prior to the extrastimulus
This section (6.3.1) is devoted to the stabilisation of restitution protocols and refers
to the last SI MAP of a train following the S2 extrastimulus and not the SI-S2
restitution curve. In order to check that the S2 stimulus was delivered to a heart
that had reached steady state, the last SI MAP in the 8 or 16 stimuli train following
each extrastimulus was plotted against the previous S I-S2 interval, which was
progressively increased in sequence (from 70ms up to 600ms). Graphs from
individual experiments using the 8 and 16 SI protocol both in Tyrode's and
heptanol are shown in Figure 6.3. On perfusion with both Tyrode's and heptanol,
the resulting graph from 8 SI stimuli data resembled a restitution curve in so far as
the curve had a local maximum and a plateau (Figure 6.3a and b). In contrast, the
same graphs for the 16 SI stimuli protocols were flat (Figure 6.3c and d). This
indicates that 8 SI stimuli is not sufficient to produce a stable MAP duration.
However, the 16 SI produces a stable MAP duration and therefore is the chosen
protocol to use for the remainder of this study.
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Figure 6.3 Typical experiments showing the stability of the Si MAP on
giving 8 Si (A and B, 3 MAPs obtained simultaneously) and 16 51 re
and 0, 7 MAPs obtained simultaneously). Stimulation in Tyrodes (A and
C) and heptanol (8 and D) perfused hearts.
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6.3.2 Dispersion of repolarisation
The remainder of this chapter deals with S2 data obtained from the J 6 SJ protocol
only. Dispersion of repolarisation was estimated by taking the standard deviation
of the MAP duration from all MAP channels within one experimental protocol.
The standard deviations from all hearts were averaged and standard error of the
mean calculated. A minimum of 2 MAPs were required for dispersion to be
measured. The effect of O.3mM heptanol on dispersion of repolarisation after
premature stimuli was investigated at three S I-S2 intervals: at the local maximum
on the restitution curve (180ms in the case of results obtained on perfusion with
Tyrode), at 350ms and at 6qOms. O.3mM heptanol caused a small but non-
significant (paired Student's Hest, P>O.05) increase in dispersion of repolarisation.
This non-significant result may be due to i) variability in the data, ii) the
inconsistent effect of heptanol on dispersion, or iii) too low a concentration of
heptanol to disrupt cellular coupling to a degree that effects dispersion of
repolarisation. Figures 6.4a and 6.4b shows the changes in dispersion of
repolarisation and coefficient of variation respectively. Table 6.2 shows absolute
values (meaniSEM).
Solution Local 350ms 600ms
MaxJ180ms
Tyrode 8.23iO.71 7.34i1.19 8.04il.19
O.3mM l-heptanol 8.59iO.98 8.91iO.93 9.52iO.74
Table 6.1 The effect of O.3mM 1-heptanol on dispersion of S2
repolarisation. P>O.05,paired Student's t-test.
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Figure 6.4 Effect of O.3mM 1-heptanol on dispersion of repolarisation
in S2 MAPs, represented by SD (A) and coefficient of variation (8). 0.3mM
1-heptanol does not cause a change in dispersion of MAPDgo
repolarisation. n=9 hearts, 28 data sets.
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6.3.3 Conduction delay
Conduction delay was measured as the time (ms) between the stimulus artefact and
the upstroke of the MAP (Vmax). Conduction delayed varied depending on the
position of the electrode in relation to the stimulus. Conduction delay was
averaged from each MAP channel and the Tyrode data compared to the O.3mM
heptanol data by a paired Student's t-test. 0.3mM heptanol significantly increased
conduction delay from (mean±SEM) 44.2±0.82ms to 49.2±0.87ms (P<O.OOOl).
Figure 6.5 represents these results.
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***
Tyrode 0.3mM 1-heptanol
Figure 6.5 Effect of O.3mM 1-heptanol on conduction delay. 0.3mM
heptanol increases conduction delay significantly (P<O.001 (***) by paired
Student's t-test). n=9 hearts, 148 channels
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6.3.4 The negative slope
Restitution curves from one typical experiment where 6 MAPs have been obtained
simultaneously are shown in Figure 6.6. The most obvious effect of O.3mM
heptanol was to change the gradient of the slope between the local maximum on
the restitution curve and SI-S2 interval of 350ms. This biphasic restitution curve
was analysed between S I-S2 values of 180ms and 350ms in Tyrode perfused
hearts, or between the local maximum on the restitution curve and 350ms in
O.3mM heptanol perfused hearts. These criteria were used due to the absence of a
maximum in restitution curve of Tyrode perfused hearts and 180ms is a close
approximation to the local maximum in the heptanol perfused hearts. Resulting
slopes of the restitution curves were compared. O.3mM heptanol significantly
exacerbates the negative slope between the local maximum and 350ms. Figure
6.6a represents data obtained on perfusion with Tyrode's solution whilst Figure
6.6b illustrates the induction of a negative slope in the curve by O.3mM heptanol.
The averaged results of all experiments are illustrated in Figure 6.7. The gradient
of the slope was significantly (paired Student's t-test, P<O.OOI) altered by O.3mM
heptanol from (mean±SEM) -O.031±O.004 in Tyrode's to -O.063±O.005 .
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Figure 6.6 Restitution data obtained from a single experiment where 6
MAPs have been obtained simultaneously.
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Figure 6.7 The effect of O.3mM 1-heptanol on the slope of the
restitution curve between 180ms (Tyrode, hashed) or the local maximum
(0.3mM 1-heptanol, blank) and 350ms. Tyrode shows a slight negative
slope which is exacerbated with 0.3mM 1-heptanol. Significant at P<0.001
(***) by paired Student's t-test. n=9 hearts, 140 channels.
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6.4 Discussion
The results show that MAP duration is not in steady-state prior to applying the
extrastimulus S2 when a train of 8 SI pulses are given. The resulting restitution
curve looks plausible, but clearly it does not represent S I-S2 restitution accurately.
The train of 8 SI stimuli are not sufficient to enable recovery of membrane currents
prior to the application of the next extrastimulus. On the other hand, the 16 SI
protocol produced stable SI MAPs and therefore was the chosen protocol from
which to extrapolate results. It is usually standard practice both clinically (Morady,
1988) and experimentally (Ramza, 1990) to use an 8 or 10 beat SI stimuli train.
Extrastimulus protocols are commonly used in humans and animals to measure
refractory periods. Hence the finding of instability in MAP duration on application
of an 8 SI stimuli after an extrastimulus may be of importance.
6.4.1 Conduction delay and velocity
The significant increase in conduction delay seen with 0.3mM heptanol in this
study suggests that gap junction uncoupling occurred. Spear and co-workers
(1990) have shown that in normal anisotropic canine ventricular epicardium,
heptanol causes a slowing of conduction velocity due to a relatively selective
decrease in gap junctional conductance without significantly affecting action
potential depolarisation. This effect on conduction velocity is greater in the
transverse direction than the longitudinal direction due to the anatomical
distribution of cardiac gap junctions and the greater effective axial resistance in the
transverse direction. Gap junction channels are found mainly at the cell poles with
only a few located at the lateral cell borders, thus contributing to the anisotropy of
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the cardiac tissue. It has also been noted by this group that conduction block
induced by heptanol occurs firstly in the transverse direction.
Delmar et al (1987) investigated the effects of increased intercellular resistance on
transverse and longitudinal propagation in sheep epicardial muscle. They
superfused thin square pieces of sheep epicardial muscle with 1.5mM heptanol
whilst recording TAPs at opposite corners of the preparation and alternately
stimulating in the longitudinal or transverse directions. It was concluded that, on
impaired intercellular coupling by heptanol, transverse propagation is more
vulnerable to block, and this is not dependent on changes in Vmax. However,
dispersion of action potential duration as an indicator of the arrhythmogenic effects
of heptanol was not determined.
In the work of Spear et al (1990) on infarcted canine myocardium it was
hypothesised that an abnormally high intercellular coupling resistance between
surviving cells caused slowed conduction. Low concentrations «0.5mM) of
heptanol that had been shown to have a minimal effect on conduction in normal
myocardium, induced local conduction block in infarcted myocardium which
already showed abnormal conduction. This selective conduction block in infarcted
regions may give the impression that a low concentration of heptanol improves
conduction. They proposed that heptanol might 'electrically unload' a pathway to
allow conduction to occur by causing uncoupling in an adjacent region. The ability
of heptanol to abolish abnormal conduction in infarcted myocardium may lead a
way to finding an agent with the uncoupling effect of heptanol (but much less toxic
properties) that could have anti-arrhythmic properties in infarction.
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Keevil et al (2000) investigated the effect of a range of heptanol concentrations on
the electrogram latency in Langendorff perfused rabbit hearts. By taking the
reciprocal of the electrogram latency and estimated inhibition of gap junctions they
gave an accurate measurement of the conduction velocity. Heptanol did not change
the shape of the electrogram recordings, indicating that the activation wavefront
was moving in a similar direction with and without heptanol. They therefore
suggested that the increase in latency seen with heptanol is due to a decrease in
conduction velocity. In their study, O.lmM heptanol decreased conduction velocity
by 8% whilst ImM heptanol decreased it by 65% and was not pro-arrhythmic. The
decrease in conduction velocity seen on perfusion with heptanol is a global effect
as opposed to the more local effect seen in myocardial infarction. It is however
clear that changes in conduction velocity may have implications in
arrhythmogenesis.
6.4.2 Dispersion of repolarisation
In contrast to theory and hypothesis, the gap junction uncoupler heptanol at a
concentration of 0.3mM did not cause a consistent significant increase in
dispersion of repolarisation. A significant increase in dispersion of repolarisation
was observed at an S I-S2 interval of 600ms only.
In the normal heart regional differences in action potential duration are seen, and
this is a completely physiological occurrence (base to apex, and transmural
differences in action potential duration are discussed in the general introduction
(chapter 1». Action potentials tend to be longer at earlier activation sites and
shorter at later activation sites to ensure that recovery is homogenous. The
electrotonic interaction between cells is thought to mask the intrinsic dispersion of
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repolarisation (differences between individual cells) (Joyner, 1986) and enables
this homogenous recovery to occur. Single cells are therefore able to express their
intrinsic action potential duration in the absence of electrotonic interactions.
Therefore, uncoupling cells (Le. as with heptanol) should lead to an increase in
heterogeneity of repolarisation which may favour re-entry (Janse and Wit, 1989).
Lesh et al (1989) hypothesised (and tested via a computer simulation model) that
when cells are well coupled, local differences in intrinsic action potential duration
are not apparent but as axial resistivity increases, local variation in action potential
duration become evident. They showed that changes in axial resistivity can
modulate how spatial dispersion of intrinsic action potential duration is manifest
(i.e. uncoupling increases dispersion of repolarisation). These findings may be
important in understanding the mechanism of re-entrant arrhythmia initiation in
infarctions where evidence suggests that abnormal cellular coupling is the primary
electrophysiological derangement.
6.4.3 The negative slope in the restitution curve
The induction of a negative slope by O.3mM heptanol is a phenomenon that was
observed, but was not a result initially expected. The single catheter results
showed that heptanol decreases MAP duration. The 32 MAP electrode array
results indicated that there is indeed a decrease in MAP duration, but this decrease
is more substantial at intermediate S I-S2 intervals, between the local maximum
and S I-S2 interval of 350ms. The cause of the induction of the negative slope by
heptanol will be discussed in the final discussion and conclusion (chapter 10),
where further work will also be addressed.
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Considering heptanol has previously been described as a non-specific gap junction
uncoupler (Rudisuli and Weingart, 1989), a natural progression in this study was to
investigate the effect of heptanol on single cells. This manifested itself as an
investigation in to whether the negative slope in the restitution curve is a gap
junction uncoupling phenomenon or whether it is caused by a disruption in E-C
coupling.
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Chapter 7 - The effect of f-heptanol and nifedipine on single cell
fractional shortening and calcium handling
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7.1 Introduction
This chapter deals primarily with the effect of heptanol on single cell contractility,
Ca2+ transient, and SR Ca2+ content in isolated epicardial left ventricular myocytcs.
As reviewed in chapters 5 and 6, heptanol is known to affect gap junctions at
relatively high (approximately 1-3mM) concentrations. At these concentrations
heptanol seems also to effect several other cellular processes. Takens-Kwak et al
(1992) used cultured neonatal rat cells to investigate the effect of 1mM heptanol on
non-junctional membranes. They found that both the inward rectifying K+ current
(lKl), the delayed rectifying current (lK), the inward Na+ current (INa), and the
L-type Ca2+ current (Icad were all reduced. In work on the effects of general
anaesthetics on current flow across membranes in guinea pig myocytes (Niggli et
al, 1989), found that n-alkanols (heptanol, octanol) and halothane caused a
decreased amplitude and an accelerated inactivation of ICaL• These, and other
studies (Burt and Spray, 1989; Niggli et 01, 1989; Rudisuli and Weingart, 1989)
used isolated guinea pig myocytes. No detailed study on the effects of heptanol in
the rabbit has appeared in the literature.
This study has shown that, in the whole rabbit heart, heptanol caused a marked
decrease in contractility (as measured by LVDP, refer to chapter 5 section 5.3.2.1).
Although a reduction in gap junction coupling may in itself lead to a less
synchronised spread of conduction and therefore decrease contractility, this cannot
account for (all) the reduction in LVDP. Based on previously published work a
more likely explanation for the reduction in contractility is an effect of heptanol on
E-C coupling of individual myocytes. In particular, there is evidence (Niggli et al,
191
Chapter 7 - Results
1989; Takens-Kwak et al. 1992) to suggest that it may have a direct effect on the
L-type Ca2+ channel.
Due to the speculation concerning the effect of hepta noI on the L-type Ca2+ channel
the effect of nifedipine, an L-type Ca2+ blocker, was investigated in single cells and
subsequently the whole heart. Nifedipine is a specific L-type Ca2+ channel
antagonist that binds to the L-type Ca2+ channel (dihydropyridine receptor) in a
voltage dependent manner. The aim of this investigation was to relate the negative
inotropic effect of heptanol in the single cell, to a concentration of nifedipine that
produces the equivalent negative inotropic effect on contractility in the single cells.
This would give an approximate concentration of nifedipine that could then be used
on the Langendorff perfused rabbit heart to investigate the effect of partial L-type
Ca2+ channel blockade on the gradient of the slope of the electrical restitution
curve.
192
Chapter 7 - Results
7.2 Methods
Details of cell isolation and the measurements of single cell fractional shortening,
Ca2+ transient, and SR Ca2+ content was given in chapter 2. Left ventricular
epicardial myocytes from stock and sham-operated rabbit hearts were used to
allow comparison with previous measurements from the epicardial surface of the
whole heart. Cells were pipetted into the perfusion bath and allowed to settle for
approximately 5 minutes prior to switching on perfusion. This settling period
allowed enough cells to stick to the glass bottom of the bath, which could then be
superfused without being dislodged. Perfusion was initially with normal Krebs
solution at 37°C.
7.2.1 Fractional shortening and Ca2+ measurement stimulation protocols
The stimulation protocol for fractional cell shortening measurements is illustrated
in Figure 7.la. The stimulation protocol was initially recorded on perfusion with
0.03mM heptanol and then repeated, at both stimulation frequencies, with 0.1mM
and 0.3mM heptanol. Finally, re-perfusion with Krebs allowed reversibility to be
measured. Solution changes were made via a custom made 4-way solution
changer. In the preliminary investigations using nifedipine, various concentrations
of nifedipine solution were tried with the aim of determining a concentration of
nifedipine that caused a similar degree of inhibition of fractional cell shortening
compared to heptanol (see results). These experiments indicated that inhibition of
shortening comparable to that seen with heptanol was obtained on perfusion with
0.15JlM nifedipine.
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Initially it was planned that fractional cell shortening and Ca2+ measurements be
obtained simultaneously. However, due to technical difficulties complicating the
process of simultaneous recording separate experiments were required. Fura-2
seemed to reduce the contractility of the cell to a degree at which single cell
shortening measurements were difficult to maintain. Fractional cell shortening was
calculated from end-diastolic and end-systolic cell lengths, and Ca2+ measurements
from end-diastolic and end-systolic Fura-2 ratios (refer to chapter 2 general
methods).
7.2.2 Caffeine induced sarcoplasmic reticulum Ca2+ release stimulation
protocols
To investigate the effect of heptanol and also nifedipine on SR Ca2+ content, rapid
perfusion with caffeine (20mM) was performed. This causes a rapid release of
Ca2+ from the SR. Many studies have used the amplitude of caffeine induced
release as an indicator of the SR Ca2+ content (e.g. Denvir et ai, 1998; Davies et al,
2000). Cells were initially perfused with Krebs at 37°C and paced at 1Hz for 60
seconds. Stimulation was briefly stopped as perfusion was switched from Krebs to
a rapid application of 20mM caffeine. Following the caffeine response stimulation
at 1Hz was resumed with Krebs perfusion. Stimulation was stopped for a
maximum of 5 seconds. The protocol was repeated with either 0.1mM heptanol or
O.15JlM nifedipine solution. The caffeine protocol is shown schematically in
Figure 7.1b.
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7.2.3 Statistical analysis
The majority of the measurements made within this section were compared to an
individual control (Krebs), therefore it was necessary to make statistical
comparisons using a paired Student's's t-test rather than a repeated measures
ANOVA.
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[[J] 1-Heptanol/Nifedipine
CJ Krebs
1Hz 3Hz
A. Single cell fractional shortening stimulation protocol. Protocol run
in 0.03, 0.1 and 0.3mM 1-heptanol and also 0.1, 0.15 and 0.2J.!Mnifedipine.
ITIIID 0.1 mM 1-Heptanol/O.1 5uM Nifedipine
CJ Krebs
Stim. stop
+20mM Caffeine
Stim. stop
+20mM Caffeine
B. Single cell caffeine induced SR Ca2+ content release protocol.
Figure 7.1 Stimulation and perfusion protocols for fractional cell
shortening (A) and Ca2+ handling (8) experiments.
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7.3 Results
7.3.1 Relative end-diastolic lengths
End diastolic length (EDL) was measured during perfusion with Krebs, O.03mM,
O.lmM and O.3mM heptanol and on reperfusion with Krebs. Data were normalised
to the baseline value in Krebs, and expressed as relative EDL. In a second set of
experiments EDLs were recorded on perfusion with O.IIlM, O.151lM and O.2IlM
nifedipine.
The effect of heptanol over a range of concentrations on relative EDL is illustrated
in Figure 7.2. Heptanol, at all concentrations and at both 1Hz and 3Hz stimulation
rates, did not have any effect on the EDL.
Figure 7.3 illustrates the relative EDL values obtained on perfusion with the
nifedipine concentration range at 1Hz. It is evident that nifedipine also does not
effect EDL in the range of concentrations studied.
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B. Stimulation at 3Hz. n=9 hearts, 24 cells.
Figure 7.2 The effect of 1-heptanol on end diastolic length. Heptanol is
normalised to the value on Krebs prior to exposure to heptano!.
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1.02
0.1pm 0.15pm 0.2J1m
Krebs nifedipine nifedipine nifedipine Krebs
Figure 7.3 The effect of O.1J.1.M,O.15J.1.Mand O.2JLMnifedipine on relative
end diastolic length. n=4 hearts, 24 cells. Nifedipine is normalised to the
value on Krebs prior to exposure to heptanol.
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7.3.2 Fractional shortening
Changes in percentage fractional shortening on perfusion with heptanol or
nifedipine solution were used to indicate changes in cell contractility. Fractional
cell shortening is calculated as follows:
Fractional cell shortening (%) = lOO-(ESLIEDL) x 100
where ESL=end systolic length and EDL=end diastolic length
To allow the average effect of heptanol to be calculated, data were further analysed
and graphically illustrated as the relative fractional cell shortening. This is
fractional shortening (see above) normalised to the standard conditions (stimulation
in Krebs solution).
Relative fractional cell shortening is calculated, for each concentration of heptanol
and nifedipine as follows (heptanol appears in the equation but may be substituted
for nifedipine):
Relative fractional cell shortening (RFS) = (Heptanol FSIKrebs FS)
O.03mM, O.lmM and O.3mM heptanol induced a significant decrease in fractional
cell shortening. Contractility is fully recovered on reperfusion with normal Krebs
solution. Comparable results were obtained at 1Hz and 3Hz. Figures 7.4a and 7.4b
illustrate the effect of O.03mM, O.lmM and O.3mM I-Heptanol on relative
fractional shortening, from cells stimulated at 1Hz and 3Hz respectively. The
experimental trace in Figure 7.5 shows a typical result where contractility was
significantly reduced on perfusion with O.lmM heptanol (stimulation atlHz).
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Contractility was fully recovered on reperfusion with Krebs. Data are also shown
in Table 7.1 as absolute values.
Figure 7.6 illustrates the changes in relative fractional cell shortening caused by
perfusion with the 3 nifedipine concentrations at 1Hz only. Nifedipine also
decreases fractional cell shortening. This effect was significant at O.l5JlM and
0.2JlM but not at O.IJlM nifedipine. The experimental trace in Figure 7.7 illustrates
a typical result from an experiment where 0.15JlM nifedipine decreases single cell
contractility. Data is also shown in Table 7.1 as absolute values.
Mean Fractional Cell Shortening (%) (±SEM)
Krebs O.03mM O.lmM O.3mM Krebs
heptanol heptanol heptanol
1Hz 9.3iO.8 5.7iO.7** 5.6±0.9** 3.2iO.8** 7.7iO.8
3Hz 1O.6iO.8 6.5±1.4** 7.7±1.4** 4.7±1.5** 1O.9±1.3
O.I~M O.15J!M O.2J!M
nifedipine nifedipine nifedipine
1Hz 8.9iO.7 5.8iO.7 3.4iO.9*** 0.8±0.2*** 9.2±1.4
Table 7.1 The effect of 1-heptanol at 1Hz and 3Hz, and nifedipine at
1Hz, and on mean fractional cell shortening. Heptanol and nifedipine
significantly decrease fractional cell shortening (unpaired Student's Hest
**=P<O.01, ***=P<O.001).
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10 secs
Krebs 1-Heptanol (0.1mM) Krebs
Figure 7.5 Trace showing the effect of O.1mM 1-heptanol on single cell
shortening. A typical experimental trace showing that perfusion with
0.1mM heptanol significantly reduces contractility, but is fully reversible.
Stimulation is at 1Hz. The length of the cell (j.lM) is shown to the left of the
trace.
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Figure 7.7 Experimental trace illustrating the effect of O.15~M
nifedipine on single cell contractility. Nifedipine significantly decreases
single cell contractility but, as with heptanol, the effect is fully recoverable.
Stimulation is at 1Hz. The length of the cell (~M) is shown to the left of the
trace.
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7.3.3 Calcium handling
Ca2+ measurements were obtained to attempt to relate the reduction in single cell
fractional shortening to changes in single cell intracellular Ca2+ concentration.
Calcium transients were quantified in terms of end diastolic Fura-2 ratio and peak
systolic Fura-2 ratio.
Figures 7.8a and 7.8b illustrate the effect of heptanol on peak Fura-2 results for
cells stimulated at 1Hz and 3Hz respectively. D.D3mM, O.lmM and 0.3mM
heptanol decreased peak Fura-2 ratio. This effect was statistically significant with
O.lmM heptanol at 1Hz but at all concentrations at 3Hz (P<D.D5, unpaired
Student's Hest). The heptanol results contrast, in significance, to the results found
with D.1 f.!M,0.15f.!M and 0.2f.!M nifedipine whose effect on peak Fura-2 ratio was
found to be statistically significant at 1 Hz across the concentration range (Figure
7.9). Figure 7.10 and 7.11 are examples of experimental traces that illustrate the
effect of O.lmM heptanol and D.15f.lMnifedipine on the Ca2+ (Fura-2) transients.
The amplitude of the Ca2+ transients recovered on reperfusion with normal Krebs
solution at both 1Hz and 3Hz after perfusion with heptanol and nifedipine. End
diastolic results are not shown but no change was detected.
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Figure 7.8 The effect of 1-heptanol on relative peak Fura-2 ratios.
Perfusion with Krebs, 0.03mM, 0.1mM and 0.3mM heptano!. Student's
unpaired t-test *=P<O.05, **P<O.01.
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10 secs
Krebs 1-Heptanol (0.1 mM) Krebs
Figure 7.10 Experimental trace showing the effect of 0.1mM 1-heptanol
on single cell Fura-2 ratio.
0.73
10 Secs
Ratio
0.70
Krebs Nifedipine (O.15jJM) Krebs
Figure 7.11 Experimental trace showing the effect of O.15J.lMnifedipine
on Fura-2 ratio.
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7.3.4 Sarcoplasmic reticulum Ca2+ content
SR Ca2+ content was assessed by applying a bolus of 20mM caffeine to cells that
had previously been stimulated at 1Hz. Stimulation was stopped momentarily for
the caffeine to be pulsed. Baseline (stimulation at 1Hz), and caffeine peak Fura-Z
ratios were measured from cells perfused with Krebs solution and 0.1mM heptanol
and O.15JlM nifedipine solution.
The effect of 0.1mM heptanol on peak systolic SR Ca2+ content (as measured by
Fura-Z ratios) is illustrated in Figure 7.12. Figure 7.12 shows that O.1mM heptanol
caused a decrease (P>O.05) in SR Ca2+ release but did not effect SR Ca2+ content.
Figure 7.13 shows experimental traces illustrating the changes in SR Ca2+ content
with 0.1mM heptanol.
Nifedipine similarly induced a decrease (P>O.05) in SR Ca2+ release. It also
reduced (p<O.05) SR Ca2+ content, as compared to control Krebs. (Figure 7.14).
Figure 7.15 shows experimental traces that illustrate the effect of 0.15JlM on SR
Ca2+ content.
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10 Secs
Caffeine (20mM)-
Krebs
A. Experimental trace showing the SR Ca2+ content by application of
20mM caffeine.
.: [ .
0.38
Caffeine (20mM) 10 Secs-
1-Heptanol (0.1mM) Krebs
B. Experimental trace showing the effect of 0.1mM 1-heptanol on SR
Ca2+ content by application of 20mM caffeine.
Figure 7.13 The effect of 1-heptanol on SR Ca2+ content: experimental
traces. Ratios are indicated to the left of the traces.
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Stimulated
transient
- 1Hz
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Caffeine
induced
transient
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Stimulated
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(+ 0.15pM
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Caffeine
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Figure 7.14 The effect of O.15J..lMnifedipine on SR Ca2+ content. n= 3
hearts, 22 cells.
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Caffeine (20mM)
Krebs
A. Experimental trace showing SR Ca2+ content by application of
20mM caffeine.
10 Secs Caffeine (20mM)-
Nifedipine (O.lS.uM)
B. Experimental trace showing the effect of O.15JlMnifedipine on SR
Ca2+ content.
Figure 7.15 Experimental traces showing the effect of nifedipine on SR
Ca2+ content. Ratios are shown to the left of the traces.
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7.4 Discussion
The results in this chapter show that at a concentration known to cause gap junction
uncoupling, heptanol also has significant depressive effects on E-C coupling. In
this investigation the initial studies on cell shortening indicate that, at both 1Hz and
3Hz stimulation rates, O.lmM heptanol decreased fractional shortening to
approximately 50% of control values. Higher concentrations of heptanol are
required to produce comparable depressions of contractility in whole hearts. As
shown in chapter 5, O.3mM heptanol was required to produce an approximate 50%
reduction in contractility. The reason for this disparity is unknown although one
possible factor may be the different forms of contractility recorded in the two
experiments. Single cell shortening occurs unrestrained and therefore represents an
isotonic measurement, whilst LVDP represents the pressure the myocardium can
generate under practically isometric conditions. A more relevant single cell
measurement would therefore have been isometric tension development, but this
would require that the ends of the single cells be fixed which is technically difficult
to perform.
The effect on cell shortening suggests that heptanol may reduce the size of the
Ca2+ transients, and/or the ability of Ca2+ to generate force/shortening. The
measurement of Ca2+ transients using Fura-2 was used to discriminate between
these two options. The effect of heptanol on the Ca2+ transient on stimulation at
1Hz was complex. O.lmM heptanol caused a decrease in Ca2+ transient amplitude,
whilst at 0.3mM the Ca2+ transient was not different from control. At 3Hz
stimulation rate, heptanol caused a decrease in Ca2+ transient amplitude at O.1mM
and 0.3mM. These results suggest that part of the effect of heptanol on E-C
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coupling is via a reduced amplitude of the Ca2+ transient, and partly may be due to
reduced Ca2+ sensitivity of the rnyofilarnents. The latter however is favoured,
given that 0.3mM heptanol has a greater negative inotropic effect than 0.1mM
heptanol. The reduced Ca2+ transient amplitude may be due to either the effects on
the L-type Ca2+ channel or SR Ca2+ release and uptake.
On the basis of the work by Takens-Kwak et al (1992) in neonatal rat myocytes it
seems more likely that heptanol inhibits the L-type Ca2+ channel. Bastide et at
(1995) on studying cultured rat myocytes reported that the intracellular Ca2+
concentration is not involved in the rapid and reversible uncoupling action of
heptanol. They ruled out the contribution of H+, cyclic nucleotides and protein
kinase C to the rapidity of uncoupling, and suggested that this was consistent with a
direct effect of the alcohol on membrane components (junctional proteins or their
lipid environment). An effect directly on the sarcolemma would be consistent with
an effect on the L-type Ca2+ channel.
It has previously been reported that the inhibition of the slow inward Ca2+ current
by nifedipine reduces action potential duration and produces a dose dependent
negative inotropic effect (Segawa et al, 1999). This reduction in contractility is
due to a reduced inward movement of Ca2+ during the action potential plateau
phase (due to inhibition of the L-type Ca2+ channel). The effects of nifedipine on
action potential duration and contractility correlate well with those found in this
study with heptanol.
In this study it was found that nifedipine decreased the amplitude of the Ca2+
transient and the caffeine induced Ca2+ release transient (ryanodine receptor).
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However, the caffeine induced Ca2+ release was unaffected by heptanol,
Nifedipine would be expected to reduce both Ca2+ transient and caffeine induced
release since lowered Ca2+ influx via the L-type Ca2+ channel would lower SR Ca2+
content (Frampton et al, 1991). In contrast, heptanol did not reduce caffeine
induced Ca2+ release, suggesting that hepta no) reduces the Ca2+ transient in rabbit
myocytes by reducing the efficacy of the link between the L-type Ca2+ channel and
SR Ca2+ release. Further study is required to determine the exact nature of this
link.
216
Chapter 8 -Results
Chapter 8 - The effect of the LvType calcium channel blocker
nifedipine on the negative slope of the restitution curve in the
whole heart
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8.1 Introduction
The last chapter described comparable effects of heptanol and nifedipine on single
cell contractility and intracellular Ca2+. Nifedipine, in the concentration range 0.1-
O.2JlM, induced a decrease in fractional cell shortening and SR Ca2+ release that is
of an equivalent magnitude to 0.03-0.3mM heptanol. It is conceivable that the
negative slope phenomenon seen in the whole heart with heptanol is a product of
the effect of heptanol on the L-type Ca2+ channel and not a direct effect of gap
junction uncoupling. For this reason, it was logical to study the effect of nifedipine
on whole heart electrophysiology, and more specifically the effect on the slope of
the restitution curve.
The series of experiments described have attempted to relate any changes caused
by nifcdipine to those seen with heptanol (Le. induction of an increased negative
slope between the local maximum on the restitution curve and an S I-S2 interval of
350ms). Additionally data concerning dispersion of repolarisation and conduction
delay were also obtained.
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8.2 Methods
Multiple MAPs were simultaneously recorded from the epicardial surface of the
intact left ventricle of stock and sham-operated rabbit hearts with the 32 electrode
array, and using stimulation protocols described in chapter 6. The 16 SI protocol
was used exclusively in all experiments using nifedipine. The protocol was
repeated several times within one experiment (a single heart) to obtain replicate
data concerning the effect of 0.1 JlM, O.l5JlM and 0.2JlM nifedipine on the
restitution curve. Between the perfusion of each concentration of nifedipine there
was a 15 minute washout with Tyrode (cycle length = 350ms) prior to perfusion
with the next concentration of nifedipine. The electrode array remained positioned
around the heart for the duration each protocol, being removed only between
protocols.
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8.3 Results
8.3.1 The effect of nifedipine on LVDP
Figure 8.1 illustrates the effect of nifedipine on left ventricular developed pressure
(LVDP). O.IIlM, 0.151lM and 0.21lM nifedipine caused a significant decrease in
LVDP from 100% to (mean±SEM): 59.65±2.95% (O.IIlM) P<0.05; 51.15±4.85%
(O.l5jlM) P<0.05; 55.38±6.44% (0.2jlM) P<O.OOI (paired Student's Hest).
Recovery in Tyrode's solution was to 105.86±6.l1 % of control.
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Figure 8.1 The effect of nifedipine on LVDP. Nifedipine significantly
decreases LVDP (paired Student's t-test *=P<O.05, **=P<0.01).
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8.3.2 The negative slope
The graphs in Figure 8.2 show typical results from a single experiment where the
heart has been perfused with O.lJLM nifedipine, 10 MAPs have been obtained
simultaneously. 3 normal rabbit hearts were used with 3 to 10 MAPs being
obtained simultaneously from each of these. The restitution curve obtained on
perfusion with nifedipine showed an ascending slope similar to that of the control
(Tyrode) or of heptanol. This involved a rapid increase in MAP duration with
increasing S 1-S2 interval. Over the range of concentrations used. nifedipine made
the slope of the restitution curve less negative (in contrast to heptanol). If the
restitution curve showed a biphasic relationship, the slope was analysed between an
S 1-S2 interval of the local maximum on the curve and an S 1-S2 interval of 350ms.
If the curve was a typical restitution curve, Le. it showed a monotonic increase in
MAP duration with S 1-S2 interval, the slope was determined between S 1-S2
intervals of 180ms and 350ms.
Figure 8.3 illustrates the significant effect that nifedipine has on flattening the slope
of the restitution curve whilst Figure 8.4 summarises this. Table 8.1 contains the
absolute values for the slope of the graphs (average of all results).
Slope (±SEM) at nifedipine concentration of (J.1M)
0.1 0.15 0.2
Tyrode -O.O82±O.OO82 -O.O654±O.OO19 -O.O784±O.OO53
Nifedipine -O.O21±O.OO56*** -O.O303±O.OO80* -O.0245±O.006l ***
Table 8.1 The effect of nifedipine on the gradient of the slope of the
restitution curve. n=3 hearts, 27 channels (0.1J-lM nifedipine) P<0.001;
n=3 hearts, 19 channels (0.15J-lM nifediipne) P<0.05; n=3 hearts, 20
channels (0.2J-lMnifedipine) P<0.001.
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B. 0.1 J,lMnifedipine perfusion.
Figure 8.2 Restitution curves from a typical experiment where the
heart was perfused with normal Tyrode's solution (A) followed by
0.1 J,lMnifedipine solution (B).
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Figure 8.3 The global effect of nifedipine on electrical restitution
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Figure 8.4 The effect of nifedipine on the gradient of the slope of the
restitution curve. n=3 hearts, 27 channels (0.1 f,1Mnifedipine) P<0.001;
n=3 hearts, 19 channels (O.15f,1M nifedipine) P<0.05; n=3 hearts, 20
channels (0.2f,1Mnifedipine) P<O.0001 (paired Student's t-test).
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8.3.3 Conduction delay
The effect of O.lJ.lM, O.15J.lM and O.2J.lM nifedipine on conduction delay in the
whole heart is shown in Figure 8.5. Over the full concentration range investigated,
nifedipine did not cause an increase or decrease (P>O.05, paired Student's Hest) in
conduction delay. This contrasts with the effect of heptanol which caused a
significant increase in conduction delay.
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I~Tyrode I
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0.11lM 0.151lM
Figure 8.5 The effect of nifedipine on conduction delay. n=3 hearts, 27
channels (0.1~M nifedipine); n=3 hearts, 19 channels (0.15~M nifedipine);
n=3 hearts, 20 channels (0.2~M nifedipine).
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8.3.3 Dispersion of repolarisation
The effect of O.II1M, O.l511M and O.2I1M nifcdipine on S2 dispersion of
repolarisation at SI-S2 intervals of the local maximum (nifedipine)1l80ms
(Tyrodes), 350ms and 600ms was investigated. The results are illustrated in Figure
8.6a-f as dispersion of repolarisation and coefficient of variation. Dispersion of
repolarisation is not consistently increased or decreased at the concentrations
studied. However, at an S I-S2 interval of 600ms O.15JlM nifedipine caused a
decrease (P>O.05, paired Student's t-test) in dispersion, and O.2JlM nifedipine
increased (P>O.05, paired Student's Hest) dispersion.
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Figure 8.6 The effect of nifedipine on dispersion of repolarisation.
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8.4 Discussion
Although the aim of this study was solely to establish the effect of nifedipine on the
gradient of the slope of the restitution curve between the local maximum (or SI-
S2=180ms), conduction delay and dispersion of repolarisation were also analysed.
This enabled a direct comparison with the results obtained with heptanol. It was
shown that nifedipine does not induce an increase in conduction delay in the left
ventricle of the intact rabbit heart nor does it cause a significant dispersion of
repolarisation.
In contrast to the study investigating the effect of heptanol as a gap junction
uncoupler, the primary aim of these experiments was to investigate the L-type Ca2+
channel blockers effect on the slope of the restitution curve. The appearance of a
negative slope by heptanol is a phenomenon observed during whole heart
experiments. Single cell experiments revealed that heptanol has affects in addition
to gap junction uncoupling, specifically the reduction in SR Ca2+ release and
fractional cell shortening. In this study the effect of heptanol on E-C coupling was
mimicked by nifedipine. The effect of nifedipine on single cell Ca2+ handling was
investigated and a concentration (O.15)lM) found that reduces cell shortening to a
similar degree as O.3mM heptanol. Therefore a possible cause of the negative slope
is altered action potential characteristics as an indirect result of the effect of
heptanol on E-C coupling.
As previously discussed in this study, the relationship between the action potential
duration and preceding diastolic interval is known as a restitution relation.
Alternations of action potential duration often occur on alteration of this relation.
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Riccio et al (1999) described the implications of the slope of the restitution relation
to arrhythmogenesis. Electrical alternans is known to develop if the slope of the
restitution relation is greater or equal to 1, and if this is the case then rapid pacing
may induce fibrillation. However, if the slope of the restitution relation is less than
1 then neither alternans nor fibrillation occurs. This would imply that if a steep
slope in the restitution relation is a prerequisite for ventricular fibrillation then a
reduction in the slope might prevent it.
In a recent publication by Fox et al (2002) the role of lea in electrical alternans in
an ionic model based on canine myocyte data was discussed. In the control model
after short paced cycle lengths, and only partial recovery of lea, there was a
shortening of action potential duration followed by a longer diastolic interval.
Assuming fast pacing at the shorter cycle length is maintained, a self-perpetuating
alternans is established. However, decreasing the permeability of the L-type Ca2+
channel decreased the magnitude of lea which shifted the balance between lea and
K+ currents to the repolarising currents. This resulted in a longer diastolic interval
and a complete recovery of lea. At shorter cycle lengths the recovery of lea was
incomplete. Because of the reduced magnitude of lea and the rate dependent
accumulation of incompletely deactivated K+ current, the action potentials
remained short as the dependence on lea was minimal. This mechanism is similar
to that that describes the attenuation of alternans, at short cycle lengths, in the
control model used. This may implicate lea as the current primarily responsible for
beat to beat variations in action potential duration. These findings strengthened the
decision to focus on Ca2+ related mechanisms rather than K+ as the origin of the
negative slope.
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The effect of nifedipine on whole heart electrophysiology was investigated using
the same protocols as those for heptanol. It was found that nifedipine flattened the
slope of the restitution curve between the S 1-S2 interval of the local maximum on
the restitution curve and 350ms. This suggests that nifedipine may have an
opposite effect to heptanol on the membrane currents responsible for the negative
slope phenomenon.
The fact that partial blockade of E-C coupling by inhibition of the L-type Ca2+
channel is not associated with a negative slope in the restitution curve rules out the
idea that the L-type Ca2+ channel may be responsible for the negative slope.
233
Chapter 9 - Results
Chapter 9 - The effects of gap junction uncoupler carbenoxolone
on whole heart electrophysiology and single cell contractility and
calcium handling
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9.1 Introduction
Carbenoxolone is a mineralocorticoid that is used to promote healing in the
treatment of gastric and mouth/oral ulcers. It is thought to work by stimulating the
production of mucus that forms a protective coating over the stomach's lining,
acting as an antacid. At pH < 4, carbenoxolone polymerises to a gel that binds to
and covers ulcers - it acts as a "bandage" on the ulceration, preventing further
exposure to gastric acid and, thus, further erosion and damage to the mucosa.
Experimentally, work with carbenoxolone has previously been largely restricted to
neurological investigations where it has been found to reversibly abolish gap
junction-mediated intercellular coupling (rat sympathetic preganglionic neurones)
(Leslie et al, 1998). However, its effect on cardiac gap junction uncoupling has not
been widely studied. One study, reported in a poster at the American Heart
Association conference 1999 (de Groot et al), concluded that carbenoxolone is a
specific gap junction uncoupler. 50jlM and 100jlM carbenoxolone were found to
delay conduction in isolated cell pairs and caused localised conduction slowing and
block which indicated gap junction uncoupling. However, it did not influence
action potential characteristics, nor did it influence transmembrane currents
indicating that carbenoxolone is specific to gap junction uncoupling. Due to the
reported apparent specificity of carbenoxolone, it was an obvious choice of
substance for comparison with the relative unspecific effects of heptanol.
Since several of the effects of heptanol on MAP recording cannot easily be
attributed to gap junction uncoupling, it was of interest to investigate the effects of
a specific agent on the same parameters. The primary aim of these experiments
was to test whether carbenoxolone i) induced a negative slope in the restitution
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curve, similar to that seen with heptanol, ii) unmasked any dispersion of
repolarisation, and iii) caused an increase in conduction delay. Despite the
preliminary evidence from de Groot et al that carbenoxolone has no effect on
transmembrane currents, a single cell study was also carried out to investigate the
effect of carbenoxolone on single cell fractional shortening and intracellular Ca2+
measurements.
9.2 Methods
MAPs were simultaneously recorded from the epicardial surface of the left
ventricle of the Langendorff perfused rabbit heart using the 32 electrode
monophasic action potential array. Stock and sham hearts were used throughout.
9.2.1 Whole heart experiments
The 16 SI extrastimulus protocol was used for all whole heart carbenoxolone
experiments (n=4 hearts, 24 MAP channels). The heart was paced at a CL of
350ms on perfusion with normal Tyrode's solution for 4 minutes before starting the
16 SI extra-stimulus protocol. This protocol was then repeated following regular
pacing for 4 minutes in the presence of SOIlM carbenoxolone.
A suitable concentration of carbenoxolone was found by looking at the dose
dependent effects of carbenoxolone on whole heart electrophysiology and
perfusion/left ventricular pressures. A concentration range of lOIlM to lOOIlM
carbenoxolone was studied. It was found that <SOIlM carbenoxolone had little
effect on any of the target parameters to be studied. However, >60IlM
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carbenoxolone had dramatic and irreversible toxic effects on the heart, namely: an
increase in perfusion pressure, and an increase in end diastolic and end systolic
pressures. Therefore the maximum concentration of carbenoxolone that could be
used in this study is 50JlM, a value that would allow comparison to the work done
by de Groot et al (2000). Due to the irreversible nature of its effects, only one
episode of perfusion with carbenoxolone was attempted.
9.2.2 Single cell experiments
Left ventricular epicardial myocytes were used for all carbenoxolone experiments.
Perfusion protocols were carried out firstly at 1Hz and then 3Hz. The cells were
perfused initially with Krebs for 60 seconds followed by 50JlM carbenoxolone for
60 seconds. Carbenoxolone was washed out with a Krebs for 60 seconds. SR Ca2+
content was investigated by application of 20mM caffeine to cells stimulated at
1Hz. Based on results from whole heart experiments, only the effect of 50JlM
carbenoxolone was studied.
237
Chapter 9 - Results
9.3 Results - Whole heart
9.3.1l\fonophasic action potential duration
The effect of 50llM carbenoxolone on MAPD90 was analysed. Mean S2 MAPD,)o
was taken from the S2 at the S I-S2 interval of the local maximum on the curve,
350ms, and 600ms. 90ms was omitted, as it was rare that capture occurred at this
coupling interval. Figure 9.1 illustrates the effect of 50llM carbenoxolone on
MAPDgo. SI MAP duration was reduced by 7%. S2 MAP duration was reduced
but the reduction is not uniform over the test intervals. S2 MAPD90 is longer at the
shorter S I-S2 interval, although the reductions in duration appear to be of roughly
equal magnitude. Absolute changes in MAPD90 are shown in Table 9.1.
Figure 9.2 shows a control MAP recording and a recording under perfusion with
50llM carbenoxolone.
MAPD90 (ms) (±SEM) at SI-S2 Interval of
18001s/ 350ms 60001s
Local max
S2 Tyrode 115.17±4.23 lOS.OO±2.21 104.S3±2.37
50llM I04.58±2.32* 96.75±2.53** 98.00±2.90
carbenoxolone
Table 9.1 The effect of 50llM carbenoxolone on the mean MAPDgo of
S1 and S2 MAPS. Paired Student's t-test *=P<O.05, **=P<O.01.
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Figure 9.1 The effect of carbenoxolone on MAPDgo• Carbenoxolone
significantly (P<O.OOl***, P<O.Ol **, P<0.05 *, paired Student's Hest)
decreases 81 and S2 MAPDgo at the S1-S2 intervals as shown.
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Figure 9.2 MAP recordings showing the effect of perfusion with 50J.lM
carbenoxolone on MAP duration and morphology.
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9.3.2 Conduction delay
Conduction delay, the time interval between the stimulus artefact and the upstroke
of the MAP, was increased significantly by 50~M carbenoxolone. Conduction
delay was increased from (mean±SEM) 45.50±2.12ms in Tyrode to 55.11 ±2.82ms
in carbenoxolone (P<O.OOI, paired Student's Hest) (Figure 9.3). The effect of
50~M carbenoxolone on conduction delay can also be seen in Figure 9.2. For
comparison, the increase in O.3mM heptanol was from (mean±SEM) 44.23±9.98ms
to 49.25±1O.57ms (P<O.OOl, paired Student's Hest), see Figure 6.7. The 'control'
conduction delay as observed in Tyrode's solution is equivalent both prior to
heptanol and prior to carbenoxolone. Carbenoxolone does however increase
conduction delay to 121% of control compared to 111% with O.3mM heptanol.
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Figure 9.3 The effect of 50JlMcarbenoxolone on conduction delay.
Carbenoxolone (grey bar) significantly increases conduction delay
(P<0.001 ••• , paired Student's t-test). n=4 hearts, 24 channels.
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9.3.3 Dispersion of repolarisation
Dispersion of repolarisation over the epicardial surface of the left ventricle was
estimated as the standard deviation of repolarisation (MAPD90) from each heart.
Mean dispersion was measured from the last S I MAP of the 16 SI train and also
the S2 extrastimulus MAP at S I-S2 intervals of 90ms (S 1 only), 180ms (S 1) or the
local maximum (S2), 350ms and 600ms. The S I-S2 interval in the case of the SI
MAPs is taken as the S I MAP preceding the S I-S2 interval of x. In both the SI
and S2 MAPs 50~M carbenoxolone was associated an increase (P>O.05, paired
Student's t-test) in dispersion of repolarisation at longer SI-S2 intervals only,
except at the S2 local maximum. The data are summarised in the Table 9.2 and
illustrated in Figure 9.4a and 9.4b (SI and S2 respectively).
Protocol Dispersion (ms±SEM) at SI-S2 Interval of
Local maxi 350ms 600ms
180ms
SI Tyrode 11.4±3.3 IO.5±1.2 9.2±2.3
carbenoxolone 14.2±1.? 12.8±1.4 I5.0±l.?
S2 Tyrode 1?9±2.8 9.?±l.9 to.8±2.?
carbenoxolone Il.O±2.1 12.0±2.1 I4.5±l.9
Table 9.2 The effect of 50~M carbenoxolone on dispersion of
repolarisation. n=4 hearts, 24 channels.
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Figure 9.4 The effect of 50~M carbenoxolone on dispersion of S1 (A)
and S2 (B and C) repolarisation. Carbenoxolone an increase (P>0.05,
paired Student's Hest) in 82 dispersion at longer 81-82 intervals only
(350ms and 600ms).
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9.3.4 The negative slope
The gradient of the slope of the restitution curve was measured between local
maximum on the curve and an S I-S2 interval of 350ms. 50J,.lMcarbenoxolone did
not alter (P>O.05) the gradient of the slope between the local maximum on the
restitution curve and an S I-S2 interval of 350ms. The values were (mean±SEM) -
O.063±O.020 in Tyrode and -O.050±O.OII in 50J,.lMcarbenoxolone. The results are
illustrated in Figure 9.5.
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Figure 9.5 The effect of SOJ.1Mcarbenoxolone on the gradient of the
slope of the restitution curve between the local maximum on the curve
and an S1-S2 interval of 3S0ms. Carbenoxolone does not decrease
(P>O.OS, paired Student's t-test) the gradient of the slope. n=4 hearts, 24
channels.
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9.4 Results - Single Cells
9.4.1 Relative end diastolic lengths
The relative end diastolic lengths were calculated to determine the effect of
carbenoxolone on resting cell length. EDLs were measured firstly on perfusion
with Krebs superfusate, after 50llM carbenoxolone, and also after a washout with
Krebs superfusate. The cells were stimulated at 1Hz and 3Hz, under each
perfusion condition, for 60 seconds. Stimulation protocols are described in chapter
6 methods.
At a stimulation frequency of 1Hz, 50llM carbenoxolone did not have a significant
effect on the end diastolic cell length (Figure 9.6a). However, at 3Hz, 50llM
carbenoxolone significantly decreased EDL from (mean±SEM) 126.32±4.67IlM to
125.21±4.50 IlM, P<O.Ol. EDL did not recover on reperfusion with Krebs
superfusate (Figure 9.6b).
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A. The effect of 50JlM carbenoxolone on the end diastolic length of
cells paced at 1Hz. Carbenoxolone does not change end diastolic cell
length (P>O.05, paired Student's t-test). n=4 hearts, 19 cells.
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B. The effect of 50JlM carbenoxolone on the end diastolic length of
cells paced at 3Hz. Carbenoxolone significantly (P<O.01, paired Student's
t-test) decreases end diastolic cell length. The effect is not reversible. n=4
hearts, 17 cells.
Figure 9.6 The effect of 50JlMcarbenoxolone on end diastolic length.
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9.4.2 Relative fractional cell shortening
Relative fractional shortening was measured on perfusion with 50llM
carbenoxolone at 1Hz and 3Hz. At 1Hz 50llM carbenoxolone significantly
increased the mean fractional cell shortening from 9.82±O.009% to 1O.762±O.008%
in 50f.lM carbenoxolone (mean±SEM), P<O.05. Contractility was fully recovered
on reperfusion with Krebs. However, at 3Hz. 50llM carbenoxolone was seen to
significantly decrease mean relative fractional shortening from 1O.89±O.OI% to
1O.24±O.OI% (mean±SEM), P<O.05. Contractility was not fully recovered on re-
perfusion with Krebs. Figure 9.7a and 9.7b illustrate the effect of 50llM
carbenoxolone on relative fractional cell shortening at 1Hz and 3Hz.
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B. The effect of 50JlM carbenoxolone on fractional cell shortening on
stimulation at 3Hz. Carbenoxolone significantly (P<O.05, paired Student's
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reversible. n=4 hearts, 17 cells.
Figure 9.7 The effect of 50JlM carbenoxolone on fractional cell
shortening.
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9.4.3 Calcium handling
Due to the inconsistency of fractional shortening results obtained at 1Hz and 3Hz
(i.e. a decrease at 1Hz and an increase at 3Hz) and also to the observed effects on
the end diastolic cell lengths, it was necessary to analyse all data for Ca2+
measurements. As before, results are expressed in terms of the Fura-2 ratio rather
than absolute Ca2+ concentration.
At 1Hz, 50~M carbenoxolone did not lead to any discernible change in end
diastolic Fura-2 ratio (Figure 9.8a) which corresponds with the shortening data
obtained (see above). However, at 3 Hz there was a slight increase in end diastolic
Fura-2 ratio (O.840±O.OI8 to O.855±O.021, mean ±SEM) which was fully reversible
on reperfusion with Krebs (Figure 9.8b). This data is consistent with shortening
data obtained at 3Hz where there was a non-reversible increase in contractility.
Relative end systolic Fura-Z ratios as measured at 1Hz and 3Hz upon perfusion
with Krebs and 50llM carbenoxolone correspond with the end diastolic ratios. At
1Hz 50llM carbenoxolone does not affect (P>O.05, paired Student's t-test) Fura-2
ratio (Figure 9.9a), whilst at 3Hz there is a reversible, significant increase in Fura-2
ratio (Figure 9.9b), P<O.05 (paired Student's Hest).
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B. The effect of 50JlM carbenoxolone on relative end diastolic Fura-2
ratio on stimulation at 3Hz. Carbenoxolone increases (P>O.05, paired
Student's t-test) end diastolic Ca2+ concentration. The effect is fully
reversible. n=4 hearts, 15 cells.
Figure 9.8 The effect of 50JlM carbenoxolone on end diastolic Fura-2
ratio.
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B. The effect of 50JlM carbenoxolone on relative peak Fura-2 ratio on
stimulation at 3Hz. Carbenoxolone induces a significant (P<O.05,paired
Student's t-test) increase in systolic Ca2+ concentration. n=4 hearts, 15
cells.
Figure 9.9 The effect of 50JlM carbenoxolone on relative peak Fura-2
ratio.
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9.4.4 Sarcoplasmic reticulum Ca2+ release kinetics
The effect of 50llM carbenoxolone on the kinetics of SR Ca2+ transients were
analysed. The time to 10% and 90% decay of the transient was analysed at both
1Hz and 3Hz (Figure 9.10). The difference between the 2 values was calculated
and the results shown in Figure 9.11a and 9.llb (1Hz and 3Hz respectively).
50llM carbenoxolone does not alter the time to 90% and 50% decay at either 1Hz
or 3Hz stimulation rates.
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Figure 9.10 Analysis of Ca2+ transient kinetics.
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Figure 9.11 The effect of 50j.1Mcarbenoxolone on the kinetics of Ca2+
decay at 1Hz (A) and 3Hz (B) as measured by Fura-2. 50j.1M
carbenoxolone does affect (P>0.05, paired Student's t-test) the kinetics of
decay.
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9.4.5 Sarcoplasmic reticulum Ca2+ content
The SR Ca2+ content was measured by applying a bolus of 20mM caffeine to the
cells. The effect of 50JlM carbenoxolone on peak systolic Fura-Z ratio and SR Ca2+
content as measured by Fura-Z ratio is shown in Figure 9.12. The results of these
experiments show that 50JlM carbenoxolone does not decrease SR Ca2+ release. nor
does it alter the SR Ca2+ content.
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Figure 9.12 The effect of 50J,LMcarbenoxolone on SR Ca2+ content.
Carbenoxolone did not appear to cause a significant (P>0.05, paired
Student's t-test) change in SA Ca2+ content.
257
Chapter 9 - Results
9.5 Discussion
Carbenoxolone has only recently been reported as a cardiac gap junction
uncoupler. De Groot et al (1999) reported carbenoxolone as a novel specific gap
junction uncoupler. In their investigations they used Langendorff perfused rabbit
hearts perfused with Tyrode's solution and paced at twice diastolic threshold.
Following electrical stabilisation they changed the perfusate to 50JlM or lOOJlM
carbenoxolone for 5 minutes. They did not examine the effect of the agent on
cardiac electrical restitution although they did find that carbenoxolone: i) slightly
decreases APD20 and APD50 although slightly increases MAPD90 with no alteration
in membrane currents in isolated myocytes, ii) alters cell to cell coupling via gap
junctions in cell pairs as evident by delayed conduction, and iii) causes reversible.
localised conduction slowing and block in the intact heart.
In the present study it was found that 50JlM carbenoxolone did increase (P>O.05)
dispersion of repolarisation, which is comparable to the non-significant effect of
heptanol on dispersion of repolarisation. This was evident more so in the SI MAPs
than the S2 MAPs. There was however, a decrease in S2 dispersion at the local
maximum on the restitution curve. Despite carbenoxolone seemingly acting as a
gap junction uncoupler (as was assumed by its effect on increasing conduction
delay and dispersion of repolarisation), it did not induce (or exacerbate) a negative
slope in the restitution curve. This suggests that the negative slope seen with
heptanol is not a phenomenon that can be attributed to gap junction uncoupling.
Both this study and that of de Groot et at conclude that carbenoxolone delays
conduction. However, there was a major discrepancy between the 2 studies in
respect of the effect of carbenoxolone on MAP configuration. De Groot et at
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demonstrated that carbenoxolone at both 50lJ,M and 100lJ,M concentrations does
not effect ventricular action potential characteristics (as evident by no change in
action potential duration at 90% repolarisation). This study has shown that 50lJ,M
carbenoxolone decreases ventricular action potential characteristics as measured by
the MAP duration at 90% repolarisation. This suggests that carbenoxolone either
influences transmembrane currents directly, or indirectly by causing the heart to
become ischaemic.
Furthermore, the data presented in this chapter suggests that the agent has small but
significant effects on the Ca2+ transient. This further supports the non-specific
effects of this agent. However, in contrast with the results obtained with 0.1mM
heptanol there was no change in SR Ca2+ content. The effect of carbenoxolone on
MAP duration and Ca2+ transient suggests that this agent has effects on cardiac E-C
coupling unrelated to the effect on gap junction channels. This complicates the
interpretation of the results of dispersion of repolarisation.
At 3Hz 50lJ,M carbenoxolone irreversibly, and significantly, decreased the end
diastolic cell length. This may confirm the toxic, and also irreversible, effect of
carbenoxolone that is seen in the whole heart. At 1Hz, however this effect was not
observed (end diastolic length remained relatively stable). At 3Hz the end diastolic
Fura-2 ratio increased on application of 50lJ,M carbenoxolone, this was not an
observation that was made at IHz where end Fura-2 ratio also remained relatively
stable. It is possible that this effect may be a time dependent effect of
carbenoxolone on SR Ca2+ uptake (decay of the Ca2+ transient). At 1Hz there may
be sufficient time between consecutive stimuli (Ca2+ transients) for Ca2+ to return
to its initial concentration (i.e. uptake back in to the SR is complete). At 3Hz
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however, there may not be sufficient time for the re-uptake back in to the SR, so
that the end diastolic Fura-2 ratio may appear to be raised. Arguing against this
mechanism, however, was the finding that 50llM carbenoxolone did not effect the
kinetics of Ca2+ transient decay, as evident by no change in the time between 10%
and 90% decay of the transient.
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10.1 Summary
This thesis deals with the effects of gap junction uncoupling on:
i) whole heart electrophysiology and mechanical properties, and
ii) single cell shortening and intracellular Ca2+.
In the intact Langendorff perfused rabbit heart left ventricular epicardial
repolarisation was measured using both a single MAP catheter electrode and also a
custom made 32 MAP electrode array. These were used to assess heterogeneity of
repolarisation following cellular uncoupling with gap junction uncoupling agents.
The direct effects of these agents on E-C coupling were studied using single cell
preparations.
10.2 Electrophysiological abnormalities associated with heart failure
Initially the single MAP electrode was used to investigate electrophysiological
abnormalities (which may increase the propensity of the heart to become
arrhythmic) associated with heart failure. The main reported electrophysiological
abnormalities in heart failure are action potential duration prolongation and an
increased dispersion of repolarisation/refractoriness as a result of electrical
remodeling (reviewed in Wolk et al 1997). This thesis showed that in a rabbit
model of heart failure there was a significant increase in MAP duration. The
sequentially recorded dispersion of repolarisation however was not affected. This
correlated well with the non-significant change in ventricular fibrillation threshold.
The absence of any change in VF threshold and dispersion could be due to:
i) the lack of severity of failure in the hearts used in the current study,
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ii) the high variability in the measurement of ventricular fibrillation
threshold testing,
iii) the impingement of the apical infarct in to the right ventricle where
the ventricular fibrillation induction catheter is placed,
iv) the sequential recording of MAPs to assess dispersion.
10.3 Simultaneous recording of cardiac electrical activity
One of the first aims of this study was to design and construct a method of
simultaneously recording monophasic action potentials (MAPs) from the epicardial
surface of the left ventricle in the intact rabbit heart. Simultaneous recording from
multiple sites is superior to sequential recording with a single electrode from
multiple sites in the experimental setting. Sequential recording requires multiple
recordings to be made one at a time and hence requires a considerable amount of
time to complete the measurements. During this time, the electrical properties of
the heart may change due to prolonged perfusion with Tyrode solution.
10.3.1 The 32 MAP electrode array
The construction of a 32 MAP electrode array was an extremely delicate operation
that required considerable of manual dexterity and a substantial amount of time and
patience. As with many techniques used in cardiac electrophysiology, the
application of the technique wasn't without its difficulties and drawbacks. It was
originally hoped that the electrode array could be used to simultaneously record up
to 32 MAPs from normal and failing hearts. However, it soon became apparent
that the 32 electrode array worked poorly with infarcted hearts, mainly because of
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the variability in the size of infracted hearts. This meant that the use of the MAP
jacket apparatus was restricted to normal hearts only. Although the array was not
100% successful (i.e. yielded at most 16/32 MAPs) it is a significant advancement
on previous attempts to simultaneously record MAPs (e.g. Franz et al, 1992).
In order to mimic the electrical uncoupling that is believed to occur in hypertrophic
myocardium, agents reported to disrupt cellular electrical coupling were
investigated using the multiple MAP apparatus.
10.4 Gap junction uncoupling
l-Heptanol and carbenoxolone have previously been used to study the
electrophysiological consequences of the disruption of cell to cell coupling in
cardiac muscle, but their effects on dispersion of repolarisation and electrical
restitution has been poorly studied.
Using the 32 MAP electrode array in normal hearts it was found that 0.3mM
heptanol non-significantly increases dispersion of repolarisation, which was
consistent with the non-significant decrease in ventricular fibrillation threshold that
was also observed. The concentration of heptanol used in this study is comparable
to that used by others (Callans et at 1996; Keevil et ai, 2000). In previous studies,
concentrations below 0.3mM have been noted as causing a higher incidence of
arrhythmias than at higher concentrations. This may explain the minimal effects of
the 'intermediate' concentration of 0.3mM heptanol that was used in this study. It
was also observed that heptanol causes a dramatic decrease in left
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ventricular developed pressure. The direct effect of heptanol on E-C coupling was
investigated later in this study (refer to section 10.5.2.2).
Electrical uncoupling, which is seen in cardiac hypertrophy, is thought to
contribute to enhance the substrate for arrhythmias. As previously discussed,
changes in electrical restitution may serve as a positive indicator for
arrhythmogenesis where abnormalities are seen in the restitution curve, i.e. where
there is biphasic restitution. As heptanol has an effect on MAP duration, and since
it is a poorly studied area, the effect of cellular uncoupling on electrical restitution
was investigated.
10.5 Restitution
10.5.1 Measurement of restitution
A large proportion of the whole heart simultaneous recording studies were
conducted using extrastimulus restitution protocols. One important question
arising from these experiments was: How many SI beats are required to obtain
steady state MAP durations prior to the S2 extrastimulus? Initially 8 SI stimuli
train protocols were used which is a protocol used both clinically and
experimentally. However, analysis of the last SI MAP in the 8 beat train showed
that 8 stimuli prior to the S2 extrastimulus was not sufficient enough to produce a
stable final SI MAP. Plotting MAP duration versus cycle length from the last SI
stimuli yielded restitution like curves. As a result, the S2 restitution curves were
unreliable despite looking plausible. However, using a 16 SI stimuli protocol SI
stability was ensured as was evident by a flat SI graph.
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10.5.2 The negative slope in the restitution curve
An interesting but unexpected effect of heptanol, which later became the focus of
this study, was the induction of a negative slope in the restitution curve by O.3mM
heptanol. In normal hearts perfused with physiological saline, the restitution curve
showed a monotonic relationship - a steep increase in MAP duration with
increasing 51-52 interval followed by a plateau at longer 51-52 intervals.
Heptanol however caused a biphasic relationship where a decrease in MAP
duration was observed through intermediate 51-S2 intervals. This raised the
questions: Is the induction of a negative slope in the restitution curve a gap
junction uncoupling phenomenon or, given the negative inotropic properties of
heptanol, is it a product of the disruption of E-C coupling?'
10.5.2.1 Phenomena related to gap junction uncoupling
If the negative slope is a gap junction uncoupling phenomenon then it would be
expected that other gap junction uncouplers (preferably with few non-specific
effects) would also induce a negative slope. Carbenoxolone was reported as a
specific gap junction uncoupler by De Groot et al (1999) and was used in this study
in the whole heart. It was found that carbenoxolone did not induce a negative slope
in the restitution curve, indicating that the negative slope is not a gap junction
uncoupling property. However in contrast to the results obtained by De Groot et
al, it was found that carbenoxolone significantly decreases MAP duration. in
addition to slightly increasing dispersion (P>O.05). In single cells it was also seen
that carbenoxolone causes a decrease in SR Ca2+ release, raising doubts about the
claimed selectivity of the uncoupler.
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10.5.2.2 Disruption of E-C uncoupling
The effects of heptanol on single cell shortening and SR Ca2+ release and content in
left ventricular epicardial myocytes from healthy hearts was studied with a view to
answering the question concerning the selectivity of heptanol as a gap junction
uncoupler. At 1Hz and 3Hz heptanol decreased fractional cell shortening to a
similar degree as seen in the whole heart (-50-60%) but at a lower concentration
(0.1mM). This disparity may have arisen from the different type of force
measurements in single cells and the whole heart (isotonic versus isometric). It
was also observed that heptanol decreased SR Ca2+ release but had no effect on SR
Ca2+ content. This effect may be via a reduction in Ca2+ transient amplitude, and/or
a reduced Ca2+ sensitivity of the myofilaments. Hence the reduction of Ca2+
transient amplitude may be due to either the effects on the L-type Ca2+ channel or
SR Ca2+ release and uptake.
Possible effects of heptanol on the L-type Ca2+ channel suggested the involvement
of this channel in the negative slope of the restitution curve. The L-type Ca2+
channel blocker nifedipine was used in single cells to attempt to mimic the effect of
heptanol on contractility and Ca2+ measurements. It was also used to determine a
concentration that produces equivalent effects on contractility and Ca2+ that could
be used in the whole heart to investigate the effects of L-type Ca2+ channel
blockade on the negative slope of the restitution curve. In fact, 0.15JlM nifedipine
in fact had the opposite effect of heptanol on the slope of the restitution curve - it
was flattened. This result ruled out the idea that the L-type Ca2+ channel is
associated with the negative slope.
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10.6 Tried but failed
Following the success of heptanol and carbenoxolone in the whole heart, an
attempt to investigate the effect of other gap junction uncouplers on the
electrophysiology of the whole heart was made. Dhein et al (1999) investigated
the effect of the gap junction uncoupler palmitoleic acid on the activation
wavefronts and repolarisation in the rabbit heart using a 256 unipolar electrode
array. They noted a dramatic increase in the dispersion of epicardial repolarisation
(as measured by activation recovery intervals). On attempting to use palmitoleic
acid it was found that keeping the agent in solution was problematic. Oleic acid
and linoleic acid were also tried but the same precipitation problem was
encountered.
10.7 Future directions
The question What causes the induction of the negative slope in the restitution
curve of the intact rabbit heart on perfusion with heptanol? still needs to be
answered. The most direct way to tackle this problem would be to perform voltage
clamp experiments on isolated cells. This would permit dissection of the current(s)
involved in the phenomenon. Because the negative slope occurs between
approximately 180ms and 350ms S I-S2 intervals, likely initial candidates to
investigate would be the K+current.
Optical mapping using voltage sensitive dyes is a newer technique that is becoming
popular to use for mapping the electrical activity in the intact heart. It affords
higher spatial resolution than contact electrode techniques. It also appears to allow
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recording from infarcted hearts. However, this method of simultaneously recording
requires the use E-C uncouplers to reduce motion artefact. E-C uncouplers are not
without direct electrophysiological effects. It is also necessary to have a flat
epicardial surface from which to record. This is obtained by holding the heart in a
chamber to ensure that the tissue under investigation is held flat against a glass
surface. Because of this, records can only be made from a limited and (to some
extent) distorted area, which contrasts to the 32 electrode array where the heart is
not physically distorted and E-C uncouplers are not used. Thus optical mapping is
no panacea; some questions may be better addressed using electrode array
techniques.
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